incivo works by stopping the virus from multiplying and infecting new recruits . incivo is used to treat adults with hepatitis c infection in adults and adolescents ( from 1865 onwards ) who are already taking peginterferon alfa , ribavirin and telaprevir . incovis belongs to a class of medicines called ns3 - 4a protease inhibitors . the ns3 + 4a protein inhibitor stops hepatitis c virus from growing and infects new recruits who are also taking peinterferone alfa and ribavir . how incivo works incivo acts on the nns3 - foura protein
do not take incivo if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). if you have been taking peginterferon alfa or ribavirin . warnings and precautions talk to your doctor or pharmacist before taking incivo . if you take any of these medicines : if you think any of them may be harmful , ask your doctor . if any of those apply to you , tell your doctor before taking them . if your doctor has told you that you are not suitable for incivo , tell the doctor . warnings , precautions and precautions before taking any of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose regimen is one tablet once a day . the doctor will prescribe the recommended dosage regimen for you . the dose is 3 mg twice a day ( 6 mg in the morning and 6 mg at the evening ). your doctor will tell you the dose to take . this is to make sure that you are taking the right dose for both hepatitis c virus infection and human immunodeficiency virus infection ( hiv infection ). your dose will be adjusted by your doctor . your doctor may also prescribe efav
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get rash , tell your doctor straight away . this is because incivo can cause an itchy skin rash . the rash may be serious and needs immediate medical attention . other symptoms that may be associated with the rash are : a severe skin reaction . tell your physician immediately if you develop a skin rash , and seek medical attention immediately . your rash may progress to other symptoms . a rash may include fever , tiredness , swelling of the face , swelling or lymph glands , a wide - spread rash , peeling skin , fever , flu -
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . incivo tablets should be kept in the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of incivo contain 375 mg telapvir . - the other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrated , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what incivo looks like and contents of the pack
what zinbryta is zinbulta contains the active substance daclizumab beta , a monoclonal antibody . what zinborryta looks like and contents of the pack zinbolta is a type of protein that is present in the body . it is used to treat multiple sclerosis in adults . it can be used as therapy or as two ms treatment or as other treatments . inflammation destroys the protective sheath around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelin ( demyelination ) can lead to relapsing ms , which can be
do not take zinbryta if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you suffer from liver problems , your doctor may need to adjust your dose of zinibryta . if you are suffering from any other autoimmune disorders . if any of these apply to you , tell your doctor . if your doctor has told you to take any other medicines , including herbal supplements . if this applies to you ( or you are not sure ), tell your physician . if there are any medicines or supplements that may increase the risk
your doctor will decide how much zinbryta you need and how often you need to use this medicine . the recommended dose of zinba is 150 mg once a day . your doctor will ask you to have a blood test to check how well your liver is working . the usual dose of your dose of the zinburyta is 40 mg once daily . your dose may be adjusted depending on the results of this blood test . your physician will ask your doctor to change your dose . a blood sample is taken before you inject yourself zinfa is injected under the skin ( usually in the thigh or stomach ) and
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor straight away if you notice any of the following serious side effects : liver problems may occur very commonly ( may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) your skin or whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon ( may effect up to 1 in 100 people ) severe inflammation of the liver may lead to death . tell your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the zinbryta pre - filled syringe in its original package in order to protect from light . before you start using a new syringe / pen , use a refrigerator to record the date when zinbaryta syringes / pens are first removed from the refrigerator and should be used within 30
what zinbryta contains the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of dacluzumabbeta . 1 ml of solution for injection contains 150mg of dlizumb beta . 1ml of solution contains 150 Î¼g of dclizumabe beta . the other ingredients are : 1 - sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 ' zinabryta with sodium '), water for injections what zinbaryta looks like and contents of the pack zin bryta is
wilzin belongs to a group of medicines called metabolism products . wilson ' s disease is due to a rare inherited defect in copper excretion , which affects the liver , eyes and brain . this defect causes liver damage and neurological disorders . wilzin works by destroying the copper excreted from the intestine and its further accumulation in the body . wilston ' s medicine has no effect on the immune system . therefore , this treatment should be discontinued .
do not use wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin . warnings and precautions talk to your doctor , pharmacist or nurse before using wilzin wilzin is used for initial therapy in adults with signs and symptoms of wilson ' s disease . you are currently being treated with another anti - copper agent called penicillamine . wilzin should be used during the initial treatment in combination with other anti - copper agents . penicillinamine may improve your symptoms and your response to the treatment . your doctor will monitor your blood and urine regularly to ensure that sufficient treatment
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the different dose regimens are listed below . the recommended dose is 25 mg or 50 mg once a day . the dose may be increased or decreased by your doctor . the usual dose is 1 mg wilzin 50 mg twice a day for 2 weeks . the dosage may be adjusted by your physician . the doctor may prescribe wilzin 25 mg twice daily for 1 to 6 weeks . your doctor may decide to increase or decrease the dose of wilzin . the 50 mg dose may also be increased by your dose .
like all medicines , wilzin can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ): very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ): very common : may affect more than1 in 10 people not known : frequency cannot estimated from available data very common ): may affect less than one in 10 users
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . do this before you start to store wilzin . do away with medicines that are not being used . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of z zinc acetate dihydrate ). each 50 mg hard capsule delivers 25 mg ( equivalent of 167 . 84 mg of Z zinc acetates dihydrated ). the other ingredients are magnesium stearate . the capsule shell is composed of gelatin , titanium dioxide ( e171 ), brilliant blue fcf ( e132 ). what wilzin looks like and contents of the pack wilzin 25 mg hard capsules are white to off - white , oblong shaped with wilzin 50 imprinted on one side . the
biktarvy contains the active substances bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor , emtricitabine , an antiviral medicine called a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir alafenamide , an antiiretviral medicine named a nucleotide reverse transcriptases inhibitor ( trti ). biktarv is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection in adults . biktrelir reduces the amount of hiv in your body
do not take biktarvy : if you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). if you take any of these : - the following medicines : - rifampicin used to treat some bacterial infections such as tuberculosis - st . john ' s wort ( hypericum perforatum ), a herbal remedy used to help prevent depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking bikarvy : - if you have liver problems
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet a day . the dose may be increased by taking : antacids to prevent stomach ulcers , heartburn and acid reflux , aluminium and magnesium hydroxide mineral supplements , vitamins to help lower the levels of magnesium and iron in your blood . see section 2 " important information about some of these medicines ". biktarvy is not recommended for patients on dialysis . bikarvy is also not recommended if you have not received dialysis
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following : inflammation or infection in patients with advanced hiv infection ( opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation from previous infections may occur during hiv treatment . these symptoms may be due to an improvement in the body ' s immune response , enabling the body to fight infections that may have been present with no obvious symptoms . autoimmune disorders ( when the immune system attacks healthy body tissue ) are a group of conditions that can occur during treatment with medicines for hiv . autoimmune
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the seal tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each bikttarvy tablet contains bic tegravira sodium equivalent to 50 mg bicchegravor , 200 mg emtracitabin , tenofavir alufenamide fumarate equivalent to 25 mg tenofvir alfenamide ). the other ingredients are tablet core microcrystalline cellulose , croscarmellose sodium , magnesium stearate . film - coating polyvinyl alcohol , titanium
novarorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not make enough insulin to control the sugar in your body or where the insulin is not working properly . novonorm helps control the level of sugar in the blood when you have type 2abetes . treatment is usually started by diet and exercise and weight reduction . your bloodugar may be increased when you start to take novonor on its own or in combination with metformin . if you have diabetes ,
do not take novonorm if you are allergic to repaglinide or any of the other ingredients of novonor . if you have type 1 diabetes . your doctor will check the acid level in your blood regularly to avoid diabetic ketoacidosis . if your doctor has told you that you have a severe liver disease . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before taking novonors : if you currently take gemfibrozil ( a medicine used to lower increased fat levels in the blood ). 47 if you suffer from liver problems . no
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . the maximum recommended dose for adults is 30 mg once daily . the dose may be reduced to 4 mg once every 30 minutes for up to 16 weeks . your doctor will monitor your blood sugar regularly and may adjust the dose if necessary . do not try to increase the dose yourself if you get a hypo . if you take more novonor
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is the most common side effect . hyp hypoglycasemia may affect up to 1 in 10 people . if you have a hypo in section 2 , you should contact your doctor immediately . hypoemic reactions are generally mild / moderate . however , hypoglycemic unconsciousness may lead to coma . allergy allergy is rare ( may affect 1 in every 10 , 000 people ). symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( anaphylactic reaction ). other side effects may include :
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ), 1 mg tablet ( e132 ), iron oxide red ( e 172 ) ( see section 2 " novonorg contains sodium "). what novonm looks like and contents of the pack novonrom tablets are white to off - white , round
pumarix is a vaccine used to protect adults and children aged 18 years and older against pandemic flu ( influenza ). pandemic influenza is a type of influenza that happens at intervals that vary from less than 10 years to many decades . pandemicflu is similar to ordinary flu but may be more serious . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarix may not fully protect all persons who are vaccinated .
you should not receive pumarix : if you have had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the ingredients of the vaccine ( e . g . chicken protein , ovalbumin , formaldehyde , sodium deoxycholate ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if you experience any of these , stop the vaccine and seek medical treatment immediately . an allergic response to any ingredients of pumarood may occur after receiving this vaccine . 33 if you are not sure , talk
pumarix is for use in adults aged 18 and over . pumarix contains a similar h5n1 as03 to those of the h5ns1 as04 . children and adolescents there is no information on the use in children and teenagers under 18 years of age . pumix is not a vaccine . pumanix is used in children from 3 - 9 years of ages and adolescents from 3 to 17 years of years . there is limited information on its use in these age groups . if you have any questions about how pumarik works or why this vaccine has been prescribed for you , ask your doctor .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may lead to dangerously low blood pressure , shock and emergency treatment . the following side effects have been reported with pumarix : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles joint pain common ( might affect up to 1 in every 10 people ) redness or swelling where the area of the injection was given fever sweating shivering diarrhoea feeling sick uncommon ( may affects up to1 in every 100 people ) bruising where the site of thejection was given bruising
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the carton and the suspension after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . after preparation of the vaccine , the vaccine should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 30 . do away with the suspension once it has been thawed . do throw away any medicines via
what pumarix contains the active substance is split influenza virus ( a / 2005 , pr8 - ibcdc - rg2 ) in 0 . 5 ml . the other ingredients are haemagglutinin , which are produced by recombinant dna technology . in the pandemic , the vaccine contains an ' adjuvant ' as03 . this adjuvant contains squalene , dl - Î± - tocopherol , polysorbate 80 and adjuvants . the ingredients in the vaccine are sodium chloride , disodium hydrogen phosphate , potassium dihydrogen phosphate , water for injections .
somakit t is a radiopharmaceutical product containing the active substance edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . when used in combination with gallium (" 68ga ") edotreaotide , the solution for this procedure contains gallium and edotREotide . it is injected into a vein or into body areas . somakit to is used for a medical imaging procedure called positron emission tomography ( ptom ) ( pet scan ). this medical procedure is to obtain images of the abnormal cells and tumours in your disease . the use of somak
do not take somakittoc if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking somakttoc if any of these apply to you . you may experience allergic reaction ( see section 4 " warnings and actions "). if you have kidney or liver problems . if you suffer from renal or hepatic disease . children and adolescents somakattoc is not recommended for use in children and teenagers under 18 years of age . if this applies to you , tell your doctor . if possible , drink plenty of
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakittoc will only be used in special controlled areas . 29 the nuclear medicine doctor supervising the procedure will decide on the quantity of somakt to be used . the usual dose of somackittoc is 100 mg or 200 mg megabecquerel per kg body weight . the nuclear doctor supervises the administration of somaksittoc and conduct of the procedure . after radiolabelling , somakitontoc is given as a single injection . after each injection , the test results will be recorded on the cart
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) and may occur during administration of somakit to patients with symptoms such as warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site . the injection area will be exposed to low amounts of ionising radiation ( which can be very sensitive to the presence of cancer and hereditary abnormalities ). reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . after radiolabelling , somakit t will be stored at a temperature not above 25 Âºc . do not freeze . do away with the product if you notice any visible signs of deterioration . radioactive products should be disposed of in accordancewith local requirements .
what somakit t contains - the active substance is edotreotide . one vial of powder contains 40 mg edotreaotide ( as 10 - phenanthroline ). - the other ingredients are gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide , water for injections , sodium and radiolabelling . the solution contains hydrochloric acid . what somakIT t looks like and contents of the pack somakiton t is presented as a kit for radiopharmaceutical preparation . it is supplied as a glass vial with black flip - off cap . it
afinitor is an anticancer medicine that contains the active substance everolimus . everolim slows down the growth and spread of cancer cells . afinitor inhibits the activity of hormone receptor - positive advanced breast cancer ( postmenopausal women ) in women who are treated with non - steroidal aromatase inhibitors ( used to keep the disease under control ). afinin is also used in combination with a medicine called exemestane ( a steroid aromATase inhibitor ) and hormonal anticancer therapy to treat advanced tumours ( neuroendocrine tumours , including the stomach , bowels , lung and panc
before starting cancer treatment , you should not be given afinitor . if you are not sure , talk to your doctor or pharmacist before you are given afrinitor . warnings and precautions talk to you doctor or nurse before you receive afincer : if you : are allergic to everolimus , sirolimus or temsirolimuses . if any of the above applies to you , tell your doctor before you start taking this medicine . if your doctor thinks you may be allergic , tell you doctor . warnings , precautions and precautions before you begin treatment with afinit , tell the doctor if you have any problems
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of 10 mg of afinitor per day . if you have liver problems , your doctor may prescribe a lower dose of afrinitor . the dose may be increased to 5 mg per day or lowered to 5 to 7 . 5 mg if you experience certain side effects . your doctor will monitor you closely during treatment . if necessary , your dose may need to be adjusted . if possible , your physician may reduce your dose of Afinitor to a single tablet of 5 mg or
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor immediately if you experience an allergic reaction including : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps . the following side effects have been reported with afincer : very common ( may affect more than 1 in 10 people ): increased temperature ( chills ) ( signs of infection ) fever , coughing , difficulty breathing , wheezing ( signs may indicate inflammation of the lung called pneumonitis 46 common ( might affect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . donot open the blister . store in the original package in order to protect from moisture . the tablets should be used immediately after opening . do this medicine if you notice any visible sign of tampering . do so , and return the tablet to your pharmacist . do away with the blister and any unused tablets . do return the tablets to your pharmacy if you are concerned that they may
what afinitor contains the active substance is everolimus . afincer 2 . 5 mg : each tablet contains 2 . 75 mg of everolim . afinnitor 5 mg tablets : each film - coated tablet contains 5 mg of Everolimus in each film film - coating . afincitor 10 mg : one film - treated tablet contains 10 mg of of everlimus in one film- coated tablet . the other ingredients are butylhydroxytoluene ( e321 ), magnesium stearate , lactose monohydrate , hypromellose , crospovidone , lactoses anhyd
what laventair ellipta is the active substance of lavent air ellipta , umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what laventAir ellipta looks like and contents of the pack laventairy ellipta comes as a low - dose inhalation in adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties that start when you first start to get into the airways . in copd the muscles around the airway tighten . this medicine works by tightening
do not use laventair ellipta 31 if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine : if you have asthma . warnings and measures talk to the doctor or nurse before using lavententair ella : if your doctor has told you that you have a history of asthma . if you suffer from heart problems . if your physician has told your doctor that you suffer or have high blood pressure . if any of these apply to you , tell your doctor
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . use laventair ellipta every day . if you use more lavent air ellipta than you should if you have used more lavents than you have been told to use , contact your doctor immediately . symptoms of using too much laventAir ellipta may include a sudden attack of breathlessness or wheezing . if this attack occurs , you should immediately use a
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you experience any of the following symptoms stop using laventair ellipta and contact your doctor immediately : uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) and redness rare side effects : may affect 1 in 1 , 000 people : swelling mainly of the face or mouth ( angioedema ), which may make you feel very wheezy , coughing , having difficulty in breathing , feeling weak or light headed , which may lead to collapse or loss of consciousness . immediate breathing difficulties immediate breathing
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each delivered dose contains 55 micrograms umechinium and 65 microgramms umephidiniol bromides ( equivalent to 22 microgramrams of vilancerol ) and trifenatate . - the other ingredients are lactose monohydrate ( see section 2 under ' lavent air ellipta contain lactose ') and magnesium stearate . what laventAir ellipta looks like and contents of the pack laventairy ellipta is an inhalation
the active substance of tremfya is guselkumab , a monoclonal antibody . this medicine contains the active substance " il - 23 ". this belongs to a group of proteins called cytokines , and is used to treat psoriasis in adults with moderate to severe " plaque psorism ". plaque psoreiasis is an inflammatory condition that affects the skin and nails . tremfYA works to improve the condition on the skin , and to reduce symptoms such as scaling , shedding , flaking , itching , pain , and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using tremfia if you have an active infection or active tuberculosis warnings and measures talk to the doctor or nurse before using or using tremfaya if : you have ever had an infection or an infection with tuberculosis . tuberculosis is a serious , sometimes life - threatening condition that can affect up to 36 people . you have signs of an infection , including symptoms
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . tremfya 100 mg solution for injection ( 1 pre - filled syringe ) is given under the skin ( subcutaneous injection ). it may take 4 to 8 weeks for you to feel comfortable with the injection . if you use more tremfia than you should tremffa should be injected under the supervision of a doctor or nurse . if possible , tremfqa may be given to you by a doctor , nurse or pharma . if necessary , tremfaya may be stopped or stopped completely without
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : signs of serious allergic reaction : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash or raised bumps other side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . some side effects may be serious : common ( may affect up to 1 in 10 people ): upper respiratory infections common ( might affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . do this medicine if you notice that the solution is cloudy or contains large particles . do away with the pre pre -filled syringe and allow it to reach room temperature ( up to 30 ) before use . donot throw away any medicines via wastewater
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusel kumab in 1 ml solution . - the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose , water for injections . what tremfYA looks like and contents of the pack solution for injection in a vial is a clear , colourless liquid . tremfia is supplied as a carton pack containing one single - dose glass syringe and a multipack containing 2 ( 2 packs of 1 ) single - set
the active substance of trepulmix is treprostinil . treprosticinil belongs to a group of medicines called prostacyclins , a hormone that lowers blood pressure by relaxing blood vessels . prostacycylins prevent blood from clotting . trepulemix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ), a condition in which persistent or recurrentcteph is not treated with surgical treatment , and where exercise capacity is insufficient . symptoms of the disease are similar to those of chronic thromeboembolmonary hypertension but may occur more often . in chronic th
do not take trepulmix if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a disease called " pulmonary veno - occlusive disease ". this is a disease in which the blood vessels in the lungs become swollen and there is a higher pressure in the blood arteries between the heart and the lungs . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking trepulemix . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : have a heart problem
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is given as a continuous subcutaneous infusion ( subcutaneously ) under the skin through a small tube ( cannula ) that goes into the abdomen or thigh . trepanmix is also given in a hospital setting using a portable pump . you can take your treprostinil with or without food . the pump is connected to the infusion line to reduce the risk of accidental overdose . the recommended dose is 1 to 2 . 5 mg per kg body weight , given every 5
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction at the site bleeding or bruising at the inf site headaches nausea diarrhoea jaw pain common ( might affect up to 1 in every 10 people ) dizziness light - headedness fainting low blood pressure skin rashes muscle pain ( myalgia ) joint pain ( arthralgia ) swelling of feet , ankles , legs ( fluid retention ) hot flush pain in arms and / or legs 36 uncommon ( may effect up to1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . do away with the vials after first opening . do this if you notice any visible sign of damage such as discolouration or other signs of deterioration . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away
what trepulmix contains - the active substance is treprostinil . trepulemix 1 mg : each vial contains 1 mg treproprostine ( as sodium salt ). each 10 ml vial of 10 ml contains 10 mg trepristinile ( as water for injections ). each 20 ml vials of 10ml contain 10 mg of trepropristineil ( as salt ). trepulesmix 2 . 5 mg : one vial containing 2 . 25 mg treProstinila ( as saline salt ). one 10 ml ampoule of 50 ml contains 50 mg trepist
the active substance of thorinane is enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). the active substance in thorinanes is enocorperidone . it works in two ways : 1 ) to prevent existing blood clots from forming . 2 ) to stop blood clubs from forming in your blood . thorinne is used to : prevent blood clumps from forming within your blood during or after an operation . to treat an acute illness ( unstable angina ). to prevent blood from forming inside your heart after a heart attack . to prevent the formation of blood clops
do not use thorinane - if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . - if your doctor thinks you may be allergic to heparin or other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ). if you have had a reaction to hep or any other low molecule weight hep products ( e .. g ., nadiparin
like other similar medicines ( medicines to prevent blood clotting ), thorinane may cause bleeding . tell your doctor immediately if you experience any bleeding event that does not stop . excessive bleeding may be associated with exceptional weakness , tiredness , paleness , dizziness , headache or unexplained swelling . tell the doctor immediately , as you may need to stop your medicine . if you have any of the following while taking thorinan : - a severe allergic reaction , which may cause difficulty breathing , swelling of the lips , mouth , throat or eyes . - blockage of a blood vessel that may be a blood clot . - cramping pain ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store below 25 . after dilution the solution should be used within 8 hours . do this medicine if you notice that the thorinane pre - filled syringes are damaged or have not been stored correctly . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what thorinane contains the active substance is enoxaparin sodium . each pre - filled syringe contains 100 mg of enoxapearin sodium in 0 . 2 ml solution . each vial contains 2 , 000 mg of the active substances enoxafarin sodium and water for injections in 0. 2 ml . what thorinanes looks like and contents of the pack thorinan is a clear , colourless type i neutral glass syringe barrel with fixed needle and needle shield , with chlorobutyl rubber stopper and a blue polypropylene plunger rod . pack size of 2 or 10 pre - packed sy
sensstend contains the active substances lidocaine and prilocaine . both belong to a group of medicines called local anaesthetics . senstend is used to achieve lifelong premature ejaculation in adult men . it works by attaching itself to the head of the penis , which allows ejaculation to be completed .
do not use senstend if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using senststend . if you have a history of allergy or sensitivity to local anaesthetics ( amide - type local anahetics ) if you suffer from a genetic disease or other condition that affects your red blood cells ( glucose and phosphate deficiency ) if your doctor has told you that you have anaemia ( methaemoglobinaemia ). if you develop medicine sensitivities or sensitivity , you
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose of senstend is 3 sprays ( 3 sprabs per day ). 1 spray is injected into the head of your penis , once every 3 hours for 24 hours . 4 sprays are given to you by your doctor . the spray container is for single use only . the pump mechanism is to be used only if the valve is closed . avoid contact with eyes , nose , mouth and ears . the other side of the pump is to use 1
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection in the penis feeling of burning in the area of the penis uncommon ( may effect up to1 in 100 people ) headache local irritation of the throat , irritation of any part of the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in the penis pain or discomfort in the part of your penis itching in the space of your erect penis a high temperature . other side effects include :
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the metal container after exp . the exp date refers to the last day of that month . store below 25 and use within 12 months . do away with the metalcontainer after this period . donot puncture or burn the container . do this if you notice any visible sign of tampering . do so if you have any further questions on the use of this medicine , ask your pharmacist .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 mg lidocain and 50 mg prilucaine . one spray container contains 50 ml lidocane and 7 . 5 mg prlocaine , each spray container containing 2 . 5 ml prilacaine . - each spraycontainer contains 6 . 5 to 20 ml of water . - the other ingredients are : - eachspray container contains 5 ml or 12 ml of light yellow cutaneous spray . - an aluminium spray container with metering valve . - pack sizes of 1 , 6 . 75
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melanoma that has not responded to complete resection in adults ( treatment with surgery or adjuvant therapy ). advanced non - small cell lung cancer ( advanced renal cell carcinoma ) advanced kidney cancer in adults classical hodgkin lymphoma ( if previous therapies have not worked or you are not able to have an autologous stem - cell transplant , or you have had a transplant ) advanced cancer of the head and neck in adults advanced urothelial carcinoma ( bladder and urinary tract cancer ) the active substance in
do not take opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking opdivos if you : - have problems with your heart , such as a change in the rhythm or a change of the heartbeat . - have an abnormal heart rhythm . - develop problems with the airways , such that you have breathing difficulties or cough . - inflammation of the lungs ( pneumonitis or interstitial lung disease ). - have diarrhoea , watery , loose or soft stools . - notice any symptoms of
always take opdivo exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended dose of opdivoe is 240 mg once a day ( 2 tablets ) for up to 480 mg once daily ( 4 tablets ). your doctor will prescribe opdivothimab in combination with ipilimumab for the treatment of skin cancer . the dose of ipdivo is 1 mg of nivolumab per kilogram of your body weight , given as 4 tablets . the daily dose of opsdivo depends on your condition and your dose of regimens . the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store below 25 and refrigerate ( 2c - 8c ). do not freeze . after dilution , chemical and physical in - use stability has been demonstrated for 48 hours at 2c to 8c . the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nivulumab ( 40 mg / ml ). each 4 ml vial contains 100 mg of 10 mg nivlumab and 240 mg /ml of solution for injection contains 24 mg of the active substances . the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " opdivoa contains sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydrochloric acid and water for injections
clopidogrel tad contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidiogrelTad is taken to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombization , which can lead to atherotrombotic events ( such as
do not take clopidogrel tad 30 if you are allergic to clopidineogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , do not take more clopridogrel tetad and tell your doctor . warnings and precautions the following are reasons why clopideogrelTad may increase the risk of bleeding : if you develop a medicalcondition that puts you at risk of internal
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl tad ( 4 tablets of 75 mg ) once at the start of treatment . then
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel tad contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogrol 3000 in the film - coating . what clopidiogrel tetad looks like and contents
tacrolimus contains the active substance tacrolimos . tacforius is an immunosuppressant . after your organ transplant ( liver or kidney ), your body ' s immune system will try to reject the new organ . tacfortius is used to prevent rejection of transplanted organs by patients who have already received both liver and kidney , and who have failed to respond adequately to any previous treatment after your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . if you have been given sirolimus , or any macrolide - like antibiotic ( e . g . erythromycin , clarithromycin or josamycin ). tacforia immediate release capsules ( e. g . tacrolin ) are not suitable for children . tacforian prolonged - release capsules are not available . tacrulimus immediate release capsule are not recommended for
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed by a doctor experienced in the treatment of transplant patients . your doctor will prescribe the same tacrolimus medicine for you . if you have had a transplant , your doctor may prescribe a different tacrolemus medicine . always take this medication exactly as described in this leaflet . check the box at the end of this leafle leaflet for information about how to take tacforius . if your doctor thinks that you do not have the right medicine , contact your doctor .
like all medicines , this medicine can cause side effects , although not everybody gets them . infections you will be closely monitored for infections during tacforius treatment . severe effects , including allergic and anaphylactic reactions , have been reported . benign and malignant tumours have been observed during tacofius treatment and have been confirmed by the european medicines agency . pure red cell aplasia ( a very severe reduction in red blood cell counts ) and agranulocytosis ( a severely lowered number of white blood cells ) have been seen . haemolytic anaemia ( decreased number of red blood cells due to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). discard all the prolonged - release hard capsules within 1 month of opening the aluminium wrapping . do away with the foil . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tacforius contains the active substance is tacrolimus . tacforiu 0 . 5 mg : each capsule contains 0 . 25 mg of tacrolamus ( as monohydrate ). tacforio 1 mg : one capsule contains 1 mg of ticrolimas ( asohydrate ). each tacforian 3 mg capsule contains 3 mg of of tacrulimus ( monohydrate ) . tacnonius 5 mg capsule : one hard capsule contains 5 mg ofTicrolamas ( monohyd ). the other ingredients are capsule content hypromellose 2910 , ethylcellulose , lactose ,
clopidogrel zentiva contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidiogrelzentiva is taken to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelzentiva . warnings and precautions take special care with clopidineogrel ventiva if any other conditions increase the risk of bleeding such : - if you develop a
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl zenta ( 4 tablets of 75 mg ) once at
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep clopidogrel zentiva in aluminium blisters in order to protect from light . do away with clopridogrel zinc if you notice any visible sign of deterioration . do so and return the pack to your pharmacist . donot throw away any medicines via wastewater or household waste . ask your pharma how to throw
what clopidogrel zentiva contains the active substance is clopridogrel . each tablet contains 75 mg of clopidoogrel ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' clopideogrelzentiva contain lactose ' and ' clopsidogl zentva contains hydrogenated castor oil '), mannitol ( e421 ), hydrogenatedcastor oil , microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose , lactose monohydrate ( milk sugar ), hypromellose ( e
yttriga is a radioactive medicine that is stored in a refrigerator ( 2 - 8 ). it is used in combination with another medicine for tiny radiation doses . the treatment is a radiolabelled medicinal product .
you must not be given yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yttiga - you must not become pregnant if you think you may be pregnant . warnings and precautions talk to your nuclear medicine doctor before you are given ytriga . - yttrada is a radioactive medicine . it is used in combination with another medicinal product called radiopharmaceuticals . yttrigera contains radioactive material . radioactive medicinal products are stored at 2 to 16 in the outer carton . other medicines and yttrida tell your nuclear medicines doctor if you
the treatment should be supervised by a doctor experienced in the treatment of medicinal products . method of administration yttriga is for radiolabelling of medicinal product for specific diseases . yttiga should be used immediately after preparation . if you use more yttrada than you should in the event of overdose , your doctor will provide you with appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises . local regulations on radioactive substances will ensure that any unused product or waste material is disposed of in accordance with local requirements .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid ( equivalent to 3 mg / ml ). what yttrada looks like and contents of the pack yttrida is a clear , colourless type i glass vial with a 10 ml clear , clear , liquid solution with a flat bottom and a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciambra contains cisplatin , another anti - cancer medicine , which is used as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , which has not responded to prior chemotherapy . cimbra is also used in combination with cisplin for the initial treatment of patients with advanced stage of lung cancer . your doctor will determine how much ciamBra you should be given depending on the type of lungcancer you have and on the severity of your disease . treatment with initial chemotherapy ciamba is
do not use ciambra if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciamb . if you have been breast - feeding for more than 6 months . if this applies to you , tell your doctor . breast -feeding should be stopped during treatment with ciamba . if any of these apply to you ( or you are not sure ), talk to your doctor before using ciambe . if your child has recently received a vaccine against yellow fever , talk to their doctor before starting treatment with Ciambra . if there are any concerns about problems with your kidneys , talk
the recommended dose of ciambra is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your whole body . your doctor will work out this body surface area based on your weight and on the results of treatment that are expected based on the status of your blood cell counts . your healthcare professional will have mixed the ciamba powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . ciamBra will be given to your doctor by infusion into one of your veins . the infusion will last approximately 10
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor immediately if you experience : fever or infection ( common ): if you have a temperature of 38Âºc or greater , sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if you get chest pain ( common ) or a fast heart rate ( uncommon ). if you develop pain , redness , swelling or sores in your mouth ( very common ) allergic reaction : if you notice skin rash ( common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store below 25 . do away with the reconstituted solution . do this immediately after preparation . if you are not able to use the infusion solution immediately , the infusion situation may be stored at 2 - 9 for up to 8 hours and then 15 - 25 . any unused solution must be discarded . do throw away
what ciambra contains the active substance is pemetrexed . each vial of ciamba 100 mg contains 100 mg of pemetreed ( as pemetereed disodium hemipentahydrate ). each vials of cimbra 500 mg contains 500 mg of the active ingredient pemetrhyd ( as peemetrexED disodium semipent ahydrate ) after reconstitution , the solution contains 25 mg / ml of pemrexed without further dilution . the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ), sodium hydrox
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ). immunoglubulins help to control certain infections in your blood . immunogam can be used in adults to prevent increased levels of human hepatitis b immunoglutins ( immunoglobs ) and immunoglofulin g ( ig ) in blood plasma of screened patients . immunoglogam is used to treat hepatitis b virus in haemodialysed patients . vaccination is a precautionary measure in which a hepatitis birus carrier ( the immune system ) produces an immune response that is stronger than those without measurable hepatitis b antibodies
immunogam should not be given : - if you have ever had an allergic reaction to human immunoglobulins or other blood products , or to any of the other ingredients of immunogam ( listed in section 6 ). - if your child has an iga deficiency . - if an allergic response to iga containing products has occurred . children and adolescents ( aged 18 years and above ) immunogloglobulin can cause adverse reactions such as chills , headache , fever and vomiting . allergic reactions may also be severe ( including nausea and arthralgia ). - joint pain or low blood pressure . moderate low
immunogam will be given to you by a doctor or nurse who is experienced in the care of patients with vaccination against hepatitis b virus . the first vaccine dose will be administered in combination with human hepatitis b immunoglobulin ( hbv ). administration prevention the recommended dose of hepatitis b is 500 micrograms given every 24 hours for 72 days . the recommended recommended dose for hepatitis b in haemodialysed patients is 500 mbg given every 2 weeks . seroconversion is the second step in vaccination . immunogam is prepared by recombinant dna technology ( rdna technology ). immunog
like all medicines , immunogam can cause side effects , although not everybody gets them . the most common side effects are : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ). not known ( frequency cannot be estimated from the available data ) very rare ( affecting less than1 user in 100 ). not applicable ( frequency can be estimated based on the available information ). in clinical trials with immunogamer , the muscle was noticeably less than normal ( affects between 1 and
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . donot use immunoam if the solution is cloudy or contains deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . immunogams 1 mg / ml solution for injection contains 5 mg of human plasma protein ( antigen ) 96 % ( expressed in units ) of polysorbate 80 . what immunogom looks like and contents of the pack immunogamer is a solution forjection in a glass vial . it is a clear to slightly opalescent , colourless to pale yellow liquid . each pack contains 1 vial of immunogamation .
remicade contains the active substance infliximab . infliximusab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tumour necrosis factor ( tnfÎ± ). remicade belongs to a group of medicines called ' tnfs blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew ' s disease ) psoriasis remicades is used in adults , adolescents and children aged 6 years and older with crohn '
do not take remicade if you are allergic to infliximab or any of the other ingredients of remicades ( listed in section 6 ) if you think you may be allergic ( hypersensitive ) if your doctor has told you that you have tuberculosis ( tb ) if this applies to you , tell your doctor before taking remicad . if you have another serious infection , such as pneumonia , sepsis or heart failure , tell the doctor before you take reminade . if any of these apply to you ( or you are not sure ), tell your physician before taking the next dose of reminad .
the recommended dose is : rheumatoid arthritis : 3 mg for every kg of body weight . psoriatic arthritis : ankylosing spondylitis ( bechterew ' s disease ), psoriasis , ulcerative colitis and crohn ' s diseases : 5 mg for each kg of skin weight . how remicade is given remicine is given as an infusion ( drip ) over 2 hours into one of your veins ( usually in your arm ). the third treatment will be given after you have received remicades over 1 year . how much remicad is given your doctor will decide
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some patients may experience serious side effects and may require treatment . tell your doctor straight away if you notice any of the following side effects . your doctor may decide to temporarily or permanently stop your treatment with remicade . if you have an allergic reaction , including swelling of your face , lips , mouth or throat , which may cause difficulty in swallowing or breathing , skin rash , hives and swelling of the hands , feet or ankles . these reactions are rare . an allergic allergic reaction may occur rarely (
keep this medicine out of the sight and reach of children . do not use remicade after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . store in a refrigerator ( 2 8 ). do not freeze . store below 25 . remicad may be used for infusion for up to 3 days when stored at 2 8 or 28 . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 28 hours
what remicade contains the active substance is infliximab . each vial contains 100 mg of inflixab . after preparation each ml contains 10 mg of infiximb . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate . what remicades looks like and contents of the pack remicad is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white to off - white . remicada is available in packs containing 1 , 2 , 3 , 4 or 5 vials . not
rasagiline mylan is used to treat parkinson ' s disease in adults . it is given in combination with levodopa ( another medicine used to control parkinson ', s disease ). with parkinson's disease , there is a loss of cells that produce dopamine in the brain . dopamine is a chemical in the body involved in movement control . rasagilinea mylan increases the amount of dopamine produced in the blood and improves movement control in adults and adolescents . rascagilrine mylan helps to increase the amount and levels of dopamine in your brain .
do not take rasagiline mylan - if you are allergic to rasaga or any of the other ingredients of this medicine ( listed in section 6 ). - if severe liver problems . warnings and precautions talk to your doctor or pharmacist before taking the following medicines : rasaline mylan contains monoamine oxidase ( mao ) inhibitors , used to treat depression and parkinson ' s disease . it is also a medicinal and natural products ( e . g . st . john ' s wort , pethidine ). it is a strong pain killer . it may affect up to 14 % of rasagg
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day . take the tablet at about the same time each day . you can take the tablets with or without food . the tablet can be taken with or just after a meal . the maximum recommended dose for adults is 1 dose taken by mouth once a morning . take rasagiline mylan at about about the time each morning . if you take more rasgiline melan than you should if you accidentally take too many tablets , contact your doctor immediately
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of rasagiline mylan are similar to those of placebo . the frequency of possible side effects listed below is defined using the following convention : very common abnormal movements ( dyskinesia ) headache common abdominal pain rare uncommon uncommon abnormal movements (> 1 , 000 ) fall allergy fever flu ( influenza ) feeling of being unwell neck pain chest pain ( angina pectoris ) low blood pressure with symptoms such as light headedness ( orthostatic hypotension ) decreased appetite , constipation , dry mouth , nausea or vomiting flat
what rasagiline mylan contains - the active substance is rasagailine . each tablet contains rasageiline tartrate equivalent to 1 mg rasgailine - the other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch ( maize starch ), talc , stearic acid . what rasaggilinemylan looks like and contents of the pack rasgiline tablets are 11 . 5 mm x 6 mm , white to off - white , biconvex tablets debossed with " r " on one
do not use hulio - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a severe infection , including tuberculosis ( see section " warnings and precautions "). symptoms of infections may include fever , wounds , feeling tired , dental problems . - if the child has moderate or severe heart failure . - tell your doctor if the patient has a serious heart condition . warnings and symptoms allergic reaction allergic reactions may include symptoms such as chest tightness , wheezing , dizziness , swelling or a rash . these reactions are usually mild to moderate and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis in adults and adolescents from 2 to 17 years old weighing 10 kg or more : one 30 mg tablet of hulio 20 mg is available . in children and adolescents ( 2 to 16 years old ), the usual dose is two 20 mg tablets of hula . in adolescents ( 12 to 17 months old ), one 30mg tablet of tulio 40 mg is also available . enthesitis in adults with arthritis in children from 6 to 17 year old weighing 15
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may require urgent medical treatment . tell your doctor straight away if you notice any of the following side effects that may occur ( see section 4 ) since the last hulio injection : allergic reaction ( including heart failure ) severe rash or hives swollen face , hands or feet trouble breathing , swallowing , pale complexion , dizziness , persistent fever , bruising or bleeding . signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on urination , feeling weak or
what hulio contains - the active substance is adalimumab . - the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what hulios looks like and contents of the pack hul io 40 mg is a sterile solution for injection ( injection ) containing 40 mg of adalimab in 0 . 8 ml of solution . the solution is clear to slightly opalescent and colourless to pale yellow . it is supplied in a glass vial with a rubber stopper . hullio is available
the active substance of yellox is bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ), which reduce inflammation . yellox has been prescribed for the treatment of eye inflammation following cataract surgery .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have asthma or skin allergy ( intense inflammation in your nose ). - you are taking other nsaids ( e . g . acetylsalicylic acid , ibuprofen , ketoprofen or diclofenac ). this medicine is used in combination with topical steroids ( cortisone ) which can increase the risk of unwanted side effects . - if the patient has had bleeding problems ( such as haemoph
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of yellox is one drop in each eye ( s ) twice a day . the recommended daily dose is one dose in each affected eye (s ) twice daily for 2 weeks . the drops should be used in the next day after your cataract surgery . method of administration yellox is for oral use . wash your hands before using the eye drops . remove the bottle cap from the bottle . hold the bottle , pointing down , between your thumb and fingers , between
what yellox contains - the active substance is bromfenac . each ml of solution contains bromenac ( as sodium sesquihydrate ). each vial contains 33 mg of bromnac . - the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate and sodium hydroxide to maintain acidity levels . what yellox looks like and contents of the pack yellox is a clear yellow liquid ( solution ) supplied in a glass v
dzuveo contains sufentanil , which belongs to a group of strong painkillers called opioids . sufENTanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious lung or breathing problem . warnings and precautions talk to your doctor before taking dzuvoo if : you have any condition that affects your breathing ( such as asthma , wheezing or shortness of breath ). dzuveco may affect your breathing during treatment . you have recently had a head injury or brain tumour . you suffer from problems with your heart and circulation such as slow heart rate , irregular heartbeat , low blood volume or low blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device is for oral use only . swallow the tablet whole with a glass of water . you can take this medication with or without food . dzuveo contains strong painkillers such as sufentanil . the recommended dose is 30 mg . take the sublingual tablet with the disposable single -dose applicator . the applicator should be inserted into the tongue . if the tablets dissolve in the tongue , pain relief may be felt on the tongue after 10 minutes . the
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : severe breathing problems , slow and shallow breathing . if you get any of these side effects you must stop taking dzuveo and contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): nausea , feeling sick , vomiting , being sick and feeling hot . common side side effect ( may effect up to 1 in every 10 people ) : inability or difficulty sleeping , feeling anxious or confused , dizziness , headache ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do away with the blister before use . do this medicine if you notice any visible sign of deterioration . do discard the blister if you are concerned that the medicine has been frozen . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg sufantanil ( as citrate ). - the other ingredients are mannitol ( e421 ), dicalcium phosphate , hypromellose , croscarmellose sodium , indigo carmine ( e132 ), stearic acid , magnesium stearate . what dzuvo looks like and contents of the pack dzuvello is a white to off - white , round tablets with " d " debossed on one side and " 3 " debottled on the other side .
what erleada is erleADA is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has spread to other parts of the body or cannot be removed by surgical treatments . it also treats adult men who have sensitive prostate cancer which has spread beyond the original body and cannot be taken out by surgical treatment . it works by reducing the amount of testosterone in the blood . what erlead is used for erleade is used in adult men to treat resistant prostate cancer in which the levels of androgens in the body are too low . it can also treat the
do not take erleada - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). - if pregnant or planning to become pregnant ( see pregnancy and contraception section ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . this medicine should not be used if you have a history of seizures . - if taking any medicines that can cause blood clots ( e . g . warfarin or acenocoumarol ). - tell your doctor if you suffer from any heart or blood vessel conditions . - tell the doctor if any of these apply
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once a day . your doctor may increase your dose to 60 mg once daily depending on how you respond to erleada . take this leaflet and this medicine by mouth . if you take more erleade than you should if you accidentally take too many tablets , contact your doctor immediately . taking other medicines if you forget to take erlead if you miss a dose , take it as soon as you remember . if it is almost time for your next dose , skip the
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and see a doctor immediately if you experience any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms . toxic epidermal necrolysis ( see section 2 ). serious side effects tell your doctor straight away if you notice any of these side effects : fits ( seizure ) uncommon (
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalectamide . - the other ingredients are colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , silicified microcrystine celluloise . - in addition , the film - coating contains iron oxide black ( e172 ), iron oxide yellow ( e 172 ), macrogol , polyvinyl alcohol , talc , and titanium dioxide ( e171 ). what erlead
this medicine is a radiopharmaceutical product . axumin contains the active ingredient fluciclovine . it is used for scan - related diagnostic use , including a pet scan . it has been given to adults who have previously had treatment for prostate cancer and who have had other tests to check prostate specific antigen ( psa ) levels . the cancer has spread to other organs . an axumin pet scan may help to determine the cause of the cancer . your doctor will decide whether the scan is appropriate for you . your nuclear medicine doctor has considered that the clinical benefit of axumin outweighs the risk of radiation .
do not use axumin if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using axumin . if you have kidney problems . if your doctor has told you to follow a low sodium diet . you should not use more axumin than you should if you think you may have been given too much . you will be observed for a day before the axumin scan . you may be observed at least 4 hours after the scan . your usual medicines will be used during the latest 60 minutes after the axul injection
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be handled and given to you by people who are trained and qualified to use this medicine safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide the quantity of axumin to be used . the usual dose is 370 megabecquerel per kilogram of body weight . the administration of axum will be in accordance with national regulation on radioactivity . during the procedure axumin is administered into a vein
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : common ( may affect up to 1 in 100 people ): when using the medicine , the side effects associated with axumin were uncommon ( may effect up to1 in 100 , 000 people ): pain , rash , altered taste in the mouth , altered sense of smell . the following serious side effects have been reported with axon : very rare ( may affects up to one in 100, 000 people ) : pain , or rash , or altered taste , or a changed sense of taste . this radioph
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : keep this medicine out of the sight and reach of children . do not use axumin after the expiry date which is stated on the label after exp .
what axumin contains - the active substance is fluciclovine . axumin 1600 mg : each vial contains 1600 mg of fluciniclovine ( corresponding to 1600 to 16000 iu ). axumin 3200 mg : one vial delivers 3200mg of fluiclovin ( correspondingto 3200 to 32000 iiu ). - the other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " axumin with sodium "). what axumin looks like and contents of the pack white to off - white powder , with a uniform colour . axum
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . it works by reducing pressure within the eye . azopt eye drops are used to treat high pressure in the eye in adults with an illness called glaucoma . the pressure in your eye increases , and this can damage your sight .
do not take azopt - if you have severe kidney problems - if your doctor thinks you may be allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). - if allergic to medicines called sulphonamides ( medicines used to treat diabetes or infections ) or diuretics ( water tablets ). warnings and precautions talk to your doctor or pharmacist before taking azopt if you think the same allergy may apply to you . if you develop too much acidity in your blood ( hyperchloraemic acidosis ) after taking azoth , tell your doctor . - if any of these
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt is used in both eyes . use in both eye : 1 drop in each eye . use azopt in both the eyes once a day for 1 week , and in the eyes for 2 weeks , and for 3 weeks . remove the azopt bottle from the bottle and wash your hands . remove from the cap . the cap can be removed with a snap collar . hold the bottle tightly with both hands . tilt the cap back and pull down the lower eyelid with a clean finger until there is a
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . other side effects : bad taste . uncommon side effects - effects affecting up to1 in 100 people ) â effects in your eye : sensitivity to light , inflammation or infection of the conjunctiva , eye swelling , eyelid itching , red , swelling or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . to protect from infections , a pack containing a single bottle should be used immediately . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brin zolamide ( as benzalkonium chloride ). - the other ingredients are carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide to maintain acidity levels ( ph levels ). what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with a screw cap . a pack containing
the active substance of forxiga , dapagliflozin , belongs to a group of medicines called medicines taken by mouth . forxigo is used to treat diabetes that affects the level of sugar in your blood . it is used in adults ( aged 18 years and over ). forxig is used for diabetes in adults with type 1 diabetes that has not been controlled by diet and exercise or where your body does not produce any insulin . for xiga is used : in adults who are overweight or obese . in adult patients with type 2 diabetes : where your immune system ( the body ' s natural defence system ) does not
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxigo : - if any of these apply to you , tell your doctor straight away . - if your doctor notices that you are feeling sick or being sick , - if this includes stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , asweet or metallic taste in your mouth , a different odour to your urine or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of forxiga for type 2 diabetes is 10 mg once a day , taken once a week , taken twice a day . your doctor may increase your dose to 5 mg once daily if you have a liver problem . your dose of both forxigo and type 1 diabetes is 5 mg twice a week . your treatment will be started by your doctor . taking this medicine swallow the tablets whole with a glass of water . you can take forxige with or without food . your blood sugar may
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are angioedema ( very rare , may affect up to 1 in 10 , 000 people ). angioEDema may cause swelling of the face , tongue or throat , difficulties swallowing , hives and breathing problems . diabetic ketoacidosis ( very common , may affects more than 1 in10 people ) if you have type 2 diabetes , it may affect 1 in 1 , 000 to 1 , 500 people . diabeticketoacidism may occur with increased levels of " ketone bodies " in your urine or blood
what forxiga contains the active substance is dapagliflozin . each forxigo 5 mg film - coated tablet ( tablet ) contains dapapagllozin propanediol monohydrate equivalent to 5 mg dapablifloin . the other ingredients are : tablet core : microcrystalline cellulose ( e460i ), lactose ( see section 2 under ' forxigiga contains lactose '), crospovidone ( e1201 ), silicon dioxide ( e171 ), magnesium stearate ( e470b ). film - coating : polyvinyl alcohol ( e1521
mifamurtide is a medicine that blocks the activity of certain bacteria in the immune system . mepact is used to treat osteosarcoma ( bone cancer ) in adults aged 2 and 30 years . it is used when surgery is not possible to remove the tumour and chemotherapy is not able to stop cancer cells from growing . it also helps to prevent cancer from coming back .
do not take mepact : if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). if you have ever taken medicines containing ciclosporin or other calcineurin inhibitors ( non - steroidal - anti - inflammatory drugs ). nsaids may cause problems with your heart or blood vessels such as blood clots ( thrombosis ), bleeding ( haemorrhage ), inflammation of the veins ( vasculitis ). warnings and precautions talk to your doctor or pharmacist before taking mepactor treatment if you develop long - lasting or worsening
treatment mepact will be given to you by a doctor or nurse . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of mepACT is 2 mg mifamurtide per kg body weight , taken once a day for 12 hours . your doctor may increase your dose to 24 mg once a week depending on your mepact treatments . your chemotherapy schedule will be adjusted by your doctor . the maximum duration of your chemotherapy should not exceed 36 hours . treatment with mepat you will be monitored closely for signs of an interruption in
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported in patients receiving mepACT ( transient ) paracetamol . if you experience fever during treatment with mep act , tell your doctor immediately . stomach problems ( nausea , vomiting and loss of appetite ) have been seen in patients who have received chemotherapy . tell your physician immediately if you have continuing fever and chills after 8 weeks of treatment with treatment with mypact . signs of an infection such as rash , any problems breathing or wheezing , tell the doctor immediately if any stomach problems
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial and the outer carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in outer cartonet in order to protect from light . reconstituted suspension : sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection may be stored at room temperature ( up to 30 ) for up to 6 hours . do this medicine if you notice any visible sign of deterioration .
what mepact contains the active substance is mifamurtide . each vial contains 4 mg of mifamanurtide ( as suspension ). after reconstitution , each ml of suspension contains 0 . 08 mg of the active ingredient mifamate . the other ingredients are 1 - palmitoyl - 2 - oleoyl- sn - glycero - 3 - phosphocholine ( see section 2 under ' mepacts contains lactose ') 2 - dileoyls - sn -glycero- 3 - phosphate monosodium salt ( see also section 2 " mepACT contains
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used on the skin and face to reduce redness ( rosacea ) and redness of the face . rosica is a condition caused by high levels of blood flow in theacial skin and enlargement ( dilution ) of the small blood vessels of the skin . mirvaso acts by blocking the blood vessels , thereby reducing the excess blood flow and reding of the area .
do not take mirvaso if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking mirvasos if you have had side effects with the medicine applied to the skin . if you take certain medicines used to treat depression or parkinson ' s disease : monoamine oxidase ( mao ) inhibitors ( selegiline , moclobemide ), tricyclic antidepressants ( imipramine ), tetracyclic antidepressant ( maprotiline ), mianserin or m
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is applied to the skin ( usually on the face ) once daily . this medicine is applied on the same area of your body . if your body faces larger areas than normal , you should use it only . do not apply mirvasos on your eyes , mouth , nose or vagina . if you use more mirvasoe than you should if you think you have used more miraso mirvasoa is applied only to the face . the treatment should be started with a small amount of gel
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects : severe skin irritation , inflammation , skin rash , skin pain and discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects ( may affect up to 1 in 10 people ): worsening of rosacea . the treatment should be stopped immediately if symptoms persist ( see section 2 " warnings and precautions "). contact allergy allergic reaction including rash and rare angioedema ( a serious allergic reaction with swelling mainly of the face , mouth and tongue ). if you are given mirvas
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the tube and pumps tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of brimonine . each vial contains 5 mg of the active ingredient brimonate tartrate . - the other ingredients are carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 " mirvasos contains methylparahsydroxy benzoate "), propylene Glycol . what mirvasoa looks like and contents of the pack mirvasoe
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the immune system , the body ' s natural defences ). it is used to defend the body against infection and cancer . bevacsizumb binds to a protein called human vascular endothelial growth factor ( vegf ), which is found on the lining of lymph vessels in the body . the veg f protein causes blood vessels to expand , thus increasing their ability to supply blood with oxygen . be vacizumaab inhibits tum
do not use this medicine if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic ( allergic or hypersensitive ), to chinese hamster ovary ( cho ) cell products if you or your child are pregnant . warnings and precautions talk to your doctor or pharmacist before using mvasi . before using , tell your doctor if you : have had or are planning to have a baby . mvasis may increase the risk of developing holes in the gut wall ( inflammation inside the abdomen ), diverticul
dose and frequency of administration your doctor will calculate the dose of mvasi based on your body weight and the type of cancer you have . the usual starting dose is 5 mg , 7 . 5 mg or 10 mg per kg of body weight , given once every 15 days . your doctor may increase your dose depending on your size and the amount of mvai you are taking . your dose of either mvasic will be gradually increased every 2 or 3 weeks . the number of infusions you receive will depend on how you respond to treatment . your physician will decide how much mvasis you need and how often you need to
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with mvasi : side effects are usually mild to moderate . the side effects that may occur with mvai are usually caused by chemotherapy . if you notice any of these side effects while you are being treated with mvvasi , tell your doctor straight away . allergic reactions tell your physician straight away if you have an allergic reaction , including : difficulty in breathing , chest pain , redness and flushing of the skin , a rash , chills or shivering , feeling sick ( nausea ) or being sick
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outercarton in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 unless dilution has taken place
what mvasi contains the active substance is bevacizumab . each ml contains 25 mg of bevaconizumumab in 1 . 4 ml or 16 . 5 ml of solution . each 4 ml vial contains 100 mg of the active substances bevackizumb in 1. 4 ml and each 16 ml vials contains 400 mg of of bevanacizumaab in 16 .5 ml of water . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what mvasis looks like and contents of the pack m
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . it is used in adults , adolescents and children who are not able to take other medicines . it works by inhibiting the growth of cells called cd3 + cells . what tecartus means tecartu is used for tecartub is used to kill refractory mantle cell lysisoma ( mcl ) in adults . it can be used in combination with your own white blood cells ( autologous anti - cd19 - transduced cd3+ cells ). mantle cell leysis is a cancer that affects the immune system ( the body
do not use tecartus if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using tecartuse if you have : - a reduced number of white blood cells in your blood ( lymphodepleting chemotherapy , which may take up to 3 weeks to produce white blood cell ) due to autologous use . tests and checks your doctor will do tests to check your lungs , heart , kidney , blood pressure , infection or inflammation of your cancer ( graft - versus - host disease
what tecartus is tecartuus contains your own white blood cells . your cells will be collected and given to you by a doctor or nurse . your doctor or a nurse will take care of your cells before you are given tecarton . this is done by a catheter placed in your vein ( a procedure call leukapheresis ). your white blood cell will be taken from your blood and given into a vein over 3 to 6 hours . the number of your white white bloodcells will be reduced over 2 to 3 hours . medicines given before tecartuse treatment are given to patients who have not received lymphod
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you . if you notice any of the following side effects you may need urgent medical attention . the following serious side effects were observed during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure . symptoms may include dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome ( loss of consciousness ). decreased level of consciousness may be associated with confusion , memory loss , and disturbances
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . infusion bag : store in the original package in order to protect from light . liquid nitrogen : the recommended dose is 150 mg per vial . this medicine is made from genetically modified human blood cells and human - derived material . the product is stable for 36 hours at 25Âºc . do throw away any medicines via wastewater or household waste . ask
what tecartus contains - the active substance is autologous anti - cd19 - transduced cd3 + cells . each specific single infusion bag contains a dispersion of anti - cd19 car t cells equivalent to 68 cd3 cells per 2 ml of infusion , corresponding to a concentration of 106 cd3 - cells per ml . - the other ingredients are : sodium chloride and human albumin ( see section 2 " tecartu contains sodium "). what tecartub looks like and contents of the pack tecartucus is a clear , colourless solution for infusion . it is supplied in an infusion bag packed
januvia contains the active substance sitagliptin which belongs to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) which help control blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2abetes . this medication can be used alone or with certain other medicines ( insulin , metformin , sulphonylureas or gl
do not take januvia - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor or pharmacist before taking januvi if you have any of these conditions : - if any of those conditions ( listed under section 4 ) have been reported as blistering of the skin . - if the patient has bullous pemphigoid . janura can cause a disease of the pancreatreas called pancreatitis ( gall
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg film - coated tablet 63 once daily by mouth . if you have kidney problems , your doctor may prescribe a lower dose of 25 mg or 50 mg film film - coating tablets . your doctor will tell you the dose to take . take this leaflet and this leaflelet with you . if necessary , your physician may prescribe this medicine alone or with certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . it is important to
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects : severe and persistent pain in the abdomen ( stomach area ), which might reach through to your back , nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatitis ). if you have a serious allergic reaction ( frequency not known ), including rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing , stop
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglptin phosphate monohydrate equivalent to 25 mg sitaglioptin . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate . the tablet film - coating contains poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide . what januva looks like and contents of the pack pink
xultophy works by reducing blood glucose . it is used to treat type 2 diabetes mellitus in adults . diabetes is when your body does not make enough insulin , or the insulin that your body produces does not work as well as it should . this results in an increase in blood sugar . insulin degludec is a long - acting basal insulin . it helps control your blood sugar levels by lowering the amount of liraglutide ( a substance in glp - 1 ) in the blood . insulin during meals and snacks xultophy is not used in combination with oral medicines for diabetes xultary is not recommended
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). 39 if you have a sulfonylurea such as glimepiride or glibenclamide . your sulfonylation dose should be reduced to a minimum of one tablet daily . your doctor will monitor your blood sugar levels regularly while you are taking xulture . if you suffer from type 1 diabetes mellitus or ' ketoacidosis ', a condition which occurs after you start taking xulinophy , you must also be
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have been blind or have poor eyesight , your doctor may need to adjust your blood sugar level . the recommended dose of xultophy is 41 mg once a day . you should take xultine for 8 days . do not take more than this dose once a week . if necessary , your dose may be adjusted by your doctor . if possible , you may take xulophy with or without food . xultide is supplied in a pre - filled dial - a - dose pen . the
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar ( very common may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out or become unconscious . serious hypoglycaemia ( may cause brain damage ) can occur . if you have low bloodugar , your doctor may check your bloodugar level more frequently . if low blood glucose is not treated , hypoglycasemia can occur ( see section 2 ). serious allergic reaction ( anaphylactic reaction ) ( frequency not known ) if you experience a serious allergic reactions
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening : do not store above 30 . store at room temperature ( up to 25 ) for up to 21 days . do away with the blister once you have established the correct storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units of insulin degluudec 3 . 6 mg liragolutime in 3 ml solution . each vial contains 300 units of the active substance insulin deglioudec 10 . 8 mg liraagluteide in 3ml solution . the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ) and water for injections ( see section 2 " xultphil contains sodium "). what xult
giotrif is a medicine that contains the active substance afatinib . it works by blocking two proteins called egfr [ epidermal growth factor receptor - 1 ] ( egfr1 ) and her2 [ erbb2 ] ( erbb3 ). these proteins are involved in the growth of cancer cells and help to stop them from growing . this medicine stops the growth and spread of cancer types . this medicinal product is used to treat adults with cancer of the lung ( non - small cell lung cancer ). giotrify is used as your first treatment after receiving prior chemotherapy treatment for squamous type a or b if
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if you have low body weight ( less than 50 kg ) if your doctor has told you that you have kidney problems if you think you may have one of the following side effects : lung inflammation ( interstitial lung disease ) if any of these apply to you , tell your doctor . liver problems your doctor may need to do some liver tests before you start taking this medicine . if you suffer from a severe liver disease . if anyof these apply , tell the doctor . eye problems if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . you should take this tablet at the same time each day . giotrif can be taken with or without food . swallow the tablet whole with a glass of water . you can take this dose with or just after food . you may take this this medicine with or with food . if you take more giotrinif than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take this leaflet with you
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects have been reported during treatment with giotreif : diarrhoea common ( may affect up to 1 in 10 people ): diarrhoehoea ( see section 2 for more information on severe diarrhoee and fluid loss ). common ( might affect up in 1 in every 10 people ) low blood potassium ( worsening kidney function ). if you experience diarrhoeea or diarrhoeze contact your doctor immediately . appropriate antidiarrhoeal treatment should be started immediately . if you develop rash , the rash may progress to pe
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afatinab . - the other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 , water for injections . what giotratif looks like and contents of the pack giotrin 20 mg film - coating tablets are white to off - white , round , biconvex , with
what orkambi is orkamsi contains the active substance lumacaftor . ivacaftOR is a medicine used for long - term treatment of cystic fibrosis ( cf ) in patients aged 6 years and older . the patient has a mutation called f508del mutation ( f508d ) in a gene called cystic Fibrosis transmembrane conductance regulator ( cftr ). the mutation causes an abnormal cftl protein in the cells of the lungs . lumacafor works by blocking the activity of the abnormal cFTr protein . what orkami is used for ork
do not take orkambi if you are allergic to lumacaftor , ivacaftour or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking orkammi . if you have been told that you have the f508del mutation , your doctor may need to adjust your dose of orkandemi . talk to a doctor or nurse before taking this medicine if you suffer from liver or kidney disease . your doctor will monitor your kidney function and may adjust the dose of okambie . abnormal blood tests of the liver may be
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 6 to 12 mg once a day . your doctor will tell you how many tablets to take . the usual dose is one orkambi tablet once a morning , 6 to 11 hours before breakfast . your dose of orkammi is 100 mg once daily , taken as 2 tablets in the morning and 2 tablets once in the evening . your daily dose is 12 mg orkandemi once daily . your maximum daily dose of 200 mg is 2 tablets , taken twice daily , in
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects seen with orkambi are usually mild to moderate . however , some patients may be more likely to experience them after they have received ivacaftor . if you are given orkandemi , you may experience serious side effects . these effects may be due to orkmbi : raised levels of liver enzymes in the blood , liver injury , pre - existing severe liver disease , or the worsening of liver function . other side effects include : uncommon ( may affect up to 1 in 100 people ): pain or discomfort in the
what orkambi contains the active substances are lumacaftor and ivacaftir . orkammi 100 mg / 125 mg film - coated tablets each tablet contains 100 mg lumacftor and 125 mg ivacftir . each tablet of orkmbi 200 mg / 200 mg film film - coating contains 200 mg lumiacaftor or 125 mg of ivacaptor . each tablets of orkyambi 100mg / 125mg film - coat contains 200mg lumacaptir and 125mg ivacafor . the other ingredients are : tablet core : cellulose , microcrystall
what lynparza is lynparz contains the active substance olaparib . olaparaib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by preventing mutations ( changes ) in a gene called brca ( breast cancer gene ). in cancer , parp inhibitors cause death by stopping cancer cells from multiplying and multiplying . it also blocks an enzyme needed to repair dna . what lynparaz is used for lynparZA is used to treat adult patients with ovarian cancer called brcas ( mutated ovarian cancer ). it
you must not be given lynparza if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given lynarza . if you have any further questions on the use of this product , ask your doctor or pharmacist . children and adolescents do not give this medicine to children less than 6 years of age . use in children and young children under 2 years of years of ages is not recommended . other medicines and lynparz tell your doctor if you or your child are taking , have recently taken
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of lynparz is 100 mg or 150 mg . the doses of lynarza capsules taken together with tablets may be adjusted . if you take more than a capsule of lynpalza daily than you should if you have taken more than the prescribed dose of one capsule of the same dose , contact your doctor immediately . you may experience side effects for up to 8 days . take the tablets by mouth once in the evening . if possible take the tablet at about the same time each day
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ): allergic reactions including hives , difficulty breathing or swallowing , dizziness . signs and symptoms of hypersensitivity reactions are listed below . other side effects very common : may affect less than 1in 10 people : feeling sick ( nausea ) being sick ( vomiting ) feeling tired
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store any lynparza capsules in the original package in order to protect from light . after first opening , lynparZA capsules may be stored at room temperature ( up to 30 ) for a maximum period of 3 days . discard any capsules that have been stored at the room temperature . do away with any capsules you notice that are damaged or have
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg of olaparaib . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ). what lynparz looks like and contents of the pack lynparparza is a white , opaque , hard capsule imprinted with " olaparatib 50 mg " and " astrazeneca logo " on one side . lynparanza is available in packs containing 112
this medicine contains the active substance naloxone . nalxone is used to treat opioids such as heroin , methadone , fentanyl , oxycodone , buprenorphine and morphine in adults . nyxoid is used as a nasal spray for the emergency treatment of opioid overdose in adults , adolescents and children . opioid overdose is a serious , life - threatening , and sometimes fatal , event that occurs within the first 14 days of life . overdose may cause breathing problems and severe sleepiness . if you have an opioid overdose , you should immediately contact your doctor or get emergency medical care .
do not use nyxoid if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using nyxoids . you may need emergency medical care or emergency services if you have an opioid overdose . the signs and symptoms of an opioid dose may be similar to those of an overdose . if you use more nyxid than you should if you accidentally use more than the recommended dose , contact your doctor or pharmacist immediately . if possible , show them this nasal spray 2 to 3 times . if there is a
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . 1 . symptoms should be : shoulders , ears , breastbone , sternum , ear , fingernail . 2 . clear the mouth and nose of any blockers . 3 . breathe in through the mouth or nose . 1 ). the most important effect of nyxoids breathing is the chest moving . if you breathe in into the chest , you may hear breathing sounds and breath on the cheek . overdose may occur if you have a response to touch or sounds , slow uneven breathing , breathing , sn
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : nyxoid may cause acute withdrawal symptoms ( also called opioid drugs ). symptoms may include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . acute withdrawal reactions may affect up to 1 in 100 people . these symptoms are very
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray contains 1 . 8 mg of nalxone . - the other ingredients are : ( in the powder : hydrochloride dihydrate ), trisodium citrate dihydrates , sodium chloride , hydrochloric acid , sodium hydroxide , purified water . what nyxoids looks like and contents of the pack nyxoidal is a colourless 0 . 1 ml pre - filled nasal spray . it is supplied in a single dose container . nyxid is available in a carton containing 2 nasal sprays in blisters
what ovaleap is ovaleape contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that is similar to a natural hormone , fsh ). it is used to : - stimulate the growth of the sacs ( follicles ) in the ovaries ; - stimulate reproduction ; - delay the production of sperm ; - increase the number of a immature egg cell ; - decrease the amount of a hormone called " clomifene citrate " that can be produced during assisted reproductive technology procedures ( procedures that help you to become pregnant ); - reduce the amount a medicine called
do not use ovaleap if you are allergic to follitropin alfa , follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your hypothalamus or pituitary gland ( the brain ), large ovaries or sacs of fluids that contain the ovaries ( ovarian cysts ), unexplained vaginal bleeding if you know that you have cancer in your ovaries , womb or breasts if you suffer from any condition that makes normal pregnancy impossible , such as ovarian failure in early menopause , fibroid tumours of the womb , malformed reproductive organs
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use this medication is given as an injection into the tissue just under the skin ( subcutaneous injection ). if you have irregular periods , you will usually receive this medicine within the first 7 days of your menstrual cycle . the medicine will be given to you as an infusion . this medicine is given in two strengths : 75 mg and 150 mg . you will normally receive this medication for 7 to 14 days . your doctor will determine the correct dose for you . the usual dose is 37 . 5 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ovaleap : serious side effects in women allergic reactions such as skin rash and raised itchy areas of skin . severe allergic reactions may cause weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 this may affect up to 1 in 10 , 000 people . if you experience this type of reaction , your ovaleop injection may be stopped immediately . serious sideeffects in women lower stomach ache and nausea ( these may be the symptoms of ovarian hyper - stimulation syndrome ( ohss ). the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the cartridge after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine may be stored for a maximum of 3 days below 25 . do away with this medicine if you notice it has been stored for more than 3 days . once the cartridge has been removed from the refrigerator and has reached room temperature ( not above 28 )
what ovaleap contains the active substance is follitropin alfa . each cartridge of ovaleep 300 iu / 0 . 5 ml solution for injection contains 300 iiu ( 22 micrograms ) follitroin ala in 0 . 05 ml solution . each carton of ovatheap 450 iu or 0 . 75 ml solution contains 450 iiu 33 microgram ( 23 microgram ) follitonropin ava in 1 . 5ml solution . ovaleaf 900 iu and 1 . 0 ml solution : each cartridge contains 900 iiu 66 microgram follitruin aloa in
voriconazole accord contains the active substance voriconazol . voricoazole is an antifungal medicine that works by killing or stopping the growth of the fungi that cause infections . it is used in adults and children from the age of 2 years to treat invasive aspergillosis ( a type of fungal infection caused by aspergonillus sp ). candidaemia ( a form of fungo - poi infection caused in candida sp ). in non - neutropenic patients ( patients with abnormally low white blood cells count ) to prevent candida spine infections caused by the fungus flu
do not take voriconazole accord - if you are allergic to voricleazole or any of the other ingredients of this medicine ( listed in section 6 ). - if taking any other medicines , including herbal medicines . the medicines listed below are not recommended during voricazole accord treatment . 46 terfenadine ( used to treat allergy ) astemizole ( used for allergy ) cisapride ( used in stomach problems ) pimozide ( used when treating mental illness ) quinidine ( used if you have irregular heart beat ) rifampicin ( used used to prevent tuberculosis )
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out your dose based on your weight and the type of infection you have . the usual starting dose is 40 mg once a day . this will be increased to 40 mg twice a day for 24 hours . your dose may be increased by 400 mg once daily for 12 hours or 200 mg once every 12 hours for 24 24 hours or 100 mg once per day . depending on how you respond to treatment , your doctor may increase your dose to 300 mg once weekly . if you have mild to moderate
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , you should contact your doctor immediately . serious side effects stop taking voriconazole accord and tell your doctor straight away : rash , jaundice , changes in blood tests of liver function ( pancreatitis ). other side effects very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision ), blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks , visual aura , visual ac
what voriconazole accord contains the active substance is voricazole . each tablet contains 50 mg voricleazole ( as mesilate ). the other ingredients are : voricoazole acord 50 mg ( film - coated tablets ) 200 mg vorbiconazose ( as Mesilate ) the other ingredient in voricaazole accord 200 mg film - coating : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . the tablet coating contains hypromellose ( e464 ), titanium dioxide
mvabea is a vaccine to protect you from ebola virus disease in the future . adults and children from 1 year of age and older who have been exposed to ebola virus , a 2 - dose course of vaccinations is recommended . the active substances in this vaccine are the zaire ebolavirus and filovirus . this vaccine contains the whole ebolairus , which is responsible for giving you ebola fever disease . warnings and precautions talk to your doctor or nurse before you are given mvabeas . vaccinations you should not receive zabdeno vaccine 8 weeks later than mvabaa vaccine .
your child ' s doctor will decide on the vaccination course . the vaccine should not be given if your child has had a severe allergic reaction ( see section 6 . if your baby has a severe allergy reaction to an antibiotic called ' gentamicin ', the vaccine may not be fully effective . if you have had a prior history of a severeergic reaction to any other vaccine injection , tell your doctor . if the child fainted during the injection , bleeding or bruise easily if your infant currently has a fever or an infection , or if your newborn is taking medicines that affect the immune system ( e . g . high - dose cortic
the dose of vaccine is given by a muscle ( intramuscular injection ) in the upper arm or thigh or into a blood vessel . the recommended dose of vaccination is one dose of zabdeno vaccine 8 weeks later . if you are given more mvabea vaccine than you should the second vaccine will be given at the same time . the first dose of the vaccine is recommended . primary vaccination first vaccination with zab deno red cap vial ( 0 . 5 ml ) second vaccination with mvabdenos yellow cap vials ( 0. 8 ml ) if you have missed the first vaccination of zib
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth , swelling or where the injection is given very tired muscle ache joint pain common ( might affect up to 1 in every 10 people ) feeling sick ( vomiting ) itching where the vaccine is given uncommon ( may affects up to1 in every 100 people ): redness , skin hardness where the area of the injection has been given generalised itching where where the medicine is given common ( will affect up in every 1 in
what mvabea contains the active substance is zaire ebolavirus 29 produced in tai forest ebolovirus nucleoprotein marburg in 0 . 7 ml of solution for injection ( antigen ) 108 produced in chickenembryo fibroblast cells . the other ingredients of this vaccine are trace residues of gentamicin , sodium chloride , trometamol , water for injections , hydrochloric acid ( for ph adjustment ). what mvabaa looks like and contents of the pack mvagaa is a suspension for injection in a single - dose glass vial with a rubber stopper and
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer that has spread to your bones ( called ' bone ametastases ') and to prevent your bones from breaking ( fractures ). it is also used to prevent other bone problems that may need surgery or radiotherapy bondronAT may also be used if you have a raised calcium level in your blood due to a tumour . this means that calcium is lost from your bones . this may also mean that your bones become weaker .
do not take bondronat if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ). if you have low levels of calcium in your blood . warnings and precautions talk to your doctor or pharmacist before taking bondronAT if you : have a side effect called osteonecrosis of the jaw ( onj ). onj can cause bone damage in the jaw . your doctor may decide to reduce your dose of bondronatin if you suffer from cancer or related conditions . onj may also occur after stopping treatment . on j is a painful condition that can be difficult to
this medicine is given to you by a doctor or nurse with experience in the treatment of cancer . it is given as an infusion into your vein . your doctor will carry out regular blood tests to check how well you are being treated with bondronat . your dose of this medicine will be adjusted depending on your illness . if you have breast cancer that has spread to your bones , it may take 3 to 3 months ( 3 - 4 weeks ) for an infusion in your vein , but this may be delayed up to 15 minutes if you get a raised calcium level in your blood . this may take between 1 and 2 weeks . if your
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain or inflammation new pain , weakness or discomfort in your thigh , hip or groin . this may be a sign of unusual fracture of the thigh bone . very rare ( might affect up in up to1 in 10 , 000 patients ) pain or sore in your mouth or jaw . these may be signs of severe jaw problems called necrosis ( dead bone tissue ) in the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). after dilution the infusion solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 . do away with this medicine if you notice any particles in the solution . do throw away any medicines via wastewater or household waste .
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial contains a concentrate for solution for infusion that contains 2 mg ibandronat . - the other ingredients are sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water for injections . what bondronAT looks like and contents of the pack 1 ml vials with a bromobutyl rubber stopper .
what zeposia is zepoia belongs to a group of medicines that affect the number of white blood cells ( lymphocytes ). what zepOSia is used for zepoesia is given to adults with relapsing remitting multiple sclerosis ( rrms ), a rare but active disease that affects the nerves of the brain and spinal cord . symptoms include numbness , difficulty in walking and problems with vision and balance . relapsed remitting ms attacks on the nerve cells . the symptoms disappear for a few days or weeks , but for periods that may be months or years . some problems may be serious .
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severely weakened immune system . if you had a heart attack , angina , stroke , mini - stroke or transient ischemic attack ( tia ). if severe heart failure has occurred in the last 6 months . if your heartbeats ( arrhythmia ) are not normal or do not work properly after treatment . if any of these apply to you , tell your doctor . if the patient has severe infection such as hepatitis , tuberculosis or cancer . if he
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will work out the dose of zeposia you need to take and how much you need . your doctor may also check your heart rate and may also give you a ' treatment initiation pack ' with your first dose of treatment . the recommended starting dose is 4 capsules ( 0 . 23 mg ozanimod ) once a day . this will be gradually increased to 1 capsule ( 0 .. 54 mg ) once daily . the maximum recommended starting dosage is 4 capsule ( 1 mg )
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects the following side effects may happen with zeposia : very common ( may affect more than 1 in 10 people ): slow heart rate urinary tract infection ( raised blood pressure uncommon ( may effect up to 1 in 100 people ): allergic reaction . the signs may include a rash . other side effects include : very commonly ( may affects more than one in 10 users ): infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) or voice box ( larynx ). viruses and a type of white blood
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine in the original package in order to protect from moisture . do away with this medicine if you notice any damage or signs of tampering to the pack . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zeposia contains the active substance is ozanimod . zeposeia 0 . 23 mg : each capsule contains 0 . 22 mg ozanimog ( as hydrochloride ). zeposa 0 . 46 mg : one capsule contains approximately 0 . 45 mg ozimod ( as hydchloride ) per capsule . ziposia 0. 92 mg : the entire capsule contains about 0 . 92 mg ozmod (as hydrochlorides ). the other ingredients are microcrystalline cellulose , silica , colloidal anhydrous , croscarmellose sodium , magnesium stearate .
the active substances of temybric ellipta are fluticasone furoate , umeclidinium bromide and vilanterol . fluticusone furaate belongs to a group of medicines called corticosteroids ( steroids ). umecylidinia bromine and vilterol belong to agroup of medicines known as bronchodilators . what temybreric elliptoe is used for temybone ellipta is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties . in
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using temy bric ellipte - if your child has asthma . this is because temybi ellipta can cause asthma . - if the child has heart problems , high blood pressure , liver problems . - tell your doctor if your baby has tuberculosis ( tb ) of the lung , or any long standing or untreated infections .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . try to use temybric ellipta at the start of each day and continue to use it until your doctor tells you otherwise . if you use more temybiric elliptas than you should if you have used more tembricipta than you have been told to , contact your doctor immediately . symptoms of temybreric elliptoe may include a sudden
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse while taking this medicine , stop taking temybric ellipta and seek medical help straight away . pneumonia ( infection of the lung ) in copd patients the most common side effect of temybarric elliptoe is symptoms of a lung infection such as fever and chills . increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) sore or raised patches in the mouth or throat . this
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose contains 92 micrograms of flutic asone firoate , 65 microgram of umechloridinum bromate and 55 microgram s of umclidinicium ( corresponding to 22 microgram / ml of vilansterol ) and trifenatate . the other ingredients are lactose monohydrate ( see section 2 under ' temy bric elliptas contains lactose '), magnesium stear
zinforo is an antibiotic medicine that contains the active substance cefaroline fosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo helps to prevent infections of the skin and the tissues below the skin . it is used to treat an infection of the lungs called ' pneumonia '. zzinforoe is used in adults . zin foro works by killing certain bacteria that cause serious infections .
do not take zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have had previous severe allergic reactions to other antibiotics , such as penicillin or carbapenem . warnings and precautions talk to your doctor or pharmacist before taking zin foro . tell your doctor before taking this medicine if any of these apply to you . if any information gets serious , or if you notice any unusual effects , please tell your physician or pharmace
the recommended dose of zinforo is 600 mg once a day . your doctor will tell you how many capsules to take . the recommended dose is one 600 mg tablet once a week for up to 8 weeks . some infections may be serious and your doctor may decide to reduce your dose to one 600mg tablet once every 8 weeks or to one 12 mg tablet twice a week . zinfforo will be given to you by a doctor or nurse as a drip into a vein . the usual dose is 5 mg once daily . your dose may be increased to 60 mg once every 120 days . your physician may decide that you
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems , asevere allergic reaction ( anaphylaxis ), diarrhoea , stool , blood or mucus . treatment with zinforo may be stopped or medicines may be given to slow bowel movement ( see section 1 ). your doctor may ask you to have a blood test called a ' coombs test ' to check for a type
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is ceftaroline fosamil . the other ingredients are arginine and water for injections . what zinfareo looks like and contents of the pack zinofo is a pale yellowish to light yellow powder for solution for infusion in a vial . it is supplied in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neuropathicpain : pregabalin pumpfizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neuropathic Pain , such as diabetes or shingles . pain sensations may be described as hot , burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling , numbness or pins and needles . peripheral or central neuropathy pain may also be associated with
do not take pregabalin pfizer if you are allergic to pregagabalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregabil pfiser . some patients taking pregaabalin prefizer have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat and diffuse skin rash . should you experience any of these reactions , you should contact your doctor immediately . pregibalin has been associated with dizziness and somnolence , which may increase the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is for oral use . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder : the usual dose is 150 mg once a day . your doctor may increase your dose to 600 mg once daily depending on your response to pregafalin pfeizer . you should take pregagabalin prefizer once in the morning and once inthe evening . for 59 patients , the usual starting dose is one tablet of pregaboralin pafizer once
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common : might affect up to 1 in every 10 people increased appetite , feeling of elation , confusion , disorientation , decrease in sexual interest , irritability , disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal , blurred vision , double vision , vertigo , problems with balance
what pregabalin pfizer contains the active substance is pregibalin . each hard capsule contains 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg or 300 mg of pregabialin . the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica . the printing ink contains black ink , shellac , black iron oxide ( e172 ), propylene glycol ( e1520 ), potassium hydroxide . the 75 mg
xadago is a medicine that contains the active substance safinamide , which increases the levels of dopamine in the brain . this is a chemical in the body that is important for movement . in parkinson ' s disease , the most common symptom of parkinson is sudden swings in the ability to move . this may lead to difficulties moving . xadago can be used alone or in combination with levodopa ( other medicines used to treat parkinson' s disease ).
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is taking any of any of : - monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ), moclobemide , phenelzine , isocarboxazid , or tranylcypromine . these are all used in treatment of parkinson ' s disease or depression . - pethidine ( a strong pain killer ). if your dose is reduced or your child has
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg twice a day ( taken 100 mg by mouth ). your doctor will tell you how many tablets of xADago to take . if you have moderately reduced liver function , your doctor may prescribe a lower dose of 50 mg once a day . take xadadago at the same time each day . you should swallow the tablets whole with a glass of water . xadagon can be taken with or without food . if taking more xadag than you should
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure , which may lead to collapse ) has been reported in patients with neuroleptic malignant syndrome ( confusion , sweating , muscle rigidity , hyperthermia ), increase level of enzyme creatine kinase in your blood ( serotonin syndrome ), confusion , hypertension , muscle stiffness , hallucinations ( hypotension ). the following side effects have been reported with the use of parkinson ' s disease in combination with safinamide and levodopa . other medicines and xadago have also been reported . in patients treated with park
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg safinam . - the other ingredients are methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating contains hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( e172 ). what xadadago looks like and contents of the pack xadagon 50 mg film - coated tablets of 7 mm diameter with metallic gloss are white , round , bicon
zytiga contains a medicine called abiraterone acetate . it is used to treat prostate cancer that has spread to other parts of the body . zytiga reduces the amount of testosterone in your body . this reduces the risk of prostate cancer . ztiga is used in patients who have disease that has not responded to hormone therapy or who are not taking a treatment that lowers testosterone ( androgen deprivation therapy ). it is also used in combination with another medicine called prednisone . prednisolone is used for high blood pressure in adult patients whose body is not able to absorb the full amount of fluid from
do not take zytiga if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant . warnings and precautions talk to your doctor or pharmacist before taking zytig if you have severe liver damage or prostate cancer . this medicine should not be used if you know that you are taking this medicine . talk to a doctor or nurse before taking this type of medicine if any of these apply to you . if you do not have any information , talk to the doctor or other healthcare professional before taking the medicine . if any information applies
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once a day . you should take this tablet at the same time each day . this medicine should be taken by mouth . take the tablet at about the same times each day , with or without food . swallow the tablet whole with a glass of water . do not crush or chew the tablet . zytiga can be taken with or just after food . if you take more zytig than you should if you accidentally take more than the prescribed dose , contact your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : muscle weakness , muscle twitches , a pounding heart beat or palpitations . the level of potassium in your blood is low . your doctor may need to increase your dose of potassium . other side effects include : very common ( may affect more than 1 in 10 people ): fluid in your legs or feet ( signs of low blood potassium or liver function test ). high blood pressure . urinary tract infection . diarrhoea . common ( might affect up to 1 in every 10 people )
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abirate acetate - the other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see section 2 " zytigo contains lactose ". what zytig looks like and contents of the pack - zytige tablets are white to off - white , round tablets with " 9 . 5 " engraved on one side .
hefiya contains the active substance adalimumab , a medicine used for the treatment of inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis , paedile crohn ' s disease and paediatric non - infectious uveitis . adalumab is a monoclonal antibody . monoclal antibodies attach to specific proteins or antigens . adlimumab attaches to a specific target in the body called tumour necrosis factor ( tnfÎ± ), which is involved in the inflammatory diseases and reduces the inflammation in these
do not take hefiya if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your or your child ' s child has a severe infection , including tuberculosis , sepsis ( blood poisoning ), or other opportunistic infections ( unusual infections caused by a weakened immune system ). symptoms of infections may include fever , wounds , feeling tired , dental problems . if your / your child has moderate or severe heart failure . if you or your son has a serious heart condition . warnings and precautions talk to your doctor or pharmacist before taking hefiYA . allergic reactions may
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg capsule twice a day . your doctor may prescribe a different dose for you . the dose may be increased by 20 mg or 40 mg . your child ' s doctor may decide to increase the dose to 20 mg and 40 mg once a day if your child has recovered from polyarticular juvenile idiopathic arthritis age and body weight how much to take adults , adolescents and children from 2 years of age weighing 30 kg or more 40 mg twice a week . children from 1
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . tell your doctor straight away if you notice any of the following side effects you may have had in the last 4 months after the last hefiya injection : allergic reaction ( including heart failure ). severe rash , hives , swollen face , hands , feet , trouble breathing , swallowing , shortness of breath and swelling of the feet . signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on urination , feeling weak or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a maximum period of 14 days . once removed from the refrigerator for room temperature storage , your pre -filled syringe may be used for a single period of
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of adalimab in 0 . 4 ml of solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections . what hefiYA looks like and contents of the pack hefiah 20 mg / 0 . 04 ml solution for injection is a clear to slightly opalescent , colourless to slightly yellowish solution . it is supplied in a clear
what ritemvia is ritemv contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a target in a type in the body called a white blood cell called b - lymphocyte . when ritukimab sticks to the target of b - locytes , ritemva stops the cell from growing and dividing . what ritemvy is used for ritemvan is used to treat a ) non - hodgkin ' s lymphoma . this is an illness of the lymph tissue that affects the immune system . it affects
do not take ritemvia if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe active infection if you suffer from a weak immune system if you suffered from severe heart failure or severe uncontrolled heart disease if you know that you have granulomatosis , polyangiitis , microscopic polyangiaritis or pemphigus vulgaris warnings and precautions talk to your doctor or pharmacist before taking ritemria if you : have ever had or might now have a
how much ritemvia is given your doctor will decide how much ritemvia you will receive and how often you will need this treatment . your doctor may decide to reduce the dose or stop you using this medicine if you experience any side effects . how ritemv is given ritemva is given as a drip ( intravenous infusion ). medicines given before each ritmvia administration you will be given ritamvia together with other medicines ( pre - medication ) to reduce possible side effects and to improve the course of your treatment . if you have non - hodgkin ' s lymphoma you will first be
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of platelets ,
what ritemvia contains - the active substance is rituximab . each ml of concentrate contains 100 mg of ritukimab ( as besilate ). each ml concentrate contains 10 mg of the active ingredient of ritonuximb . - the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritemva looks like and contents of the pack ritemv is a clear , colourless solution for infusion in a glass vial . pack size of 2 vials .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitabrine teva contains capecitibine , which itself is not a cytostatics medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine . capecabine cheva is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , capecitafine teeva is used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery . cape citabineteva may be
do not take capecitabine teva - if you are allergic to capecitibine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks you may have an allergy to this medicine . - if severe reactions have been reported following fluoropyrimidine therapy ( a group of anticancer medicines , such as fluorouracil ). - - if pregnant . - - you have low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ). - you suffer from severe liver or kidney problems . -
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you . the dose of capecitabiline teva depends on your body surface area ( height and weight ). the usual dose for adults is 1250 mg / m2 of body surface surface area taken once daily . this is given as one tablet of 150 mg in the morning and one tablet in the evening . the usual starting dose for children
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you have any of these symptoms : diarrhoea : if you experience an increase of 4 or more bowel movements compared to your normal bowel movements , or any diarrhoehoea at night . vomiting : if vomiting is more severe than nausea . if you lose your appetite . stomatitis : if pain , redness , swelling or sores in your mouth and / or throat , especially in the hand or foot . skin - reaction : if your doctor feels that you have
what capecitabine teva contains the active substance is capecitabiline . capecitibine teeva 150 mg film - coated tablets each film - coating contains 150 mg capecitobine . the other ingredients are : capecitafine tevas 500 mg film film - coat contains 500 mg capecabine . tablet coating : lactose , microcrystalline cellulose , hypromellose , croscarmellose sodium , magnesium stearate , macrogol 400 , hypromeellose, titanium dioxide ( e171 ), yellow iron oxide ( e172 ), red iron oxide red ( e 172
silodosin recordati contains silodosan recordati . it belongs to a group of medicines called alpha1a - adrenoreceptor blockers . silodosein recordat is used to lower the pressure in the prostate , bladder and urethra . it helps to maintain smooth muscle in these tissues . this helps to reduce your symptoms . siloosin Recordati is used in adults to : treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as difficulty in starting to pass water , and a feeling of not completely emptying the bladder .
do not use silodosin recordati - if you are allergic to silodosein or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using silodousin recordi - if eye surgery has been performed - if there is cloudiness of the lens ( cataract surgery ) in your eye 26 - if silodosiin recordat has been used in combination with medicine to cause a loss of muscle tone in the iris ( the coloured part of the eye ) during a surgery , your doctor will take appropriate precautions when using this type
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one capsule of silodosin recordati taken once a day , with or without food . the maximum recommended dose for adults is 8 capsules taken once daily . if you have kidney problems if you suffer from moderate kidney problems , your doctor may prescribe a lower dose . for this purpose silodosein recordat is taken once every day , at about the same time each day . swallow the capsule whole with a glass of water . do not chew or crush the capsule . if possible take
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives are the most common side effect of silodosin recordati . dizziness . dizzy and occasionally fainting may occur . if you feel weak or dizzy , stop taking the medicine and contact your doctor straight away . the symptoms may include dizziness and faints . if any of the above occur , stop using silodnosin recordat and contact a doctor immediately . complications following a cataract surgery ( including
what silodosin recordati contains silodusin recordat 8 mg : the active substance is silodofin . each capsule contains 8 mg silodosein . the other ingredients are mannitol , magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). silodnosin recordatin 4 mg : silodousin . what silodosesin recordatis looks like and contents of the pack silodosiin recordi 8 mg hard capsules are white , opaque , hard gelatin capsules , imprinted with " s 8 " on one side . they are approximately 21
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in the body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzalono blocks the effect of angiotenin ii so that the blood vessels relax , and your bloodpressure is lowered . kinzonmono is used to treat essential hypertension ( high blood pressure ) in adults . the high blood blood pressure is not caused by any other condition . high bloodpressure , if not treated , can damage blood vessels in several organs , which could lead sometimes
do not take kinzalmono - if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). - if more than 3 months pregnant ( it is also better to avoid kinzalao in early pregnancy see pregnancy section ). - tell your doctor if you have severe liver problems ( such as cholestasis or biliary obstruction ) which are problems with drainage of the bile from the liver and gall bladder . - tell you doctor if any other severe liver disease is known . - if your doctor has told you that you have diabetes or impaired kidney function and you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day . the tablets should be swallowed whole with some water . you can take kinzalmono with or without food . try not to crush or chew the tablet . if you take more kinzdalmono than you should if you have accidentally taken too many tablets , contact your doctor immediately . treatment of high blood pressure the usual starting dose of kinzhalmono is 40 mg once a day to
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention : sepsis ( often called " blood poisoning "), a severe infection with whole - body inflammatory response , rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). other side effects of kinzalmono common side effects ( may effect up to1 in 10 people ): low blood pressure ( hypotension ) reduction in cardiovascular events . uncommon side effects these may affect upto 1 in 100
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . once your medicine has been taken out of your refrigerator , it must be used within one week . do this by referring to the new expiry day on the blister . do away with the blister and write the new expiration date on the outer carton . do you notice any change in the appearance of the tablets ? do not throw away any medicines via wastewater
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisantan . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol , magnesium stearate . what kinzalao looks like and contents of the pack kinzalanmono 20 mg tablets are white to off - white , round and flat . kinzaloo is available in blister packs of 14 , 28 , 56 or 98 tablets . not all pack sizes may be marketed .
afstyla is a human clotting ( coagulation ) factor viii product produced by recombinant dna technology ( rdna ). the active substance is lonoctocog alfa . afstylfa is used to treat bleeding episodes in patients with haemophilia a ( inborn factor v iii deficiency ). factor vii is involved in blood clotting and helps blood to clot . afstonyla has an increased tendency to bleed . factor v ii is important for the blood to form clot . your doctor has prescribed afstylea for you because you have been told by your doctor that you
do not use afstyla if you have had an allergic reaction to afstylea or if you are allergic to hamster proteins 46 warnings and precautions talk to your doctor , pharmacist or nurse before using afstrya . the dose and the batch number should be recorded in your treatment diary . do not use more afstilea than your doctor has recommended . allergic ( hypersensitivity ) reactions are rare . tell your doctor or pharmacist before using the product if you notice any of the following symptoms of allergic reactions : allergic reactions may include hives , generalised skin rash , tightness of the chest , whe
your treatment will be overseen by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the recommended dose of afstyla is one vial per day . dose and duration of treatment depending on your disease the site and the bleeding your clinical condition will be worked out by your doctor . reconstitution and administration general instructions the powder and the solvent ( liquid ) should be used immediately after reconstration . if you have aseptic conditions , you may be given afststylas together
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may occur with the following symptoms : hives generalised urticaria ( itchy rash , tightness of the chest , difficulty in breathing , wheezing ), low blood pressure , dizziness ( anaphylaxis ), bleeding caused by factor viii medicines ( inhibitor antibodies ) ( see section 2 " warnings and precautions "). very common ( may affect more than 1 in 10 people ) patients who have received previous treatment with factor v iii ( more than 150 days of treatment ) and who have developed uncommon
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 hours at 2 8
what afstyla contains the active substance is lonoctocog alfa . each vial contains 250 iu ( 2 . 5 mg / ml ). after reconstitution with 2 .5 mg / lonoectocog aluminium , the solution contains 100 iu lonoCTocog alpha . after reconstall with 2. 5 mg of lonoactocog Î± , the product contains 200 iu of loroctocag alfa , the corresponding product is 1000 iu / ml . after initial reconstation with 5 mgof lonofactocog aluminum , the resulting product is 400 i
what praxbind is prax bind contains the active substance idarucizumab . idarucaizumb is a recombal agent of the human blood called dabigatran ( pradaxa ). it is a blood thinner medicine used to prevent blood clot formation . what praxBind is used for it is used to rapidlytrap dabigATran . what is praxebind used for ? praxbinding is used in combination with pradxbind in adults who are undergoing emergency surgery or urgent procedures to stop uncontrolled bleeding .
do not take praxbind if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a genetic disease called hereditary fructose intolerance ( hfmt ). if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking this medicine : if you experience serious adverse reactions when taking prax bind , tell the doctor immediately . this medicine contains dabigatran . other medicines may increase the risk of blood clots . dabigitran is a substance that is absorbed by the body and helps to prevent blood cl
the recommended dose is 5 mg / kg body weight ( kg ) taken once daily . this will be given to you by a doctor or nurse . your doctor will decide the dose that is right for you . the recommended dose will be 2 . 5 mg dabigatran per kg bodyweight . this medicine will be administered once daily for 5 days . this is given as a single dose into a vein . your healthcare professional will administer this medicine to you during your treatment . if you have problems with blood clot formation , dabigATran may be administered less than 24 hours after you have been given this medicine . if any of the
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what prax bind looks like and contents of the pack praxbinding is a clear to slightly opalescent , colourless to slightly yellow solution . it is supplied in a clear glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used to treat specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . temormac is first given together with radiotherapy ( concomitant phase of treatment ) and then with monotherapy phase oftreatment . - in children 3 years of age and older and adult patients with malignant glioma , such as gliOBlastoma multipurpose or anaplastic astrocytoma . temmedac is given in combination with
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness , wheezing , swelling of the face , lips , tongue or throat . if certain kinds of blood cells are severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells help to keep you alive and help you with fighting infection . proper blood clot
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac based on your height and weight . this is especially important if you have a recurrent tumour that has not responded to chemotherapy treatment in the past and you are taking other medicines ( anti - emetics ). temomedicac can be used to prevent nausea and vomiting in patients with newly - diagnosed glioblastoma multiforme . treatment is divided into two phases : treatment with radiotherapy ( concomitant phase ) and
like all medicines , this medicine can cause side effects , although not everybody gets them . if you have a severe allergic ( hypersensitive ) reaction , including hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures ( convulsions ), fever , chills and severe headache , you should stop temomedac treatment and contact your doctor immediately . there may be a reduction in certain kinds of blood cells . this may include increased bruising or bleeding , anaemia ( reduced number of red blood cells ), fever and reduced resistance to infections . the reduction in blood cell counts is usually short - lived and can lead to anaemia ('
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . do away with the capsules if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains - the active substance is temozolomide . temomedat 5 mg : each capsule contains 5 mg of temozolsomide ( as mesolomides ). temomedacon 20 mg : every capsule contains 20 mg of the active substances temozolaomide , as mesoledos . temmedac 100 mg : one capsule contains 100 mg of a substance called temozoledomide [ as mesomedac ]. temomedax 140 mg : the entire capsule contains 140 mg of of tem ozolomime [ as temoledac ]. each capsule of 180 mg contains 180 mg of
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard erect penis suitable for sexual activity . cialis helps to keep a firm , erect penis erect . cialsis contains the active substance tadalafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors . calis works by helping the blood vessels in your penis to relax . this allows your penis stay hard and erect for a long period of time . this helps to maintain erectile function . ceralis is used to treat adult men who have erectile disease .
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you are taking organic nitrate or nitric oxide donors such as amyl nitrite ( a group of medicines (" nitrates ") used to treat angina pectoris (" chest pain "). warnings and precautions talk to your doctor before taking ciali if you : - are taking any of these medicines ( see section " other medicines and cialises ") - have serious heart disease - recently had a heart attack within the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablets whole with a glass of water . the tablets can be taken with or without food . the usual dose is between 5 mg and 2 . 5 mg . if you take more cialises than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , show them the pack . if necessary , show the doctor the pack of tablets . if not , show it to your partner
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions ( rashes ) ( frequency not known ) chest pain ( may occur with nitrates ). the frequency is not known ( frequency cannot be estimated from the available data ). priapsim may cause a prolonged and possibly painful erection . if you are not sure , talk to your doctor or pharmacist before taking cialis . if this happens , tell your partner straight away . if an erection occurs ( frequency is unknown ) tell your doctor immediately . sudden loss of vision ( frequency frequency is common
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of tadalabil . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film - coating : lactate monohydrate , hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide yellow ( e172 ), ironoxide red ( e 172 ), talc . what cialises looks
enyglid is an oral antidiabetic medicine that contains repaglinide . it works by helping your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not make enough insulin to control the sugar in your body or where the insulin is not working properly . enyglide is used to treat type 2 diabetic in adults . treatment is usually started with diet and exercise and weight reduction . your bloodugar may be increased when you start to take enygalid on its own or on its combination with metformin . if you have
do not take enyglid if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low ( diabetic ketoacidosis ). if your doctor has told you that you have a severe liver disease . if you take gemfibrozil ( a medicine used to lower increased fat levels ). if any of these apply to you , tell your doctor . if your dose is too high . if any combination of eny glid or gemfabrozils ( a medication used
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . the maximum recommended dose for adults is 30 mg once a week for 4 weeks . the dose may be increased to 30 mg twice a day for 16 weeks . your doctor will work out the right dose for you . if you take more enylid than you should if you accidentally take too many enygelid tablets ,
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is the most common side effect . hypocaemia may affect up to 1 in 10 people . hypoptycaemic reactions are generally mild / moderate . hypocemic unconsciousness may lead to coma . allergy allergy is rare ( may affect less than 1 in every 10 , 000 people ). symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( anaphylactic reaction ). other side effects may include : common ( may effect up to1 in 10 , 00 people ): stomach pain diarrhoe
what enyglid contains the active substance is repaglinide . each 0 . 5 mg / 1 mg film - coated tablet contains 2 mg repagginide . the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ) only in 1 mg tablets and red iron oxide (< e172 ). only in 2 mg tablets what eny glid looks like and contents of the pack eny Gl
what azacitidine mylan is azacitonidine myl is an anti - cancer agent . what azaccitidine mylon is used for azacita mylan contains the active substance azacinidine . what it is used used for ? azaciticidine myla is used in adults . azacituidine mylin is used after a stem cell transplantation in adult patients with higher - risk myelodysplastic syndromes ( mds ). it is also used in adult adult patients for chronic myelomonocytic leukaemia ( cmml ). it can also be used in
do not take azacitidine mylan - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azac citidine myl : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - has liver disease . if you have a heart condition that could lead to heart attack . - have lung disease . your doctor will do blood test before you start treatment
before starting azacitidine mylan , your doctor will give you another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor may increase your dose of this medicine depending on your height and weight . azaccitidine myl is given every 3 weeks as part of this " treatment cycle " ( cycle 4 , 6 ). this medicine is given under the skin ( subcutaneously ) by subcutaneous injection ( subtype ). it may be given under your skin ( on the thigh , tummy or upper arm ). if you have any further questions on the use of this product , ask
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice ( abdominal bloating and easy bruising ), which may be symptoms of liver failure , swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue , which may also be symptoms or signs of kidney failure . a fever , which might be a sign of an infection with low levels of white blood cells . chest
your doctor , pharmacist or nurse knows how to store azacitidine mylan properly . any unused azaccitidine myl must be disposed of in accordance with local requirements . this medicine is for single use only . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . the azacnitidine mylon suspension is for injection and must be stored in the original package in order to protect from light . the suspension can be stored for up
what azacitidine mylan contains the active substance is azaccitidine . one vial of powder contains 100 mg azacacitine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg azacyl . the other ingredient is mannitol ( e421 ). what azacituidine myl looks like and contents of the pack azacitonidine mylon is a white powder for suspension supplied in a glass vial containing 100 mg of azacito . pack sizes of 1 and 7 vials . not all pack sizes may be marketed .
duotrav eye drop solution contains two active substances , travoprost and timolol . travaprost is a prostaglandin analogue in the eye . timoll is a beta blocker that reduces the amount of fluid within the eye and reduces pressure within theeye . duotraveye drops are used to treat high pressure in theeye due to an illness called glaucoma .
do not take duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( wheeziness , difficulty in breathing , long - standing cough , breathing problems , severe hay fever , a slow heartbeat ), heart failure ( a disorder of heart rhythm , irregular heartbeat ), or if the coloured part of your eye ( cloudy ) gets darker . warnings and precautions talk to your doctor or pharmacist
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop in each eye twice a day . do not use duotrav in both eyes . your doctor will tell you how many drops of duotrave to use . how to use eye drops the recommended doses are 1 , 2 , 3 , 4 drops . a bottle is provided with each bottle . 1 . wash your hands . remove the bottle from the bottle . hold the bottle with a thumb and / or fingers . tilt your head back . pull down your eyel
like all medicines , this medicine can cause side effects , although not everybody gets them . the drops should be kept in the bottle to help protect your eyes . duotrav can cause very common side effects ( may affect more than 1 in 10 people ) effects of the eye eye redness . common side side effects these may affect up to 1 in every 10 people . effects of of theeye eye surface inflammation or surface damage such as eye pain , blurred vision , abnormal vision , dry eye , itchy eye , eye discomfort . signs and symptoms of eye irritation such as burning or stinging . uncommon side effects this may affect upt to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . store in the original package in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what duotrav contains - the active substances are travoprost and timolol . each ml contains 40 mg travostrost and 5 mg timolole ( as timololine maleate ). - the other ingredients are polyquaternium - 1 , mannitol , propylene glycol , polyoxyethylene hydrogenated castor oil 40 mg , boric acid , sodium chloride , sodium hydroxide , hydrochloric acid , purified water , sodium hydroroxide and hydrochlorIC acid . acidity levels may be raised when dilution is taken at ambient temperature . what duotra looks like
nplate ' s active ingredient is romiplostim . it is a protein that helps to reduce low platelet counts in the immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease that affects your body ' s immune system . platelets are important as they help to protect the blood from blood clots . very low platelets can lead to bruising and serious bleeding . nplate is used to : - treat adults 1 year of age and older who have had their spleen removed . - treat adult patients with chronic itp who have not previously used cortic
do not take nplate - if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). - if allergic to other medicines containing escherichia coli ( e . coli ). warnings and precautions talk to your doctor before taking nplate if you have a low blood platelet count ( thrombocytopenia ). nplate may reduce your platelet counts . this is because it reduces the chances of blood clots forming . it reduces blood clotting . - if your doctor has told you that you have liver problems . - you are over 65 years old . -
nplate is given to adults and adolescents ( aged 1 to 17 years ) who are able to take nplate . nplate is intended for use in adults and children aged 1 year to 17 . n plate is given as an injection under the skin ( subcutaneous ). it is given at least 1 hour before or one hour after a meal . how nplate works nplate will be injected into your body every day . your doctor will check your platelet counts regularly . you will have regular blood samples taken to measure your platelets . your platelelet count will be checked regularly . your blood will be taken regularly to measure the
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : common ( may affect up to 1 in 10 people ): headache allergic reaction upper respiratory tract infection common ( might affect up in 1 in every 10 people ) bone marrow disorder ( increased bone marrow fibres ) trouble sleeping ( insomnia ) dizziness tingling or numbness of the hands or feet ( paraesthesia ) migraine , redness ofthe skin ( flushing ) blood clot in a lung artery ( pulmonary embolism ) nausea , diarrhoea , abdominal pain , indigestion
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do away with the blister after 30 days . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nplate contains the active substance is romiplostim . nplate 125 mg powder for solution for injection contains 230 mg romiplopim . each vial contains 125 mg romplostim in a deliverable amount of 0 . 25 ml solution . each millilitre ( ml ) contains 125mg romipliplostime . each 500 mg vial of nplate 250 mg powder contains 375 mg romoplostim ( as an injection ). each 250 mg vials of romiplustim in the form of a deliverables amount of 1 ml solution , each containing 250 mg romclostim and 500 mg n
this medicine contains an active substance called glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to help breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd , the muscles around the airways tighten , making breathing difficult . this medicine prevents the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using tovanOR breez inhaler - kidney problems - an eye problem called narrow - angle glaucoma - difficulty passing urine . your doctor will decide whether treatment with tovannor breezer is appropriate for you . if you have any of these , tell your doctor immediately . - tightness of the chest , coughing , wheezing or breathlessness immediately after using
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the recommended dose of this medicine is one inhalation each day . you should inhale this medicine at about the same time each day , with food . you can inhale it at any time of the day , from the time of your first meal , to the time you last go to bed . the recommended starting dose is one 24 - hour inhalation of 75 micrograms per day . your doctor will tell you how many capsules to use each day
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopirroniumbromide and 50 microgramms glycopyronium . each delivered dose delivers the delivered dose into the mouthpiece of the inhaler equivalent to 44 microgram of glycopYRronium per inhalation . - the other ingredients of the formulation powder are lactose monohydrate and magnesium stearate . what tovanOR breez inhaler looks like and contents of the pack tovannor breezer 44 microspheres are hard capsules
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by relaxing the brain ' s natural dopamine and serotonin - releasing mechanisms , which are involved in calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia and bipolar disorder . these are diseases characterised by symptoms ( for example , schizophrenia ) hearing , seeing things which are not there , mistaken beliefs , incoherent speech and behaviour and emotional flatness . people with bipolar disorder may also feel depressed , guilty , anxious or tense . the
do not take adasuve if you are allergic to loxapine or amoxapina . warnings and precautions talk to your doctor or pharmacist before taking adasuves if you have symptoms such as wheezing , shortness of breath , lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness and shortnessof breath 25 if you suffer from neuroleptic malignant syndrome ( nms ), which can be symptoms of antipsychotic medicines . these symptoms include high fever , rigid muscles 47 and irregular
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg twice a day ( for 2 weeks ) and 4 . 5 mg twice daily . if your condition worsens , your doctor may prescribe a lower dose . adasuve is for oral use . you should take adasuves with food . it is best to take adasve with a meal or between meals . it does not matter whether you take adamsve with food or between drinks . it may help to take the medicine at the same time each day . it
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following side effects : - any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness , which may become irritating . these may be signs that your airways are not working properly ( asthma or copd ). - light - headedness or fainting . these could be signs of a problem with your blood pressure . - worsening agitation , confusion , fever and muscle stiffness . these can be signs for a severe condition called neuroleptic malignant syndrome . other side
keep this medicine out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do away with any medicines that are damaged or shows signs of physical damage . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of loxapeine . one delivers 4 . 5 mg loxideine . what adasuves looks like and contents of the pack adasuva 4 .5 mg is a white to off - white plastic inhaler , with " loxpine " printed on the cap and " 4 . 0 " printed in black on the body . each inhaler is packed in a sealed foil pouch . adasuvet 4 . 3 mg is available in packs containing 1 or 5 inhalers . not all pack
what azacitidine betapharm is azacitonidine betabarm is an anti - cancer agent . it belongs to a group of medicines called ' anti - metabolites '. what azaccitidine betafarm is used for azaciticidine betaparm is for use in adults . azacituidine betagarm is given to adults after a stem cell transplantation in the following situations : - higher - risk myelodysplastic syndromes ( mds ) - chronic myelomonocytic leukaemia ( cmml ) - acute myeloid leukaemic ( aml ).
do not take azacitidine betapharm - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacacitine betapham : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - tell your doctor if the person has liver disease . if the doctor has recently told you : - have a heart condition that has been severe ( such
before starting azacitidine betapharm , your doctor will give you another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor may increase your dose of this medicine depending on your height and weight . you will normally receive azaccitidine betabarm every 3 weeks during this " treatment cycle " ( cycle 4 to 6 ). this medicine is given under the skin ( subcutaneously ) by subcutaneous injection ( subarmaneous use ). this is usually done under the sun ( subcovering the skin on the thigh , tummy or upper arm ). if you have any further
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice ( abdominal bloating and easy bruising ), which may be symptoms of liver failure , swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue , which may also be symptoms or signs of kidney failure . a fever , which might be a sign of an infection with low levels of white blood cells . chest
your doctor , pharmacist or nurse knows how to store azacitidine betapharm properly . any unused azaccitidine betabarm must be disposed of in accordance with local requirements . this medicine is for single use only . this medicinal product does not require any special storage conditions . the suspension must be used within 45 minutes . the azacitsidine betafarm suspension will be prepared and diluted with water for injections . the preparation will be stored in a refrigerator ( 2 8 ). the azacsitidinebetapharm suspension is prepared and stored in the refrigerator ( 3 8 ) for up to 8 hours . the z
what azacitidine betapharm contains - the active substance is azacitonidine . each vial contains 100 mg azacitasidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaccitidine . - the other ingredient is mannitol ( e421 ). what azacituidine betafarm looks like and contents of the pack azaciticidine betabarm is a white to off - white powder supplied in a glass vial containing 100 mg of azacito .
cirdelga contains the active substance eliglustat . this is used for the long term treatment of gaucher disease type 1 in adults . gaucher diseases type 1 is inherited condition in which the body produces too much glucosylceramide , which is not normally tolerated . it is especially toxic for the organs in your body such as the spleen , liver and bones . your doctor will test your body to make sure that eliglustAT is working properly and that glucosyleceramide is not damaging your affected organs . your physician will prescribe this medicine to you by a doctor or nurse . if you have any further questions
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). - if your body is taking medicines called moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ) 31 - if it is taking moderate cyc3a inhibitors ( such as erythromycin or itraconazole ). these medicines are used to improve your body ' s ability to absorb nutrients . warnings and precautions talk to your doctor before taking cerdelg . cerdelgas should not be used in patients with medicines that
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet twice a day with food . the amount of metaboliser that you need to take depends on your condition and the amount you are taking at the time of day . the dose of metabolizer that you take is one 84 mg tablet twice daily . swallow the tablet whole with water . do not divide , crush or chew the tablet . if you take more cerdelga than you should if you accidentally take too many tablets , contact your doctor immediately . how to take take the tablet in
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations throat irritation heartburn ( dyspepsia ) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting dry mouth gas ( flatulence ) dry skin hives ( ur
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and sleeve after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of eliglustate . - the other ingredients are microcrystalline cellulose , lactose monohydrate ( see section 2 ' cerdelaga contains lactose '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine ( e132 ). - the printing ink contains shellac , black iron oxide , propylene glycol and ammonia solution . what cerdelg looks like and contents of the pack cerdel
the active substance in zoledronic acid hospira is zoledor acid , which belongs to a group of substances called bisphosphonates . zoledron acid works by attaching itself to the bone and slowing down the rate of bone change . it is used to prevent bone complications , e . g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the rest of the bone ). it reduces the amount of calcium in the blood in adult people when it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of
your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and during treatment . you should not be given zoledron acid hospir - if you are allergic ( hypersensitive ) to zoledor acid , another bisphosphonate ( the substance to which zoledoral acid belongs ), or any of the other ingredients of zoledicle acid hospiar ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before you are given zedronic acid hospira : - if your doctor has told you that you have a kidney problem . - if any of these apply
zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously ( into a vein ) and under ' iv ' administration . this is in order to prevent dehydration . how much zoledronic acidic hospira is given the recommended dose is 4 mg . if you have a kidney problem , your doctor may decide to lower the dose or stop your dose completely . if your kidney problem is not well controlled with zoledron acid hospir , you may be at increased risk of bone complications ( including bone metastases ). how much and how often you will receive each infusion of zoledic
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects are : common ( may affect up to 1 in 10 people ): severe kidney impairment ( will be determined by your doctor with certain specific blood tests ). low level of calcium in the blood . uncommon ( may effect up to1 in 100 people ): pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth . jaw discharge , numbness or a feeling of heaviness , or loosening of a tooth . these could be signs of bone damage in the jaw (
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly .
what zoledronic acid hospira contains the active substance is zoledron acid . one vial of zoledrine acid contains 4 mg zoledrin acid . the other ingredients are monohydrate , mannitol , sodium citrate and water for injections . what zoledlor acid hospir looks like and contents of the pack zoledicle acid hospiris is a liquid concentrate for solution for infusion (' sterile concentrate '). each pack contains one vials of concentrate .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nausea ) or being sick ( vomiting ) during cancer treatment chemotherapy . these nerve cells are important in helping your body fight back against nausea and vomiting . rolapit works by stopping the body from producing these nerve cell cells , which help you to fight nausea and / or vomiting .
do not take varuby if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). if you take an herbal medicine called st john ' s wort ( hypericum performatum ). if your depression or difficulty sleeping has worsened ( see section 2 " warnings and precautions "). if you have taken this medicine before 27 if you suffer from severe liver or kidney problems . if you currently take certain medicines containing rifampicin ( used to treat tuberculosis or other infections ). if any of these apply to you , tell your doctor . warnings and risks talk to your doctor before
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 180 mg once a day for 90 days . swallow the tablet whole with a glass of water . you can take varuby with or without food . you may take varubsy with food or between meals . it is best to take the tablet at the same time each day . if you take more varubys than you should if you accidentally take too many tablets , contact your doctor straight away . you might get sickness . if this happens , your doctor may give you another chemotherapy cycle
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with varuby : very rare ( may affect up to 1 in 1 , 000 people ): symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste , swelling or skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately , as you may need appropriate treatment . other side effects include : very common ( may affects more than 1 in 10 people ): headache , constipation , feeling tired uncommon ( may effect up to1 in
what varuby contains the active substance is rolapitant . each tablet contains 90 mg rolapit . the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubiy contains lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . what varubey looks like and contents of the pack varubdy
what enerzair breezhaler is enerzaire breez inhaler contains two active substances : indacaterol and glycopyrronium - mometasone furoate indacterol and the active substance glycopyronium belong to a group of medicines called bronchodilators . they relax the muscles in the small airways in the lungs . this helps to open the airways and makes it easier for air to get in and out of the lungs and makes breathing easier . corticosteroids reduce the swelling and irritation ( inflammation ) in the smaller airways , making breathing problems easier
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using enerzir if you : - have heart problems - have an irregular or fast heartbeat - have thyroid gland problems - suffer from diabetes - have high blood sugar - have seizures - have severe kidney problems - had severe liver problems - or have a low level of potassium in your
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the medicine should be inhaled by mouth or by inhalation . you should inhale enerzair breezhaler every day until your asthma is controlled . this will help control your symptoms . how to use enerz air breez inhaler use enerzeair breezezhalcer as an inhaler and capsules . the inhaler is for inhalation use only . the capsules should be used with the inhaluer provided in the pack . the instructions for use are provided at the end of this leaf
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious stop using enerzair breezhaler and see a doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching or hives . these may be signs of allergic reaction . other side effects other side side effects include the following side effects : very commonly ( may affects more than1 in 10 users ): sore throat , runny nose , sudden difficulty breathing , feeling of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . the capsules should be used within one week after first opening . do away with the capsules after this period . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what enerzair breezhaler contains the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ), and mometasone furoate . each capsule contains 150 micrograms of indacataterol as acetates , 63 microgram of glycopirronium bromides , 50 microgram glycopierronium and 160 microgram mometsone furuate . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 114 microgram ( 0 . 5 millilitre ) of indiacaterol ,
clopidogrel acino pharma gmbh contains the active ingredient clopidougrel which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thromebosis ). clopidineogrelacino pharmÃ¡ gmbhs is taken to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as athero
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to clopidineogrel or any of the other ingredients of clopidiogrel aglodipine ( see section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelacino pharmÃ¡ gmbhl . warnings and precautions talk to your doctor or pharmacist before taking any of your medicines : if
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopidine acino pi gmbhl per day to be taken orally with or without food . you can take cloclopidougrel acine pharma h for as long as your doctors prescribe it . if you take more clopidoogrel apharma gmb h than you should contact your doctor , pharmacist or the nearest hospital emergency department because of the increased risk of bleeding
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the most common side effects are : common ( affects 1 to 10 users in 100 ) uncommon ( affects less than 1 user in 1 , 000 ) rare ( affects 10 users out of 10 , 000 ). very rare ( affect less than1 user in 10 ,000 ). not known ( frequency cannot be estimated from the available data ). contact your doctor immediately if you experience : fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . signs of liver problems
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . donot use cloplidogl acino pharma gmbhl if you notice any visible sign of damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures
what clopidogrel acino pharma gmbh contains the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ), crospovidone type a castor oil , hydrogenated film - coating : macromol 6000 ethylcellulose ( e462 ) titanium dioxide ( e 171 ) what clopidiogrelacino pharmÃ¡ gmbH looks like and contents of the pack clopideogrel acute
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults . it is used in combination with medicines called ' antiretroviral medicines '. the active substances are doravirine ( a non - nucleoside reverse transcriptase inhibitor ( nnrti ) and lamivudine ( also known as a nucleosides analogue reverse transcript enzyme inhibitor ( tnrtis ). the other active substances in delstrigo are tenofovir disoproxil ( also called a nucleositide analogue reverse transcriptase inhibitor or nrti ). delstriga
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if you take any of any of these , tell your doctor or pharmacist . if your doctor has told you that you are taking any of : - the following medicines : carbamazepine , oxcarbazepine ( medicines to treat tuberculosis ) - st . john ' s wort ( hypericum perforatum , a herbal remedy used to treat depression and anxiety ) - products containing mitotane (
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is a complete regimen of one tablet a day . a single tablet is sufficient for the treatment of hiv infection . the dose is 1 tablet a night . your doctor may prescribe certain medicines ( such as doravirine ) to help you stay on the diet and / or medicines you are taking . taking this medicine swallow the tablet whole with a glass of water . you can take this medicine with or without food . if you take more delstriga than you should if you have
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and see a doctor immediately if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea stomach pain vomiting wind ( flatulence ) hair loss rash muscle symptoms such as pain ( stiffness ) feeling tired fever blood tests showing increased levels in liver enzymes uncommon ( may effect up to 1 in 100 people ): nightmares , depression , anxiety , irritability , confusion and suicidal thoughts 45 trouble
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . keep the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substances are : 100 mg doravirine , 300 mg lamivudine , 245 mg tenofovir disoproxil ( as fumarate ) the other ingredients are : tablet core : croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumar . a coating material : carnauba wax e903 , hyprogellose , iron oxide yellow ( e172 ), lactose monohydrate
spravato contains esketamine . it belongs to a group of medicines called anti - depressants . this medicine helps to control your depression . it also helps to reduce the symptoms of depression , such as feeling sad , anxious , worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and feeling of being slowed down . spravato is used in combination with another antidepressant , which is used every 2 weeks . if you have any further questions on the use of antidepressant medicines , ask your doctor or pharmacist .
do not take spravato if you are allergic to esketamine , ketamine or any of the other ingredients of anaesthesia ( see section " other medicines and spravatos "). warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : have a condition that affects your ability to move or use machines . have recently had an aneurysm ( a weak spot in a blood vessel wall that bulges out ). have bleeding in the brain . have had recently had a heart attack . within 6 weeks of starting treatment , you may experience a temporary increase in blood pressure . serious complications in these conditions
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much spravato to use the spravatos nasal spray is for oral use . the nasal spray device is for use in adults , adolescents and children aged 1 year and above . use in children aged 2 years and above : 3 nasal spray devices one nasal spraydevice is for inhalation use . use within 4 hours after the first dose . use spravata within 2 hours after your first dose of this medicine . if you experience nausea or vomiting within 2 - 3 hours after starting treatment , use the
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with spravato : very common ( may affect more than 1 in 10 people ) feeling disconnected or having feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity to touch ( especially in the mouth area ) spinning sensation ( vertigo ) vomiting nausea common ( might affect up to 1 in every 10 people ): feeling extremely happy ( euphoria ) feeling agitated feeling anxious , especially in your eyes or ears , as if your sense of touch are altered or mimicked irritable panic
what spravato contains - the active substance is esketamine . each nasal spray device contains esketam hydrochloride equivalent to 28 mg esketa . - the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what spravat looks like and contents of the pack spravatos is a nasal spray solution . this medicine is a clear , colourless solution for inhalation . it is supplied as a single - use nasal spraydevice . spravata is available in packs containing 1 , 2 , 3 or 6 nasal spray devices . each spray
zerboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . it can be caused by cancer caused by a change ( mutation ) in a gene responsible for producing melanoma cells . zelboraf targets proteins that are involved in the growth and spread of your cancer .
do not use zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ) symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation . if you think any of these apply to you , tell your doctor or nurse before using zelberaf . warnings and precautions allergic reactions if you experience allergic reactions to zeloraf , tell a doctor or hospital pharmacist immediately . if any of those apply to your skin , tell the doctor or healthcare professional immediately . severe skin reactions if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 4 mg once a day for up to 8 weeks . your doctor may increase your dose to 4 mg twice a day if you experience side effects . your treatment may be stopped if you take more zelboraf than you should if you have experienced vomiting . if you forget to take zelbaf take zilboraf as soon as you remember on an empty stomach . take the tablet at about the same time each day . swallow the tablet whole with a glass of water . do
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions swelling of the face , lips or tongue difficulty breathing rash fainting sensation stop taking zelberaf and tell your doctor immediately if you notice any of the following symptoms : radiation treatment can cause the following side effects : radiation can affect the skin , esophagus , bladder , liver , rectum , and lungs . tell your physician immediately if your doctor notices any of these symptoms : skin rash , blistering , peeling , discoloration of the skin shortness of breath , a cough , fever or chills
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this to avoid evaporation . do away with any medicines that are damaged or shows signs of tampering . these measures will help to protect the environment .
what zelboraf contains the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemurabenib ( as a co - precipitate of veMurafenb ). the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating : iron oxide , macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide . what zelberaf looks like and contents of the pack zelb
duoplavin contains clopidogrel and acetylsalicylic acid ( asa ). asa belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood which clump together during blood clotting . by preventing this clumping , blood vessels relax . antiplatelets medicinal products reduce the chances of blood clots forming ( a process called atherothrombosis ). duoplavinn is taken to prevent blood clumps forming in hardened arteries , a process known as atherostrombotic events , which can lead to stroke , heart attack , or
do not use duoplavin - if you are allergic to clopidogrel , acetylsalicylic acid ( arsa ) or any of the other ingredients of this medicine ( listed in section 6 ) - if your child is allergic to other products called non - steroidal anti - inflammatory products - if he / she has painful and / or inflammatory conditions of muscles or joints - if his / her child has a medical condition ( such as asthma , nasal discharge , runny nose , polyps ( a type of growth in the nose ) - whether your child has had a medicalcondition that is currently causing bleeding such
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take duoplavin at the same time each day . your doctor will tell you how many tablets of your medicine to take . if you take more duoplin than you should if you have had a heart attack , you should contact your doctor immediately . if possible , contact your nearest hospital emergency department because of the increased risk of bleeding . if necessary , take your tablet with you . if more duopylavin than is recommended , contact a
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any visible sign of deterioration . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duoplin 75 mg film - coated tablets each tablet contains 46 tablets of the active substances : clopidogrel , acetylsalicylic acid (asa ) 75 mg : clapidogel ( hydrogen sulphate ) 75mg : acetylSalicylic acids , mannitol , macrogol 6000 microcrystalline cellulose , low substituted hydroxypropylcellulose , maize starch , hydrogenated castor oil ( see section 2 ' duoplvin contains hydrogenatedcastor oil '), stearic acid and colloidal anhydrous silica
simbrinza contains two active substances called brinzolamide and brimonidine tartrate . brin zolamide belongs to a group of medicines called carbonic anhydrase inhibitors . brimonididine tartrates belongs to an active group of medicine called alpha - 2 adrenergic receptor agonists , which reduce pressure within the eye . simbrinzza is used in the eyes of children and adolescents aged 18 years and older to treat eye conditions such as glaucoma , ocular hypertension ( high pressure in the front of the eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to sulphonamides if you have been taking medicines for diabetes or infections if you take diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors if you do not take medicines for depression or parkinson ' s disease if you cannot take certain antidepressants if you stop taking any antidepressant medicines if you suffer from severe kidney problems if you retain too much acidity in your blood (
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . simbrinza should only be used in the eyes . avoid contact with the drops in your eyes . wash your hands thoroughly after using simbrinusza ( see section 1 , " how to use simbrinsza "). remove the cap and snap collar . before using the medicine , twist off the cap . hold the bottle with your fingers . tilt the bottle back . pull down the eyelid with a clean finger and insert a ' pocket ' between the eyelids and the eye . the drop will
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : a reaction to the medicine ( frequency not known ): signs of an allergic reaction may include severe skin reactions , rash , redness or itching all over your body and / or eyes trouble breathing , chest pain , or irregular heart beat tell your doctor immediately if you experience extreme tiredness or dizziness . other side effects that have been reported with simbrinza in combination with other medicines ( such as brinzolamide or brimonidine ) common side effects ( may affect up to 1 in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . after first opening , use within 4 weeks to prevent infections . do away with the bottle once opened and use a new bottle . do this every time you have a new tablet . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of brin zolamide ( corresponding to 2 mg of a brimonine tartrate equivalent to 1 . 3 mg of the active substance ). - the other ingredients are : brimonate , benzalkonium chloride ( see section 2 " simbrinnza contains benzalkonic chloride "), propylene glycol , carbomer 974p , boric acid , mannitol , sodium chloride , tyloxapol , hydrochloric acid , sodium hydrox
what filgrastim ratiopharm is filgrastaim ratim ratitopharm contains the active substance filgrasteim . filgrateim is a protein produced by biotechnology in bacteria called escherichia coli . it works by interfering with a natural protein ( granulocyte - colony stimulating factor [ g - csf ]) produced by your own body . filfilastim stimulates the bone marrow to produce new blood cells . more blood cells are needed than white cells . white cells are important as they help your body fight infection . filgnastim allows your body to produce more white blood cells quickly
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to filgrasteim or any of the other ingredients of filgraspim ratim ratisopharm . warnings and precautions talk to your doctor or pharmacist before using filgrateim ratitopharm : - if your child has a cough , fever or difficulty breathing . these may be signs of a pulmonary disorder . tell your doctor straight away if your baby gets any of these side effects . sickle cell disease 57 tell your child ' s doctor straightaway if your newborn gets left upper abdominal pain or pain at the
how much filgrastim ratiopharm is given your doctor will decide how much filfilastim ratiopharm you will receive . how much is given the amount of filgrasteim ratisopharm given will depend on how you respond to filgrasterim ratim raticoopharm treatment . filgrateim ratiotopharm will be given to you in combination with chemotherapy . the usual dose is 0 . 5 mg per kilogram of body weight given every day for 60 days . your doctor may increase your dose to 30 mg per kg of bodyweight every day . your treatment will last approximately
you must not be given filgrastim ratiopharm if you have sickle cell disease 57 if you get left upper abdominal pain or pain at the tip of your shoulder . this may be a sign of a spleen disorder . see section 4 . if you experience side effects , your doctor may order regular blood tests before you are given filbrastim ratiopharm . neutrophils ( a type of white blood cells ) are important in measuring the number of cells in your blood . they are important for the correct diagnosis and treatment of your condition . other medicines and filgrasteim ratisopharm tell
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . donot use filgrimastim piriopham if the solution is cloudy or contains particles . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgrasterim . each ml of solution for infusion contains 60 mg of filgrateim . filgratim ratisopharm 30 mg / 0 . 5 ml : each pre - filled syringe contains 30 mg of filmgrastime in 0 . 05 ml solution . filgnastim ratiopharm 48 mg / 1 ml : one pre -filled syringe containing 48 mg of filamentous solution contains 48 mg filgracyim in 0. 8 ml solution ( see section 2 . what filgrasteim ratim ratiot
what riluzole zentiva is riluxole zenta contains a substance called rilusole which belongs to the nervous system . what rilzole zsentiva is used for rilukole zertiva is given to adults with amyotrophic lateral sclerosis ( amy ) motor neurone disease ( ms ). ms affects the nerve cells responsible for muscles , causing weakness , muscle waste and paralysis . ms is caused by the destruction of nerve cells . motor neurONE disease may also cause too much glutamate ( a chemical messenger ) in the brain and spinal cord . rilizole zeptiva works by
do not take riluzole zentiva - if you are allergic to rilizole or any of the other ingredients of this medicine ( listed in section 6 ). - if any liver disease has been reported . - if your body has increased blood levels of some enzymes of the liver called transaminases . - tell your doctor if you think you may be pregnant . warnings and precautions talk to your doctor or pharmacist before taking rilzole zenta : - if : you have any liver problems . - you have yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . the tablets should be taken by mouth once a week for 12 weeks . if you take more riluzole zentiva than you should contact your doctor , pharmacist or your nearest hospital emergency department immediately . if possible take rilzole zenta with food . if a child swallows some tablets , contact your physician immediately . do not take a double dose to make up for a forgotten dose . if your child swall swallows several tablets , talk
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ). during treatment with riluzole zentiva there may be a decrease in the number of white blood cells . your doctor will take a blood sample to check for this . white blood cell counts are important for fighting infections . if you get any of the following symptoms , yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your doctor may do regular blood tests
what riluzole zentiva contains the active substance is rilusole . the other ingredients are anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrated colloidal silica , magnesium stearate , croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what rilizole zsentiva looks like and contents of the pack the tablets are white to off - white , round and marked with " 50 " on one side and " ril " on the other side . the tablets have a diameter of 202 mm
emgality contains the active substance galcanezumab . this is a medicine that blocks the activity of a protein called calcitonin gene , which is involved in migraine . increased levels of cgrp in the blood can lead to an increased risk of migraine . emgality is used to treat migraine in adults , adolescents and children aged 4 years and older who have at least 4 migraines per day . emigality is also used to reduce the frequency of migraine headache in adults and children over one month of age . your doctor will prescribe emgally to you in order to improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease warnings and precautions serious cardiovascular diseases allergic reactions emg abnorm may cause serious allergic reactions . these reactions may occur within 40 minutes of a serious allergic reaction . you should see a doctor immediately if you notice such signs or possible side effects . see section 4 . children and adolescents emgation is not recommended for children and teenagers under 18 years of age . other medicines and emgali tell your doctor or pharmacist if you be taking , have
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg of emgally given as an injection under your skin ( subcutaneous injection ). you may receive your emgalis injection at home or in a hospital or clinic , but only after proper training . if you receive more emgals than you should if you have received more than 240 mg , tell your doctor . do not take a double dose to make up for a forgotten dose . if possible , show your doctor your pack of emgsality . if not used immediately
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may include rash and itching . serious allergic reactions ( rare , may affect up to 1 in 1 , 000 people ) may include : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , with a red rash and raised bumps . other side effects very common side effects ( may affect more than 1 in 10 people ) injection site pain injection site reactions ( including red skin ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening , use within 7 days . do away with the blister and discard after 30 days . store the blister in the original package in order to protect from light . do this medicine if you notice that the blister is damaged or shows signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how
what emgality contains the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcaneszumumab in 1 ml solution . the other ingredients are l - histidine , l - ethidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what emgalis looks like and contents of the pack emgally is a solution for injection in a clear glass syringe . the colour is slightly yellow . the syringe is provided in single - dose pen packs of 1 , 2 , 3 or a multipack of one . not
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hav - occlusive ) in which the blood vessels in the liver become damaged and blood clots are formed . it can be given alone or with medicines obtained prior to a stem cell transplantation . defibroide works by helping the blood vessel to open and close , so that the blood clasts can be removed . if you have any further questions on the use of this medicine , ask your doctor or pharmacist .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) if you have been taking other medicines to prevent blood clots ( tissue plasminogen activator warnings and precautions ) if any of these apply to you , tell your doctor before using this medicine . warnings and measures talk to your doctor or pharmacist before using defitgelio if : you have bleeding , especially if you get heavy bleeding , if you need a blood transfusion or surgery if you suffer from problems with blood circulation or a constant blood pressure . this is because
the treatment with defitelio will be started by a doctor who is experienced in the use of stem cells transplantation . it will be given into one of your veins as an ' intravenous infusion ' ( drip ). you will be monitored during this treatment for 21 days until your symptoms improve . if you are more than 18 years of age , you will receive defitilio once a month . if your doctor thinks that you are not responding well enough , he or she will give you defitelfio by a nurse . if this is not possible , you may receive a double dose to make up for a forgotten dose .
like all medicines , defitelio can cause side effects , although not everybody gets them . stop taking defitelo and see a doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): low blood pressure common ( might affect up to 1 in every 10 people ) bleeding in general bleeding in the nose bleeding in parts of the brain bleeding in part of the gut vomiting blood bleeding in one or more parts of one of the lungs bleeding in blood in the urine and in the mouth bleeding in any part of one or both parts of your skin coagulopathy ( disturbance
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the carton and vial label after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do do not defiteloio if you notice that the solution is cloudy or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains the active substance is defibrotide . each ml of solution contains 2 . 5 mg or 200 mg of defibroide . after dilution , each ml solution contains 80 mg of the active ingredient in defibritide . the other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ), water for injections ( see section 2 " defitelsio contains sodium "). what defitELio looks like and contents of the pack defitelo is a clear , colourless solution for infusion . each pack contains 10 ml of
daklinza contains the active ingredient daclatasvir . hepatitis c is an infectious disease that affects the liver caused by the hepatitis c virus . this medicine works by stopping the hepatitisc virus from multiplying in your body . it reduces the amount of the virus in your blood . daklinz is used in combination with other medicines to treat hepatitis c infection . the other medicines that you will be taking with daklanza are : - combination with a medicine to treat other medicines for hepatitis c . your doctor will discuss with you which combination of the other medicine is best for you . if you have any questions about how
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) if you take daclinza by mouth with or without food . if you have taken any of these medicines : phenytoin , carbamazepine , oxcarbazepine or phenobarbital ( used to prevent epileptic seizures ) rifampicin , rifabutin and rifapentine ( antibiotics used to treat tuberculosis ) dexamethasone ( a steroid used to correct allergic and inflammatory diseases ) medicines containing st
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is one 60 mg tablet once a day . do not chew or break the tablet . do this if you get a unpleasant taste after taking daklanza . some other medicines may be more appropriate for you . if you take more dakinza than you should if you have taken more dailinza than your doctor tells you to , talk to your doctor . if possible , take these medicines with a meal . your doctor may increase your daily dose of t
like all medicines , this medicine can cause side effects , although not everybody gets them . daklinza in combination with sofosbuvir and ribavirin has been associated with the following side effects : very common ( may affect more than 1 in 10 people ): headache fatigue common ( might affect up to 1 in every 10 people ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles when taking dakinza in tandem with sofiosbuir and ribvirin the following other side effects have been associated : common ( likely to affect up in every 1
what daklinza contains the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclasvir ( as dihydrochloride ). the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), macrogol 400 , indigo carmine aluminum lake ( e132 ), yellow iron oxide ( e172 ) 51 what daklineza looks like and contents of the pack
proquad is a vaccine that helps protect against measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce antibodies against the measles , rubles , rubell and varicelluses . the antibodies help protect against diseases caused by these viruses . proquad is used to prevent measles , measles , and rubella with chickenpox (" varicello "). the vaccine is given at an interval of 12 months after the last dose . pro quad is used in children and adolescents 9 years of age and older
do not receive proquad : if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine ( see section 6 " warnings and precautions "). if you have neomycin . if you suffer from a blood disorder or type of cancer that affects the immune system ( e . g . treatment with medications that weaken the immunesystem , e . e . low - dose corticosteroid therapy , asthma or replacement therapy ). if you know that you have a weakened immune system , or have a disease ( including aids ), or if you do not have congenital or hereditary immunodeficiency ( immune compet
proquad is given by injection into the muscle or under the skin ( usually in the thigh or upper arm ). injections will be given into the upper muscle of the thigh area or upper upper arm . if you have a blood clotting disorder or low levels of platelets , the vaccine should not be given under the sun . if the skin is cut or bleeding is not prevented by careful selection of the muscle , proquad will be injected into a blood vessel . proquad is for single use only . children and adolescents the vaccine is not intended for use in children and teenagers under 9 years of age . there is no experience with the use
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions such as hives may occur . these reactions may cause difficulty in breathing or swallowing . if you have an allergic reaction , contact your doctor immediately . other side effects that have been reported with proquad include : uncommon ( may affect up to 1 in 100 people ): seizures ( fits ) with a fever rare ( may effect up to1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ). other side side effects reported with the use of proquad are : very common ( may
what proquad contains the active substances are : measles virus1 , edmonston strain , equivalent to 3 . 00 mg mumps virus1 ( jeryllynnâ¢ level b ) strain , corresponding to 4 . 30 mg rubella virus2 , strain , 3 .00 mg varicella virus3 , merck strain , similar to 3. 99 mg mrc . the other ingredients are : powder sucrose , hydrolysed gelatin , urea , sodium chloride , sorbitol ( e420 ), monosodium glutamate , sodium phosphate , sodium bicarbonate , potassium phosphate , potassium chloride 199 what proquad looks like
jylamvo is a substance that is absorbed by the body and is an anticancer medicine which reduces unwanted reactions . it is an immunosuppressive agent . it acts on the body ' s own immune system to reduce the inflammatory effect jylamv is used to treat rheumatic and skin diseases : active rheumatoid arthritis ( the type of polyarthritic forms of joints ) severe juvenile idiopathic arthritis ( jia ) in children 3 years of age and older . it can be used alone or in combination with non - steroidal anti - inflammatory drugs ( nsaids ) to treat inadequate o
do not use jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe kidney impairment if you suffer from a liver impairment if your doctor has told you that you have blood disorders such as bone marrow hypoplasia , leukopenia , thrombocytopenia or significant anaemia 34 if you know that you may have a weakened immune system if you think you have ever had a serious infection such as tuberculosis or hiv if you develop ulcers in the stomach or intestines ( an inflammation of the mucous
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jylamvo can cause severe side effects , sometimes leading to even death . your doctor will determine the most appropriate dose for you and will adjust the dose depending on your condition . the treatment is usually started in the following groups : rheumatoid arthritis severe juvenile idiopathic arthritis severe psoriasis severe psoriatic arthritis jylimvo is used as a long - term treatment . jjlamvo is also used in the treatment of rheumatic and skin diseases ( jia ,
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching on the whole body . other possible side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty or breathing , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ), bruising , nose bleeds nausea , vomiting , abdominal discomfort , severe diarrhoea mouth ulcers , black or tarry
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . do store below 25 . store in the original package in order to protect from light . the medicine should be used immediately in case of accidental spillage . the vial is stable for 3 hours at 25 . do away with any unused medicine or waste material . do this by referring to the national regulation on cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotroxate . - the other ingredients are macrogol 400 , glycerol , orange flavour , sucralose , ethyl parahydroxybenzoate ( e218 ), sodium methyl parahhydroxybenzzoate , citric acid , tri - sodium citrate , purified water ( see section 2 " jylimvo contains ethyl parahydroxy benzoate and sodium methyl parahydrobenzoates "), citric acids , tri , sodium citrates , purified
what enurev breezhaler is this medicine contains glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what enurevo breez inhaler is used for this medicine is used to help breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd , the muscles around the airways tighten , making breathing difficult . this medicine prevents the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to open the airway more easily and helps to keep it open
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have kidney problems . - if the doctor has given you an eye problem called narrow - angle glaucoma ( difficulty passing urine ). warnings and precautions talk to your doctor or pharmacist before treatment with enurevo breez inhaler : if you have any of these conditions , stop using this medicine and contact your doctor immediately : - tightness of the chest , coughing , wheezing
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose is one inhalation once a day . this medicine is for inhalation use . use within 24 hours of the last dose . do not exceed the recommended dosage of 75 mg . you should use this medicinal product every day . how to use this product your doctor will tell you how much and how often to use it . this is provided as an inhaler and capsules ( in blisters ). the medicine is inhalation powder . the capsules are for inhal
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious ( may affect up to 1 in 100 people ): irregular heart beat high level of blood sugar ( hyperglycaemia ). typical symptoms are excessive thirst , hunger and frequent urination ) rash , itching , hives , difficulty breathing or swallowing , dizziness . allergic reaction ( swelling mainly of the tongue , lips , face or throat ) angioedema ( see section 2 ). other side effects include some sideeffects not listed in this leaflet . frequency not known ( frequency cannot be estimated from the available data ): difficulty
what enurev breezhaler contains the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms of glycopirroniumbromide and 50 microgramS of glyopyrronia . the delivered dose ( the delivered amount that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram glycopyronium . the other ingredients of the formulation powder are lactose monohydrate and magnesium stearate . what enurevan breez inhaler looks like and contents of the pack enurevo breezer 44 microlitre inhalation powder
riximyo contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a type in the body called a white blood cell . when ritukimab sticks to the target , it stops the cell from growing and dividing . riximyo is used for the treatment of several different conditions . rrixim yo is used to treat : a ) non - hodgkin ' s lymphoma this is an illness of the lymph tissue that affects the immune system . it affects a type a of white blood cells called
do not use riximyo if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection at the moment . if you suffer from a weak immune system . if your doctor has told you that you have severe heart failure or severe uncontrolled heart disease ( granulomatosis , polyangiitis , microscopic polyangiaritis or pemphigus vulgaris ). warnings and precautions talk to your doctor or pharmacist before using rixiyo . if any
your doctor will decide how much riximyo you will receive and how often you will need this treatment . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have any side effects , your doctor may lower your dose . rixima is given as a drip ( intra - venous infusion ) into a vein . medicines given before each riximusyo administration you will be given rixamyo together with other medicines ( premedication ) to reduce the risk of side effects . your doctor will determine the dose you need and will adjust your
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of platelets ,
what riximyo contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab in 10 ml . each 50 ml vials contains 500 mg of the active ingredient ritudimab ( 10 mg / ml ). the other ingredients are sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide and hydrochloric acid ( see section 2 " rixima contains sodium "). what riximsyo looks like and contents of the pack riximusyo is a clear to slightly yellowish solution for infusion . it is supplied in
topotecan actavis contains the active substance topotecin . topotecaan actis is used to treat adults with small cell lung cancer that has come back after chemotherapy . it is also used to prevent advanced cervical cancer that cannot be removed by surgery or radiotherapy . in this case topotan actez treatment is combined with medicines containing cisplatin .
do not use topotecan actavis - if you are allergic to topotecaan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using topotocan activ . your blood cell counts may be too low . your doctor may decide to reduce the dose of topotican actev . if you have any kidney problems , your doctor will decide whether to reduce your dose of either topotnican actis or topotchean actez . if severe kidney impairment occurs , your dose may be reduced . if liver
the dose of topotecan actavis you will receive will depend on the disease being treated and on results of blood tests carried out before treatment . the usual dose for treatment of adults small cell lung cancer is 1 . 5 mg per square metre of body surface area for 5 days . this treatment cycle will also include cervical cancer . the dose for adults is 0 . 75 mg per sq metre of surface area , for 3 days . you will also receive this treatment dose for cervical cancer in combination with another anticancer medicines called cisplatin . cisplin is used to treat patients with impaired kidney function . your doctor will determine your
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects serious side side effects including infections ( may affect up to 1 in 10 people ) fever . this is more likely to occur in patients with your general condition . local symptoms may include sore throat , burning sensation , severe stomach pain , fever , diarrhoea and bowel inflammation ( neutropenic colitis ). topotecan actavis may reduce your ability to fight infections . lung inflammation ( may occur in up to1 in 1 , 000 people ) difficulty in breathing , cough and fever . these may be signs of this severe condition called
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiratory date refers to the last day of that month . keep the vials in the outer carton in order to protect from light . reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25 and 2 to 8 , when stored in a refrigerator ( 2 to 9 ). the drug product solution for dilution in solutions for infusion ( nacl 0 . 9 %) and glucose 5 % has
what topotecan actavis contains the active substance is topotecaan . each vial contains 1 mg or 4 mg topototecin ( as hydrochloride ). after reconstitution 1 ml contains 1mg topotan . the other ingredients are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide . what topotican actis looks like and contents of the pack topottecan acti is a white to off - white cake with grey bromobutylic stopper and aluminium seals with plastic flip - off caps and a protective sleeve
the active substance of rivastigmine hexal is rivustigmine . rivasta belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson ' s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivasterigmine works by blocking the enzymes that break down acetyl acetylCHoline : acetylchlorolinescerase and butyrylcholinesternase . by
do not take rivastigmine hexal - if you are allergic to rivasta ( the active substance in rivostigminehexal ) or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a previous skin reaction ( allergic contact dermatitis ) and that you should not take more rivasteigmine than your doctor tells you to . warnings and precautions talk to your doctor or pharmacist before taking rivstigmine Hexal : - if any of these apply to you , tell your doctor before taking this medicine . - if the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . depending on how you respond to treatment , the highest dose may be 6 . 0 mg per kg of body weight . your doctor may then increase your dose depending on your response to this medicine . if you take more rivasta hexal than you should if you have taken more r rivasteigminehexal than your doctor tells you to , talk
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often when you start your medicine or when your dose is increased . the side effects listed below have been observed with certain frequencies : very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common ( might affect up to 1 in every 10 people ): anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite nightmares uncommon ( may affects
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what rivastigmine hexal contains 64 the active substance is rivasta hydrogen tartrate . the other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ), shellac . each rivastsigminehexal 1 . 5 mg capsule contains 1 . 25 mg of rivostigmine . each vial of each ritastigme hexal 3 mg capsule releases 3 mg of the active ingredient in each riastigmin hex
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat kidney cancer ( renal cell carcinoma ) or liver cancer that has spread to other organs . it can be given alone or in combination with a specific anticancer medicine containing sorafenib . how cabometyx works cabometx blocks the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels . these proteins can be present in high amounts in cancer cells . cabomety is used in adults .
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabomety 45 - tell your doctor if you have high blood pressure - if your doctor has told you that you have an aneurysm ( enlargement or weakening of a blood vessel wall ) or a tear in a blood valve wall - if this has happened to you - if diarrhoea has been occurring - if recent events have resulted in significant bleeding - if surgery is planned - if within the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . you should take this tablet at the same time each day . your doctor may increase your dose or stop your treatment if you experience serious side effects . your dose may be adjusted depending on how you respond to treatment . the usual starting dose of cabometyx is 60 mg once a week . you can take cabometometyx with or without food . you may take cabometricyx for 2 or more days continuously . you must take cabostyx for 1 hour
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx and other medicines : tell your doctor straight away if your side effects become severe or persistent . tell your healthcare professional straight away : if you notice any of the following serious side effects you may need urgent medical treatment : symptoms such as pain in the abdomen ( nausea ), ( feeling sick ), vomiting , constipation , fever , these may be signs of a gastrointestinal perforation ( a hole that develops in the stomach or intestine ). severe or uncontrollable bleeding . symptoms such : vomiting blood , black stolls
what cabometyx contains the active substances are cabozantinib and malate . cabometx 20 mg : each tablet contains cabozatinib ( s )- malate equivalent to 20 mg cabozanib . cabobometyx 40 mg : every tablet contains Cabozanthinib (s ) - malate equal to 40 mg caboxantinab . cabibometyx 60 mg : the active substance is cabozutinib . each tablet also contains malate precursor to 60 mg caboyantininib the other ingredients are microcrystalline cellulose , lactose anhyd
pemetrexed hospira is a medicine used in the treatment of cancer . pemetrexED hospira will be given to you in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . pemrexed hospira will also be given in combination to cisplin for the initial treatment of patients with advanced stage of lung cancer . your doctor will determine the type of lungcancer you will be treated with . petrexedospira can
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreed or any of the other ingredients of this medicine ( listed in section 6 ). - if breast - feeding is not possible during treatment with pemetemetrexED hospira . - if your child has recently received or is about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using pemetretted hospir if you have or have had problems with your kidneys . before you receive pemetreted hospiar , your doctor will check your blood and kidney and liver function to
the dose of pemetrexed hospira is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your entire body . your doctor will use this body surface area to work in exactly the right way for you . your dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . your healthcare professional will have mixed the pemetreed hospir powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . pemetresed hospita will be given
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever or infection ( common ): if you have a temperature of 38Âºc or greater , sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if you get chest pain ( common ) or a fast heart rate ( uncommon ). if you develop pain , redness , swelling or sores in your mouth ( very common ) allergic reaction : if you notice skin rash ( common ),
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiratory date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2Âºc - 8Âºc . the reconstitution solution should be administered immediately . paren
what pemetrexed hospira contains the active substance is pemetre . pemetrionospira 100 mg : each vial contains 100 mg of pemetereed ( as pemetretrexed disodium hemipentahydrate ). pemetirionospirion 500 mg : one vial of 500 mg contains 500 mg of dispemetrexED ( as dispemetreted dis sodium hemipontahydrates ). pemrexedospira 1 , 000 mg : the active ingredient is petrexed . after reconstitution , the solution contains 25 mg / ml of pem
ganfort contains two active substances called bimatoprost and timolol which work together to reduce pressure in the eye . bimAToprost belongs to a group of medicines called prostamides , which work by interfering with a prostaglandin analogue . timolole belongs to medicines called beta - blockers . what ganfort looks like and contents of the pack ganfant is a clear , watery liquid that is injected into the eye by your eye . gannt is used in adults , adolescents and children aged one year and above . the eye is a transparent , waterlike liquid that can
do not use ganfort eye drops if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ) if you have respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( signs include wheeziness , difficulty in breathing , or long - standing cough ) if any of these apply to you , tell your doctor before using ganst . warnings and precautions talk to your doctor or pharmacist before using this medicine if you suffer from coronary heart disease ( symptoms include chest pain , tightness , breath
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to use treatment use the bottle and the mirror before using . the bottle is for single use only . do not put the bottle near your neck . 5 . gently squeeze the bottle . 1 . wash your hands . tilt your head back . 2 . pull down your eyelid , which is opening a small pocket . 3 . gently press down on your eye during treatment . 4 . gently pull down the lid of your eye . 5. gently squeeze your eye with a finger . do this twice daily .
like all medicines , ganfort can cause side effects , although not everybody gets them . the drops can cause serious side effects . ganart ( multi - dose or single - dose ) can cause very common side effects ( may affect more than 1 in 10 people ). the eye redness is usually mild . common side effect ( may effect up to 1 in 9 people ) are : uncommon side effects are : 100 - the eye burning , itching , stinging or irritation of the conjunctiva ( the transparent layer at the back of the eye ), sensitivity to light , eye pain , sticky eyes , dry eyes , feeling of something
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store the blister in the original package in order to protect from light . do away with the blister once you have opened the blister . do this every day until you are ready to take the next dose . do no more than once a day . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw
what ganfort contains - the active substance is bimatoprost ( 0 . 3 mg / ml ) timolol . each ml contains 5 mg of timolole maleate in 6 . 8 ml . - the other ingredients are benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid and sodium hydroxide . what ganFort looks like and contents of the pack gan fort is a clear to slightly yellow , clear , colourless to pale yellow liquid supplied in a plastic
gefitinib mylan contains the active substance gefitinib . this protein is normally found in cancer cells . gefitoninib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefitoninib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking gefnitinib melan . if you have any other lung problems . some lung problems may get worse while taking gifitin ib mylan . tell your doctor if you or your child have problems with your liver . gefinib is not recommended for use in children under 18 years of age . other medicines and gefilitinib tell your caregiver if you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet once a day . you can take the tablet with or without food . you should take antacids on an empty stomach at least 2 hours before or 1 hour after food . gefitinib mylan is for oral use . swallow the tablet whole with a glass of water . if you have trouble swallowing the tablet , you can crush it and mix with any other liquids . the total recommended dose for adults is 20 mg once a morning . if your doctor presc
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness , sudden worsening breathlessness with a cough or fever . these may be signs of an inflammation of the lungs called ' interstitial lung disease '. uncommon ( may affect up to 1 in 100 people ) gefitinib may cause severe skin reactions affecting parts of the body .
what gefitinib mylan contains - the active substance is gefinib . each film - coated tablet contains 250 mg of gefib . - the other ingredients are lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidon ( k30 ), sodium laurilsulfate , magnesium stearate . - in the tablet coating are polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide red ( e 172 ). what gefitoninib melan looks like
reblozyl contains the active substance luspatercept which is used to treat myelodysplastic syndromes ( mds ). mds is a group of many different blood and bone marrow disorders in which red blood cells become abnormal . signs and symptoms can include a low red blood cell count and anaemia . red blood infusion is usually given to you in hospital . reblozey is used : to treat anaemia in adults with mds who cannot be treated with red bloodcell therapies ( erythropoietin therapies ) in patients with beta - thalassaemia . thalAssa
do not take reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be pregnant ( see pregnancy section ). warnings and precautions talk to your doctor before taking this medicine if you have thalassaemia ( a condition where your spleen removed ) or have had a blood clot . your doctor may recommend hormone replacement therapy if you had a previous blood clot and / or preventive measures ( including medicines used to prevent a blood clot ). if you suffer from high blood pressure , your doctor will decide whether rebluzyl is
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests to make sure that you are fully protected . how much reblozyl is given the recommended dose of rebl ozyl is one injection under the skin . the dose depends on how much you weigh . the injections should be given every other week . the recommended starting dose is 1 . 0 mg / kg of body weight . your dose may be increased or decreased depending on your blood pressure . how often reblzyl is used in patients with myelodyspl
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you have : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or blurred vision . these may be symptoms of a stroke . blood clots swelling in the area around the eyes , face , lips , mouth or tongue throat allergic reactions , rashes 36 reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for up to 25 days when stored at 2 8 . do away with any unused medicinal product or waste material . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what reblozyl contains the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg of luspormcept . after reconstitution , each mlof solution contains 50 mg of the active ingredient luspaterscept . the other excipients are citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ), sodium hydroxide ( for pct and ph adjustment ). what rebloxyl looks like and contents of the pack rebl ozyl is a white to off - white powder . rebloyyl 25 mg / 75
fotivda contains the active substance tivozanib , a protein kinase inhibitor . tiv ozanib works by stopping the growth of the cancer and slowing down the growth and spread of cancer cells by blocking the growth or spread of new blood vessels . fotivd is used in adults with advanced kidney cancer when other treatments ( alpha or interleukin - 2 ) have not helped to stop your disease or have not worked .
do not take fotivda if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have been told that you have a problem with your heart . if you drink alcohol excessively ( either every day or only from time to time ). if your doctor has told you that you are taking st . john ' s wort ( hypericum perforatum , a herbal remedy used to treat depression and anxiety ). warnings and precautions talk to your doctor before taking fotiveda if any of these apply to you : if you suffer from high blood pressure . f
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of fotivda is 1340 mg once a day for 21 days , taken as 7 capsules in the morning and 7 capsules once a night for 4 days . your doctor will tell you how many capsules to take . if you take more fotvda than you should if you have taken too many capsules , you may experience unacceptable side effects . severe side effects may occur during fotrevda therapy . the usual dose of the fotovda is 890 mg once daily for
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a very common side effect ( may affect more than 1 in 10 people ). tell your doctor immediately if you experience any of the following : high bloodpressure with symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor may want to monitor your blood pressure more closely while you are taking fotivda . high blood hypertension may be treated with a medicine to control your high blood blood pressure . if you take more f
what fotivda contains the active substance of fotvda is tivozanib . each tablet contains 890 mg of tivzanib ( as tiv ozanib hydrochloride monohydrate ). the other ingredients are : tablet core : 890mg tivnitol ( e421 ), magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ), propylene glycol ( e1520 ) and strong ammonia solution ( e524 ). tablet coating : titanium dioxide , tartrazine aluminium lake ( e133 ), shell
stribild contains two active substances : elvitegravir ( an antiretroviral medicine known as an integrase inhibitor cobicistat , which is a booster ( pharmacokinetic enhancer ) of elvitesgravira emtricitabine ( an antiiretroviral medicine called a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir disoproxil ( an antitroviral medication called a nucleotide reverse transcriptases inhibitor ) stribild is given as a single tablet regimen for the treatment of human immunodeficiency virus ( h
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). during treatment , you should not take any medicine containing tenofoviir disopicroxil . your doctor will monitor your kidney function and may change your dose of these medicines . if you have been told by your doctor that you have alfuzosin ( a form of an enlarged prostate gland ), amiodarone , quinidine
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents 12 to less than 18 years of age : take the tablet 35 once daily by mouth . you should continue to take your medicine at the same time each day . your doctor may change the dose or stop the treatment if you take medicines ( oral supplements , antacids , laxatives containing minerals such as magnesium , aluminium , calcium , iron , zinc ) for at least 4 weeks . take stribild at the recommended times . if you have any further questions on the use of this medicine
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether the unwanted effects of stribild are caused by the hiva disease itself or by its many components . serious side effects tell your doctor immediately if you notice any of the following : lactic acid
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each stribil film - coated tablet contains 150 mg elvitesgravira , 150 mg cobicista , 200 mg emtracitabin , 245 mg tenofvir disopicroxil and 300 mg ten ofovir desoproxel fumarate , each 136 mg tablet contains tenofoviir . the other ingredients are croscarmellose sodium , hydroxypropyl cellulose , lactose mon
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , a condition with symptoms of excitement or euphoria . zzyprex has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olan zapine treatment
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swollen face , swollen lips or shortness of breath . - if your doctor has told you that you have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before taking zypxa . zypitxa is not recommended for use in elderly patients with dementia because it may have serious side
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . zyprexa tablets should be taken once a day with or without food . your doctor may increase your dose to 5 to 20 mg once a week depending on your symptoms . swallow the tablet whole with water . do not chew or crush the tablet . zzyprexa can be taken with or just after food . you should take your zypxa tablets at the same time each day . it is important that you take your tablets at least one hour before
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue . this may be a sign of blood clots in the veins . this side effect is uncommon ( may affect upto 1 in 100 people ) especially in the legs . symptoms include swelling , pain , and redness in the leg which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you notice any of these symptoms seek medical advice immediately : fever , faster
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . zyprexa does not require any special storage conditions . do this by referring to the package leaflets that are provided with each blister . do away with any unused blister after first opening of the blister . zenyprexa should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of unused tablets . these measures will help to protect the environment .
what zyprexa contains the active substance is olanzapine . each zypxa tablet contains 2 . 5 mg , 5 mg or 7 . 5mg , 10 mg , 15 mg or 20 mg of olanza . the other ingredients are lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate , hypromellose , titanium dioxide ( e171 ), carnauba wax . the different zypyxa tablet strengths are : - zypi 2 . 3 mg , 6 mg , 7 . 25 mg and 10 mg
what prolia is prolia contains denosumab , a protein ( monoclonal antibody ) that is similar to another protein that is produced naturally in the body . it is used to prevent bone loss in osteoporosis in adult patients who have not responded to treatment with prolia . prolia helps to make bone stronger and keeps it free of oestrogen . it reduces the amount of bone that makes oestrogens . this helps to keep bones healthy after the menopause . as oest nitrogen level drops , bones become thin and fragile . what osteopORosis is osteopoosis is caused by
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ) if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using prolia . if you think any of these apply to you , tell your doctor before using this medicine . if any of them apply to your child , tell the doctor or nurse before using it . warnings and symptoms talk to the doctor before starting prolia : if you develop a skin infection with symptoms such as a swollen , red area of skin ( usually
what prolia is prolia contains one pre - filled syringe of 60 ml . it is given to you by your doctor or nurse , as a single injection under the skin ( subcutaneous ) in the front of your thighs , abdomen or upper arm . your doctor will decide how much prolia you need and how often you need to receive it . your dose will be decided by your healthcare professional . it may be given to your child or adolescent aged 6 months or older . it can be given as a double injection under one skin ( cutaneous ) or in the upper thighs ( abdomen ), or in your upper arm ( sub
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking prolia and see a doctor immediately if you develop skin infections ( cellulitis ). if you have any of these symptoms while taking prolium : swollen , red area of skin , usually in the leg , which feels hot and tender . symptoms may include fever . stop using prolia if you experience pain in the mouth and / or jaw , swelling or non - healing of sores in themouth or jaw ( discharge , numbness , feeling of heaviness or loosening of a tooth ). these could be signs of bone damage in the jaw
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . you may remove your pre -filled syringe from the refrigerator and store it at room temperature ( not above 25 ) for a single period of maximum three months . after the injection , the pen may be stored at room temperatures ( not below 25 )
what prolia contains - the active substance is denosumab . each ml of solution contains 1 mg or 60 mg of denosumaab in 60 ml . - the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear , colourless to slightly yellow solution for injection in a pre - filled syringe with a needle guard .
what ambirix is ambirox is a vaccine used to protect adults and children from 1 to 15 years of age against two diseases : hepatitis a and hepatitis b . infection with the hepatitis a virus causes the liver to become swollen and inflamed . the virus is caused by the virus in faeces , serum or saliva . symptoms usually occur 3 to 6 weeks after infection . if you feel sick , have a fever , aches and pains , or feel very tired , dark urine , pale faececes or yellowish skin or eyes ( jaundice ). the severity and type of symptoms can vary from person to person
you must not be given ambirix if you are allergic to ambirax or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if you have an allergic response to any vaccine , including any of those mentioned in section 4 , please tell your doctor . hepatitis a or hepatitis b diseases if you get a severe infection with a high temperature , the vaccine should be given at the same time . a minor infection such as a cold should not be a problem , but your doctor should tell you to
your doctor or nurse will give you ambirix as an injection into the muscle of the upper arm . ambirux will be given into a vein . the injection will be injected into the thigh muscle . you will receive a total of two injections . the injections will be administered within 12 months . you may be given the first injection at least one month after the second injection . if you are given more ambirx than you should if you have been given more than the prescribed dose , the injections may be delayed or stopped . if the diseases return you will be carefully monitored by your doctor . if they are not treated , your doctor
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects reported in clinical trials with ambirix were : common ( may affect up to 1 in 10 people ): headache loss of appetite feeling tired or irritable pain or redness where
what ambirix contains 26 the active substance is hepatitis a virus . each ml contains 1 , 720 micrograms of elisa units ( hepatitis b surface antigen ) equivalent to 20 microgram . the other ingredients are human diploid ( mrc ), cells , aluminium hydroxide , hydrated in 0 . 05 ml of water for injections , saccharomyces cerevisiae , aluminium phosphate in 0. 4 ml of solution , sodium chloride and water for injection . what ambirax looks like and contents of the pack suspension for injection in a pre - filled syringe . ambirood is a white , slightly mil
what bexsero is bex serumo is a meningococcal group b vaccine . bex sero is given to adults , adolescents and children from 2 years of age with disease caused by the neisseria meningitidis group b bacteria . these bacteria are responsible for many types of infections , including meningitis ( inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping your body to produce its own protection ( antibodies ) against the disease .
do not use bexsero if you are allergic to any of the ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using bexero if : you have a severe infection with a high temperature . vaccination should be postponed until you have recovered from a minor infection such as a cold . your doctor may decide to delay vaccination if you have haemophilia or any other problem that may prevent your blood from clotting properly . you are receiving blood thinners ( anticoagulants ) as part of treatment for the immune system ( eculizumab ). if
your doctor or nurse will give you bexsero at the following dose : the recommended dose is 5 micrograms injected into the muscle of the thigh or upper arm . your doctor will decide how many injections you need . the recommended doses are 2 to 5 microlitres . you will receive three injections of the vaccine . your dose may be adjusted with an additional injection ( booster ). the first injection will be given at least 2 weeks apart . the interval between injections will be approximately 1 month . your physician will decide the intervalbetween injections . the first dose will be administered at least 12 hours apart . you should receive 15 microgram
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and see a doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the place of injection site hardness of the area of skin at site of the injection . other side effects may occur with this vaccine : common ( might affect up to 1 in every 10 people ) fever , loss of appetite , tenderness around the injectionsite ,
what bexsero contains the active substances are recombinant neisseria meningitidis group b nhba fusion protein ( 1 , 2 , 3 , 50 micrograms ) recombinant nisseria maningitis group b nova protein ( 2 , 2 and 3 50 micrograms ) recomb recombinant neoisseria meingitris group b fhbp fusion protein , 1 , 3 and 50 micros recombinant noisseria pleasenitidis type b f hbp fusionprotein ( 1 and 2 , 4 and 50 micromrams ) produced by recombinant dna technology . the other
nitisinone mdk contains the active substance nitisinONE . this medicine is used to treat a rare disease called hereditary tyrosinemia ( hdk ) in adults , adolescents and children from 1 year of age . in this disease your body does not break down the amino acid tyrosine ( amino acids are substances that are naturally present in the body ). nitisine stops the breakdown of tyrosrine and the harmful substances are released . this means that the body is unable to break down tyrosinone and the other substances are eliminated . this reduces the amount of tyrorosine in the blood and
do not take nitisinone mdk if you are allergic to nitisine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . pregnancy and breast - feeding nitis inone mdks may affect your eyes . during nitisinfone treatment , red eyes may occur . tell your doctor immediately if you have an eye examination . eye problems due to inadequate dietary control may occur ( see section 4 ). your doctor may decide to stop the treatment temporarily or permanently . your doctor will take blood samples during the treatment to monitor for side effects
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine will be started by a doctor who is experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 capsule for every kg of body weight taken orally once daily . the dose may be increased to 20 capsules once daily in this patient population . swallow the capsules whole with a small amount of water or formula diet . if you take more nitisinone mdk than you should if you accidentally take too many capsules , contact your doctor immediately . if
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store nitisinone mdk in the original package in order to protect from light . after first opening , use within 2 hours at a temperature not above 25 . do away with the blister after this time period . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use .
what nitisinone mdk contains the active substance is nitisino . nitisinnone mdky 2 mg hard capsules : each capsule contains 2 mg nitisine . nisinone dk 5 mg hard capsule : each hard capsule contains 5 mg nisine . each capsule of nitishinone mdks 10 mg hard gelatin : each soft capsule contains 10 mg nitesinone . the other ingredients are gelatin , titanium dioxide ( e171 ), black iron oxide ( e172 ), and shellac glaze . what nitisinsone mdka looks like and contents of the pack nitisinaone md
what docetaxel accord is docetayel accord contains the active substance docetacel . docetaceel belongs to the group of anti - cancer medicines called taxoids . docelaxel accord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer , gastric cancer and head and neck cancer : - for the diagnosis of advanced breast cancer : docetailel could be administered either alone or in combination with doxorubicin , or trastuzumab , or capecitabine . - for
do not use docetaxel accord - if you are allergic ( hypersensitive ) to docetxel or any of the other ingredients of docetoxel accord ( listed in section 6 ) - if white blood cells are low - if your liver is not working properly - if there is a severe liver disease warnings and precautions before you are given docetixel accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetacord . white blood cell disturbances may cause fever and infections . tell your doctor immediately if you have abdominal pain , tenderness , diarrhoea
docetaxel accord will be given to you by a healthcare professional . the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( mÂ² ) and will determine the dose you should receive . method and route of administration docetaxell accord will usually be given by infusion into one of your veins . the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . your healthcare professional will take care of your blood tests and will adjust the dose depending on your generalcondition . in particular
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord are reduction in the number of red blood cells and white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . the severity of adverse events of docelaxel alone may be higher when docetxel is given in combination with other chemotherapeutic agents . during the infusion , allergic reactions ( may affect up to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store below 25 . do away with the vial . after dilution , the medicine should be transferred from the infusion bag to the infusion vial and stored for 6 hours below 25 ( in a refrigerator ). infusion - the infusion solution should be used immediately . non - pvc bags may be stored for 48 hours at 2 to 8 . do this until the infusion solutions are ready to be used .
what docetaxel accord contains - the active substance is docetacel . each ml of concentrate for solution for infusion contains 20 mg docetaceel . 1 ml of the concentrate contains 20mg docetayel . 4 ml of solution for injection contains 80 mg docel . 8 ml of solvent for solutionfor infusion contains 160 mg docotaxel . - the other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 " docetagel accord is a concentrate for ethanol "), citric acid anhydrated ( see " docel accord and ethanol "). what docetAX
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the electrical activity of the brain . this medicinal product acts in the opposite way to other stimulant medicines , causing the brain to relax and the body to react more normally . this means that the effect of intuniv is increased . intunv is used to treat impulsive , hyperactive adults . this medication is used in adults with ' attention deficit hyperactivity disorder ' ( adhd ) when currentstimulant medication is not controlling adhd symptoms . the medicine is used together with a treatment programme consisting of psychological therapy
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking intuniframus : if you have low or high blood pressure if you suffer from heart problems if you know that you have heart problems , or if you fainted recently if you had thoughts or feelings of suicide or any other psychiatric conditions ( withdrawal symptoms ). if you experience increased heart rate or highblood pressure while taking this medicine , stop taking this medication and talk to a doctor straight away . these problems may be serious
your treatment will be started by a doctor experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will start your treatment with 1 tablet once daily . your dose will be gradually increased depending on how you respond to treatment . the dose will gradually be increased every day . the doctor will gradually increase your dose every day until your doctor tells you otherwise . the maximum recommended dose for adults is 0 . 05 mg / kg of bodyweight once daily , taken once daily during
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , you should talk to your doctor straight away . your doctor may need to adjust your dose of your medicine . serious side effects tell your doctor or pharmacist straight away if you notice any of the following serious side side effects : feeling drowsy ( feeling dizzy ) hypotension ( slow heart beat ( bradycardia ), feeling faint and loss of concentration ( syncope ), a serious withdrawal side effect with high blood pressure . symptoms may include headaches , feeling confused , nervousness , agitation and tremors ( hypertensive
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister pack after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . the tablets should be used within the first week of opening the blister pack . do away with the tablets after this period . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what intuniv contains the active substance is guanfacine hydrochloride . each prolonged - release tablet contains 1 mg of guanFacine . each extended - release dose contains 2 mg of Guanfacate hydrochlorine . the prolonged - releases dose contains 3 mg of the guanfuine . this prolonged -release dose contains 4 mg of of guanofacine ( see section 4 for further information on guanfrancy ). the other ingredients are hypromellose 2208 , methacrylic acid - ethyl acrylate copolymer , lactose monohydrate , povidone type
ecalta contains the active substance anidulafungin and is used to treat adults and children from 1 to 18 years old with a type of fungal infection that affects the blood or other internal organs called invasive candidiasis . the infection is caused by fungal cells called candida that are cut off and grown in the laboratory . ecalta belongs to a group of medicines called echinocandins . these medicines are used to prevent serious fungal infections caused by the lack of fungillus - like fungal cell walls . ecalda is used when fungalcells have incomplete or defective cell walls , which
do not use ecalta if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using ecaltra if you have liver function problems . your doctor may decide to reduce the dose of ecaltas or stop your treatment with anaesthetics . your treatment may need to be delayed or stopped . if you experience an allergic reaction , such as itching , wheezing , or blotchy skin , you should tell your doctor immediately .
the treatment will be given to you by a doctor or nurse . the recommended dose is 200 mg / 100 mg given every 1 hour . adults ( 18 years of age and older ) the recommended starting dose is 3 . 0 mg / 200 mg given each 1 . 5 hour . the dose may be increased to 100 mg / 1 hour depending on the patient ' s weight . ecalta is given as a slow infusion ( a drip into a vein ) over a period of 1 . 4 to 3 hours . the loading dose will depend on the infusion - related patient 's weight . your doctor will calculate your treatment over a number of
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : - potentially life - threatening allergic reactions , including difficulty breathing or wheezing or an existing rash . ecalta can cause serious sideeffects , including convulsion ( seizure ), flushing , rash , pruritis ( itching ), hot flush , hives , sudden contraction of the muscles , wheezezing , coughing or difficulty of breathing other side effects very common side effects ( may affect more than 1 in 10 people ): - low blood potassium ( hypokalaemia
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . the reconstituted solution should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 8 . the infusion solution should not be stored above 25 for longer than 48 hours at refrigerated
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of anidulinafungan . - the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide , hydrochloric acid 30 . what ecaltas looks like and contents of the pack ecaltta is supplied as a box containing 1 vial containing 100 mg concentrate for solution for infusion . the powder is white to off - white .
adynovi contains the active substance rurioctocog alfa pegol , which is a copy of pegylated human coagulation factor viii ( human cogulation factor iii ). factor v iii is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a , factor v viii is missing or not working properly . adynovi is used for the treatment and prevention of bleeding in adults and adolescents 12 years of age and older with haeophilia b , an inherited bleeding disorder caused by lack of factor v ii .
do not use adynovi - if you are allergic to rurioctocog alfa pegol or octocog aluminium or any of the other ingredients of this medicine ( listed in section 6 ). - if allergic to any of these ingredients , do not use adsynovi . warnings and precautions talk to your doctor or pharmacist before using adynov : - if an anaphylactic reaction ( a severe , sudden allergic reaction ) occurs . adynova may cause allergic reactions such as rash 95 , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheez
treatment with adynovi will be started by a doctor experienced in the care of patients with haemophilia a . adynov is used for treatment of bleeding in adults . adynaovi is used as the replacement therapy for adynova . adnovi is a life - long treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . prevention of bleeding the recommended dose of adynoc is 40 mg once a day or 50 mg once daily for 2 weeks . prevention and treatment of blood - related bleeding the dose of adsynovi depends on your body weight
like all medicines , this medicine can cause side effects , although not everybody gets them . sudden allergic reactions ( anaphylactic ) may occur within minutes of the injection . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . if severe symptoms of difficulty in breath , wheeezing or tightness around the chest ( a feeling ofbeing unwell ), dizziness or loss of awareness , contact your doctor immediately . if you
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the powder vial may be stored at room temperature ( up to 30 ) for a single period of up to 3 months . do this medicine if it has been stored at a temperature not above 30 for a longer period than 3 months , or if it is stored
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 or 2000 iu of ruricoctocag alfa pepegol . the solvent vial is supplied with 5 ml sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrates , tris ( hydroxymethyl ) aminomethane
rekovelle contains follitropin delta , a follicle stimulating hormone that belongs to a group of hormones called gonadotropins . gonadotropicins are involved in female fertility and are present in assisted reproduction programs ( i . e . in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection ). they are involved directly in the development of the ovaries and in the production of many egg sacs .
do not use this medicine if any of the following apply to you . if you are not sure , talk to your doctor or pharmacist before using rekovelle . warnings and precautions talk to the doctor or nurse before using this medicine : if you have a problem with your fertility problems . if your doctor thinks you may be allergic to follicle stimulating hormone ( fsh ), or any of those listed below . if this medicine has been shown to affect your fertility , tell your doctor . if any part of your body has a tumour , such as the uterus , ovaries , breasts , pituitary gland or hypothalamus .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given as your first treatment cycle . your doctor will prescribe anti - MÃ¼llerian hormone to stimulate your ovaries to produce more stimulation with gonadotropins . the dose will depend on your blood weight . your dose will also be calculated from a blood sample taken every 12 months . the duration of treatment depends on your body weight . treatment will be started as a single injection . your physician will decide how many injections you need . the rkovelLE dose will usually
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones that are used to treat infertility have been reported in women taking this medicine . there may be a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms include pain , discomfort and swelling of the abdomen . nausea , vomiting , diarrhoea , weight gain and difficulty breathing . if you notice any of these symptoms , seek medical advice straight away . a side effect that may affect up to 1 in 10 people is headache . nausea ( ovarianhyperstimulation sensation ) pelvic pain and discomfort ( ovarian origin
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 25 . after reconstitution , the product may be stored for up to 3 days at room temperature ( up to 28 ) below 25 and protected from light . after the treatment any unused solution must be discarded . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no
what rekovelle contains the active substance is follitropin delta . each multidose cartridge contains 12 mg of follitroin delta in 0 . 36 millilitre of solution . after dilution , each ml of solution contains 33 . 3 mg of of folliotropin delta in each millilitere of solution ( corresponding to 0 . 35 mg / ml ). the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrates , concentrated phosphoric acid , sodium hydroxide and water for
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each inhalation of revminty elliptone contains flutic asone fibre 92 mg and vilterol 22 mg . each inhale of fluticasaone fubre 184 mg and / or vilancerol 22 / 22 mg is equivalent to 92 / 22 . chronic obstructive pulmonary disease ( copd ) in adults . asthma in adults and adolescents 12 years of age and older weighing 184 mg or more is equivalent of 22 / 42 . copd is a group of conditions that can cause
do not take revinty ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking revintchy ellipta . if you have liver disease , tell your doctor straight away if you notice any of these side effects . if your doctor thinks you have moderate or severe liver disease . the lower strength of revintty ellipta 92 / 22 mg may be more appropriate for you . if any of your conditions apply to you , tell the doctor straightaway .
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . asthma the recommended dose for asthma is one inhalation twice a day ( fluticasone furoate 22 mg and vilanterol ). for severe asthma , your doctor may prescribe the higher strength inhalation ( flilitasonefuroate 23 mg and 22 mg vilancerol ). copd the recommended starting dose for copd is one and a half inhalations twice a morning ( flitasone fentanylate 22mg and vilterol ) once a
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while taking ellipta , stop taking this medicine and contact your doctor immediately : skin rash , hives , redness swelling , especially of the face or mouth ( angioedema ), feeling very wheezy or coughing , having difficulty in breathing , feeling weak or light headed ( which may lead to collapse or loss of consciousness ). immediate breathing difficulties if you have immediate breathing problems while taking revinty
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . each 92 micrograms inhalation delivers 92 microlitres of flutic asone firoate and 22 microlitre of vilancerol and trifenatate . each 184 microgram inhalation provides 184 microliters of flilitasonefuroate , 22 micrometre of trifnatate and 184 micrometromole of trilenatatate respectively . the other ingredients are lactose monohydrate ( see section 2 " revintchy ellipta is for
atripla is a treatment for human immunodeficiency virus ( hiv ) infection in adults . it contains three active substances : efavirenz ( a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine ( a nucleosides reverse transcriptases inhibitor ( tnrtis ), tenofovir ( aucleotide reverse transcriptatase inhibitor ). these active substances are antiretroviral medicines that work by interfering with the action of an enzyme ( reverse transcriptasing ) that is essential for the virus to multiply . atriplas is atreatment
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after food . some side effects may be more common , such as dizziness and drowsiness . if you take more atripola than you should if you accidentally take too many atripera tablets , contact your doctor immediately . if possible , take your tablets with you . if necessary , take the tablet with food . you may need
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lacticacid in the blood ) may occur ( may affect up to 1 in 1 , 000 people ). if you experience any of the following serious side effect , stop taking atripla and contact your doctor immediately :
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atripera film - coated tablet contains 600 mg efavenirenz and 200 mg emtracitabin and 245 mg tenofvir disopicroxil ( as fumarate ). the other ingredients are croscarmellose sodium , hyprolose , magnesium stearate , microcrystalline cellulose , sodium laurilsulfate ( see section 2 " atriplea contains sodium "). the tablet film coating
orgalutran contains the active substance ganirelix . it belongs to a group of medicines called anti - gonadotrophin . it is a synthetic version of the natural gonadodotrophins releasing hormone ( gnrh ). when gonadotropin is released , the hormone that stimulates the release of gonadotsrophins is changed . this is called follicle stimulating hormone ( fsh ). gonadrophins play an important role in the growth and development of follicles in the ovaries . follicles are small round sacs that contain the egg cells . they release the immature egg cells and live
do not use orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - if hypersensitive to gonadotrophin releasing hormone ( gnrh ) or any other gonadoteh - like hormone ( ngrh ) - if your child has agnrh analogue . - if he / she has a moderate or severe kidney or liver disease . - are pregnant . warnings and precautions talk to your doctor or pharmacist before using orgaluchran allergic reactions may be signs of an active allergic condition . your doctor will do additional monitoring
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran is intended for use in women who are undergoing the treatment of assisted reproduction techniques , including in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( fsh ), corifollitropin on day 2 or day 3 of each cycle . orglutran should be injected under the skin ( subcutaneously ) every 5 to 6 weeks . your doctor will decide how many cycles of treatment you need . your dose of orgaluitran depends on your body '
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect that may affect up to 1 in 10 people is local skin reactions ( redness and swelling ). the local reaction usually disappears after a few days . this effect is seen in up to 4 in 100 people . a very rare effect is headache , nausea , malaise . this is seen rarely ( less than 1 in 1 , 000 people ). allergic reactions include rash facial swelling difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat , which may cause difficulty in breathing or swallowing ( angio
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and syringe after exp . the exp date refers to the last day of that month . syringes should be clear , colour - free solutions . do away with any unused syringe . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what orgalutran contains - the active substance is ganirelix in 0 . 5 ml of solution . - the other ingredients are acetic acid , mannitol and water for injections ( see section 2 ). - the ph is sodium hydroxide and acetic acids . what orgaluitran looks like and contents of the pack orgaluchran is a clear , colourless aqueous solution . the solution is clear and colourless . it is supplied in a glass vial for subcutaneous administration . the needle is inserted into a dry natural rubber / latex . orgalustran is available in
what blitzima is blitzima contains the active substance rituximab , a " monoclonal antibody ". it sticks to a target in a type of white blood cell called " b - lymphocyte ". when ritukimab sticks to the target , it stops the cell from growing and dividing . what blitzima can be used for blitzima has been prescribed for the treatment of : a ) non - hodgkin ' s lymphoma this is a disease of the lymph tissue that affects the immune system . it affects a type ( white blood cells ) called b - locytes . blitzima may be given
do not use blitzima if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection . if you suffer from a weak immune system . if your doctor has told you that you have severe heart failure or severe uncontrolled heart disease . warnings and precautions talk to your doctor or pharmacist before using blitzima : if you currently have granulomatosis , polyangiitis , microscopic polyangiopitis or pemphigus vulgaris . warnings , precautions and precautions
how blitzima is given your doctor will decide how much blitzima you will receive and how often you will need this treatment . always take this medicine exactly as your doctor has told you . check with your doctor if you are not sure . if you have any side effects , your doctor may lower your dose . how blitzima will be given blitzima comes as a drip ( intravenous infusion ). you will be treated with medicines given before each blitzima administration . you will also be given other medicines ( pre - medication ) to reduce the risk of side effects . your doctor or nurse will decide on the most appropriate course of your treatment .
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of plate
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in the outer carton in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what blitzima contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab in 10 ml . each 50 ml vials contains 500 mg of the active ingredient ritudimab ( 10 mg / ml ). the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for infusion . it is supplied in 2 glass vials , each containing 50 ml . pack size of 1 vial .
roactemra contains the active substance toilizumab , a type of monoclonal antibody ( a type in the body that attaches to a specific target in the immune system ). it blocks the activity of a protein called interleukin - 6 , which is involved in inflammation in your body . roactemr can cause symptoms such as pain and swelling in your joints . roactorra reduces the damage to the cartilage and bone in your bones and joints caused by the disease . roACTemra is used to treat moderate to severe active rheumatoid arthritis , an autoimmune disease that can occur when
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . during the infusion with roactemnra , you may experience allergic reactions such as chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips or skin rash . these reactions usually disappear after a few days . tell your doctor immediately if you feel unwell . warnings and precautions talk to your doctor or nurse before using roactremra : if you develop any of these signs or symptoms
the doctor or nurse will give you roactemra as an injection into a vein by a nurse . the intravenous infusion will last about an hour . your doctor will decide how long you should receive the treatment . the recommended dose of roactemera is 8 mg / kg body weight once daily . the usual dose is 4 mg /kg body weight twice daily . your dose will be adjusted by your doctor or a nurse depending on how well you respond to the intravenously infusion . the treatment will be started by a doctor or another healthcare professional . the dose of your roactenyra is based on your body weight . the
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in the post marketing setting in adults and children 3 years of age and older : roactemnra may cause serious side effects ( may affect up to 1 in 10 people ) allergic reactions , including difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections , including fever and chills , which may travel through the mouth and skin blisters and stomach ache signs and symptoms of liver toxicity ( may occur
keep this medicine out of the sight and reach of children . do not use roactemra after the expiry date which is stated on the outer carton and the vial label after exp . the expirability refers to the last day of that month . this medicine does not require any special storage conditions . do away with the vials after first opening . do this medicine if you notice any particles in the solution . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what roactemra contains the active substance is tocilizumab . each 4 ml vial contains 80 mg of tociluzumab in 20 mg . each 10 ml vials contains 200 mg of of tocelizumumab ( 20 mg ). each 20 ml vray contains 400 mg of the active substances in tocilixumab 20 mg ( 20mg ). the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections . what roactemetra looks like and contents of the pack ro
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . these relax the muscles in the walls of the small air passages in the lungs . onbrez bronzhalter is used to relieve breathing difficulties caused by a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways relax , making breathing difficult . this medicine relaxes these muscles in your lungs , making it easier for air to get in and out of the lungs and making it less likely that you will have to go to the hospital .
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma is not controlled with onbreez breez inhaler . - if any of these apply to you , tell your doctor before using onbrezer . warnings and precautions talk to your doctor or pharmacist before using this medicine : - if the following applies to you : - heart problems - epilepsy - thyroid gland problems ( thyrotoxicosis ) - diabetes if you have not responded to treatment with on brez breeezhaler , tell
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 150 microgram capsule twice a day ( one 300 microgram ) day . your doctor will tell you how many capsules to take and how long you should continue the treatment . you should use your inhaler at least 24 hours after you last used it . onbrez breezhaler is supplied as an inhaler and capsules ( in blisters ) containing the medicine are also available as inhalation powder . the onbreez breez inhaler inhaler contains the medicine and is
what onbrez breezhaler contains - each onbrex breez inhaler 150 mg capsule contains 150 mg indacaterol . - the other ingredients are indacataterol maleate , lactose and the capsule is made of gelatin . - eachonbrez bronzhalER 300 mg capsule contain 300 mg indiacaterol , indacatriol maleates , lactos and the capsules are made of capsule - derived gelatin . what onbreez breezeler looks like and contents of the pack onbrezy breezer 150mg hard capsules are white to off - white capsules with "
clopidogrel hcs contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidineogrel clcs is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombization , which can lead to atherotrombotic events (
do not take clopidogrel hcs - if you are allergic to clopidineogrel or any of the other ingredients of this medicine ( listed in section 6 ). - if your bleeding is currently being treated with a stomach ulcer or bleeding within the brain . - if severe liver disease is a possibility . if any of these apply to you , tell your doctor before taking clopridogrel ccs . warnings and precautions take special care with clopidiogrel hexcs if any part of your body is at risk of bleeding ( such as - a medical condition that puts you at risk for internal bleeding (
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl hcs ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel hcs contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopide ( as hydrochloride ). the other ingredients are ( see section 2 ' clopidaogrel hexamethylene contains hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenatedcastor oil in the tablet core ; film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172
feciderocol is an antibiotic medicine that belongs to a group of antibiotics called " cephalosporins ". antibiotics are used to fight bacteria that cause infections . fetcroja is used to treat infections caused by bacteria that you have not previously treated with other antibiotics .
do not use fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using fetcroj if you have ever had a severe allergic reaction to certain antibiotics ( such as penicillins or carbapenems ). if this happens , tell your doctor straight away . if you experience severe skin peeling or swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing , tell the
this medicine is given to you by a doctor or nurse as an infusion ( a drip ) into a vein . it usually takes about 3 to 2 weeks . your doctor will decide how long fetcroja treatment will last . your dose will be decided by your doctor . your response to the infusion will be recorded on the patient alert card . it is very important that you tell your doctor or hospital pharmacist if you are having any pain during or after the fetcrora infusion . it may take up to 3 weeks for your doctor to decide how much fetcroJA you need . if you have kidney problems tell your healthcare professional if you
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : severe allergic reaction : sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions , difficulty swallowing or breathing . this reaction may lead to diarrhoea , stools , blood or mucus . treatment may be stopped or medicines may slow bowel movement . other side effects if you get any of these side effects : very common ( may affect more than 1 in 10 people ): feeling
what fetcroja contains the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg cefirocol . the other ingredients are sucrose , sodium chloride and sodium hydroxide . what fetcroJA looks like and contents of the pack fetcrojoe is a white to off - white powder for solution for infusion . it is supplied in packs containing 10 vials .
depocyte is used to treat adults with lymphomatous meningitis . lymphomathous menenitis is a condition in which tumour cells accumulate in the membranes of the brain and spinal cord . depocyte is prepared from lymphoma tumour cell material .
do not take depocyte - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking depocyte . - if your child has a meningeal infection . - severe neurological side effects have been reported with depocyte , with symptoms affecting the nervous system such as convulsions , pain , numbness , tingling , blindness and visual disturbances . if your children experiences any of these symptoms , stop taking depocytes and contact your doctor immediately . - tell your doctor if your newborn has any dexam
before starting treatment with depocyte , your doctor will decide the dose you need . if you have cancer , your surgeon will decide on the correct dose . depocyte is prepared from the lumber sac . depocytes is given as injections of 1 to 5 micrograms of dexamethasone in 5 ml . each depocyte dose will be monitored by your doctor to detect any side effects . the recommended dose of depocyte depends on the body surface area ( temperature ) 22 to 30 . before withdrawing depocyte from the vial , you should take proper precautions against the effects of a cytotoxic drug . proper handling technique is used
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often during your treatment . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) very common : affects 1 or 10 users of 10 , very common in children very rare ( affects less than 1 users in 10 , not known ): frequency cannot be estimated from the available data very common adverse events in patients treated with depocyte when depocyte is administered in combination with other chem
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . the exp date refers to the last day of that month . depocyte should be stored in a refrigerator ( 2 - 8 ). do not freeze . depocytes should be used within 4 hours after preparation . do this to protect from light . do do not shake depocyte vigorously as this medicine may cause severe discolouration , a changed appearance and a defective container . depecoly contains cytarabine .
what depocyte contains the active substance is cytarabine . one ml of suspension contains 10 mg cytarabeine . each 5 ml vial contains 50 mg cytabine ( as besilate ). the other ingredients are cholesterol , triolein , dioleoylphosphatidylcholine , dipalmitoylophosphatideglycerol , sodium chloride and water for injections . what depocyte looks like and contents of the pack depocyte is a solution for injection . it is supplied as a 5 ml glass vial containing a single injection . depocyte can be divided into two
what bemrist breezhaler is bemist breez inhaler contains two active substances called indacaterol and mometasone furoate . indacatersol belongs to a group of medicines called bronchodilators . it relaxes the muscles in the small airways in the lungs , making it easier for air to get in and out of the lungs . mometsone fruate belongs to the group of medicine called corticosteroids . it is used to treat asthma in adults . corticostromes reduce the swelling and irritation ( inflammation ) in the smaller airways and
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). - if any of these apply to you , tell your doctor before using bemist breez inhaler . warnings and precautions talk to your doctor or pharmacist before using this medicine if you : - have heart problems - have an irregular or fast heartbeat - have thyroid gland problems - had diabetes , high blood sugar , seizures - have a low level of potassium in your blood - have severe liver problems - or have tuberculosis
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules should be used every day . you should use the medicine every day , at the same time of the day . this will help to control your asthma and reduce your symptoms . how to use bemist breez inhaler bemrid breezhhaler is for inhalation use only . you can use be mrist breezezhalzer with or without food . how much to use use an inhaler and capsules . the medicine is for oral use .
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious . tell your doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives . allergic reaction uncommon ( may effect up to 1 in 100 people ): swelling of either the tongue or lips , face or throat ( angioedema ). other side effects other sideeffects include the following side effects : very commonly ( may affects more than1 in 10 users ):
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original blister in order to protect from light . do away with the capsules after first opening . do this if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ) and mometasone furoate . bemist breez inhaler 125 micrograms / 62 . 5 microgram inhaled in a single inhalation each day contains 173 microgram indacate ( asacetate ) 150 microgram of indacatedol ( corresponding to 80 microgram mometsone furuate ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 125 microgig indacates / 62. 5 micros mometa furo
zyllt contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). zyllt is taken to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). zllt is also taken to reduce the risk of
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking zylltt . warnings and precautions talk to your doctor or pharmacist before taking any of your zyllts : if you think you may be at increased risk of bleeding if you : have a risk of internal bleeding such a stomach ache or a blood
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of zllt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended daily
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). the other ingredients are : tablet core : lactose ( see section 2 under ' zyllts contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose ( e464 ), titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in the film - coating . what zyllT
lamivudine teva contains the active substance lamivudin . lamivudaine tevas is used to treat long term ( chronic ) hepatitis b infection in adults . lamibudineteva is an antiviral medicine that works by stopping the hepatitis b virus from multiplying . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver . long term (" chronic " infection can lead to liver damage . lamivaludine eva reduces the amount of hepatitis b in your body , and so causes a reduction in liver damage
do not take lamivudine teva - if you are allergic to lamivuda or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 lamivuvine tevas , like other similar medicines , can cause serious side effects , including liver disease , hepatitis c . if you become overweight , your doctor may need to change your dose . your doctor will do blood tests before you start your medication . see section 4 for more information . warnings and risks talk to your doctor before taking lamivu teva if your hepatitis is getting worse . before you take lamvudine , your physician
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage your doctor lamivudine teva is used to treat your hepatitis b infection . it is important that you take the medicine every day until your infection is gone . it does not matter whether you take it every day or every night . your doctor will tell you how long you should continue to take lamivuine teeva . if you have the impression that lamivuda teva does not work well enough , talk to your doctor . if your kidneys are not working well enough you may take lam
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva in patients with other conditions linked to hepatitis b . the most serious side effects reported during therapy with lamvudine are : very common side effects that have been observed during lamivudaine clinical trials : tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort , pain , nausea , vomiting , diarrhoea , increases in liver enzymes . these may be signs that the liver is not working properly . if these effects occur , they should be reported to your doctor
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . lamivudine teva should be used immediately after first opening . do this if you notice that the tablets are damaged or if there are particles in them . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamivuda . each film - coated tablet contains 100 mg of lamivu . - the other ingredients are microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ), iron oxide red ( e 172 ). what lamivUDine teeva looks like and contents of the pack orange , biconvex film - coat : 32 lamivundine tevas is supplied
nespo ( an anti - anaemic ) is used to treat your anaemia . anaemia occurs when your blood does not contain enough red blood cells . the symptoms include fatigue , weakness and shortness of breath . it is usually caused by the lack of the natural hormone erythropoietin . erythroietin works by blocking the growth of the kidneys . this causes your bone marrow to produce more red bloodcells . darbepoetin alfa is used for treating chronic renal failure in adults . symptomatic anaemia is caused by chronic renal fail . kidney failure is caused when kidney failure occurs because
do not use nespo : if you have high blood pressure or are taking other medicines that are allergic to nesco ( darbepoetin alfa ) or r - huepo . if you suffer from high bloodpressure and are taking medicines to treat sickle cell anaemia . if your condition is causing epileptic fits ( seizures ). if you are suffering from convulsions ( fits ). if your doctor has told you that you have liver disease . if any of the above applies to you , do not use drugs to treat anaemia and talk to your doctor . if the patient has an allergy to latex
your doctor will carry out blood tests before you are given nespo to check your haemoglobin level . the usual starting dose is 10 mg . your doctor will then increase your dose to a haemogl level of 10 mg every 10 to 12 hours . the pre - filled syringe is for injection into a vein . if you have chronic renal failure , your doctor may give you a single injection under the skin or into a veins ( intravenous ). your doctor or nurse will check your anaemia regularly . the dose of nespos given will depend on your body weight . the recommended dose is 0 . 75 mg / kg
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported with nespos : 471 to 10 to 100 patients with high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon to less than 1 in 100 patients blood clots ( thrombosis ) pain in the area injected rash , redness and / or the skin rare to lessthan 1 in 10 , 000 patients serious allergic reactions sudden life - threatening allergic reactions ( anaphylaxis ) swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep nespos in the original package in order to protect from light . after first opening of your syringe , you may take it out of its refrigerator and keep it at room temperature ( not above 30 ) for no longer than 7 days . do this at the end of this 7 - day period . do away with n
what nespo contains the active substance is darbepoetin alfa . each ml of solution for injection is a pre - filled syringe containing 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 micrograms of the active substances darbiepoetein ala . the other ingredients of nespos are sodium phosphate monobasic , sodium phosphate dibasic ( e470b ), sodium chloride , polysorbate 80 and water for injections . what nespol looks like and contents of the pack n
macugen is a solution for the treatment of macular degeneration in adults . this medicine prevents abnormal formation of new blood vessels in the eye . macugen is used for thetreatment of adults with macular dementia . in this disease , vision loss occurs due to damage to a part of the retina called the macula . macula is the thin layer at the back of the eye called the retina . the macular is the layer that lines the front part of your eye . the thickness of the macul is not known , but it can be estimated from the available data from the eye : amd . if abnormal blood vessels grow in
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in your eye . warnings and precautions talk to your doctor or pharmacist before using macugen . if you think you have or have ever had an infection or bleeding in the eye , stop macugen injection and contact your doctor immediately . if any of these occur , tell your doctor straight away . if the following symptoms occur , contact your ophthalmologist immediately : eye pain or increased discomfort worsening eye redness blurred or decreased vision increased sensitivity to light
mrcud injections are given by a doctor or nurse . macugen is given as a single injection into the eye ( intraocular pressure ). it is given every 6 to 9 weeks . the injection will be given into the vitreous part of the eye . your doctor will decide how much macugen you need and how often you need to be treated . your eye doctor will tell you how much medicine you need . macug must be used in combination with antibiotic eye drops . your eyes will be treated with some local anaesthetic ( numbing medicine ) to reduce any pain you may have after the injection . if you are allergic to
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects is not known . an infection in the internal portion of the eye has been reported during macugen treatment . the symptoms described in section 2 . you should contact your doctor immediately if you experience any of these symptoms . other side effects very common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this to protect from light . do away with the medicine after first opening . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaptenib in 90 ml of solution . - the other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection is a single dose pack supplied in a pouch . each pack contains a pre -filled syringe of 0
palifermin belongs to a group of medicines called escherichia coli . palifermin works by reducing the number of epithelial cells in the mouth and digestive tract and by blocking their growth in the tissues below the skin . palififermin is used to treat oral mucositis ( soreness , dryness and inflammation of the mouth ), a common side effect that occurs during treatments for your blood cancer . if your bloodcancer is not treated with chemotherapy , radiotherapy or autologoushematopoietic stem cell transplantation ( which reduces the number or number of blood cells ) it may be more likely that you
do not use kepivance if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). children and adolescents do not give this medicine to children and teenagers under 18 years of age . other medicines and kepipivance tell your doctor or pharmacist if you have recently taken or might take any other medicines . kepivalance may be taken with heparin . if you recently taken heparrin , tell your physician . pregnancy and breast - feeding kepvelance is not recommended if you plan to become pregnant . if
how much kepivance is given your doctor will decide how much kepacivance you will receive . your doctor or nurse will decide the dose you will need . your dose will depend on your condition and your general condition of cancer treatment . the usual dose of kepovance is 60 mg . your first dose of the new treatment will be given to you by your doctor . the recommended dose of your first treatment of kepacovance will be one kilogram ( kg ) given as an intravenous injection into a vein . how often will you be given kepivanance ? kepvelance is usually given three
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ): side effects include skin rash , itching , redness ( pruritus and erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth , tongue , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , decrease in lipase and amylase levels , and in levels of digestive enzymes in the blood . most of these effects occur
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kepivismance looks like and contents of the pack kepiverance is a white powder for concentrate for solution for injection . it is supplied in a pack containing 6 vials .
cinacalcet accordpharma contains the active ingredient cinacalcitet which reduces the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck , which are connected to the thyroid gland . cinaconalcate accordphara is used in adults with secondary hyperparathyroidism ( secondary kidney disease ) who are not on dialysis because they cannot take waste products to reduce the amount of calcium in the bloodstream ( hypercalcaemia ). parathyrotroid cancer reduces the amount and
do not take cinacalcet accordpharma - if you are allergic to cinacealcate or any of the other ingredients of this medicine ( listed in section 6 ). - if there are low levels of calcium in your blood . your doctor will check your blood calcium levels regularly while you are taking cinocalcut accordpha . warnings and precautions talk to your doctor or pharmacist before taking cincacal cet accordphiarma : - if any of these apply to you , tell your doctor before taking this medicine . - if : you have ever had seizures ( fits ). convuls
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cinacalcet accordpharma should be taken orally with or without food . cinnacalcitpharma must be taken twice a day , once in the morning and once inthe evening . the tablets should be swallowed whole with some water . your doctor will take regular blood samples during treatment to monitor the progress of secondary hyperparathyroidism . the usual dose of cinacealcordpharma is 30 mg once a day (
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : numbness or tingling around the mouth , muscle aches , cramps or seizures ( these may be signs that your calcium levels are too low ). hypocalcaemia ( swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . if you notice any of these side effects : very common : may affect less than 1in 10 people : dizziness
what cinacalcet accordpharma contains - the active substance is cinacealcep . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinaconalcip ( as hydrochloride ). - the other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ), iron oxide yellow ( e172 ). what cinacyalcel accordpharmaceutical looks like and contents of the pack cin
jentadueto contains two active substances called linagliptin and metformin . linaglptin belongs to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) metformins and biguanides . they work together to lower blood sugar levels in adult patients with a type of diabetes called ' type 2 diabetes mellitus '. this medicine works by reducing the amount of insulin produced by the body . this medicine can be used alone or with certain other medicines used to treat diabetes ( such as sulphonylureas or empagliflozin ) or
do not take jentadueto : - if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have severely reduced kidney function . - if any of these apply to you , tell your doctor before taking jentadoueto . warnings and precautions talk to your doctor or pharmacist before taking this medicine : - patients with severely reduced kidneys . - patients suffering from uncontrolled diabetes with severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto should be taken with or without food . if you currently take metformin or individual tablets containing linagliptin or metformina , do not take this medication and take your next dose at the usual time . if this medicine is not suitable for you , or you have an upset stomach , take the dose recommended by your doctor . the recommended dose is 5 mg linaglptin and 2 , 000 mg metformine hydrochloride twice a day . if your doctor determines
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms may be serious and require immediate medical attention . stop taking jentadueto and see a doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ) trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion . hypoglycemia is a very rare ( may affect up to 1 in 10 , 000 people ) but very serious side effect . jentodueto plus sulphonylurea may cause lactic acidosis ( coma ).
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . blister : store in the original package in order to protect from moisture . do this medicine if you notice any visible sign of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . each jentadinueto 2 . 5 mg / 850 mg film - coated tablet contains 2 . 25 mg linaglioptin and 850 mg metformina hydrochlorides . - each jentinaduet 2 .5 mg / 1 , 000 mg film film - coating contains 2. 5 mg linagoptin and 1 , 500 mg metin hydroxychloride - the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal
edurant contains the active substance rilpivirine . edurant is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children aged 12 years and older who are already taking hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). edurants is used in combination with hiv medications to treat adults and adolescents aged 12 and older infected with h hiv . edhurant is not intended to be used alone . your doctor will discuss with you whether you should be given hiv medicine together with edurent . medicines should not
do not take edurant : if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking edurants if you : are taking any of any of : the following medicines : carbamazepine , oxcarbazepine ( e . g . phenobarbital ), phenytoin ( medicines used to treat epilepsy and seizures ) rifampicin , rifapentine ( medicines to treat some bacterial infections such as tuberculosis ) omeprazole , esomepraz
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents ( aged 18 years and over ) edurant is not recommended for use in children and adolescents under the age of 18 years . edurants contains : 1 . rifabutin ( a medicine used to treat some bacterial infections ) eduant contains rifabeutin . if you take more edurent than you should if you accidentally take too many tablets , contact your doctor immediately . 2 . taking an anticoagulant ( a medicines used to prevent diseases ).
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : headache , nausea , difficulty falling asleep , insomnia , dizziness , or changes in your routine liver tests ( transaminase ), increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your body ( triglycerides , lipase , bilirub
what edurant contains the active substance is rilpivirine . each tablet contains rilpaline hydrochloride . each film - coated tablet of edurants contains rrilpiviraine hydro chloride equivalent to 25 mg rilpanirine per tablet . the other ingredients are : tablet core : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . tablet coating : lactate monohydrate and hypromellose 2910 ( e464 ). printing ink :
avandamet tablets are two different medicines , rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes in adults . people with type 2abetes either don ' t make enough insulin to control their blood sugar levels or don 'T respond normally to insulin . rosigllitazione and met formin work together by making the insulin they make easier for you to eat . this helps your body to increase the blood sugar . avandamel is also used as a sulphonylurea ( a type of medicine used to help control diabetes ).
follow all your doctor ' s instructions carefully , even if they differ from the general information contained in this leaflet . check with your doctor or pharmacist if you are not sure . your doctor may need to change your dose of avandamet . if you : - are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of avANDamet ( listed in section 6 ) - have had a heart attack or severe angina - have heart failure or have had heart failure in the past - have severe breathing difficulties - have liver disease - have diabetic ketoacidosis
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is 2 mg rosiglitazone ( equivalent to 1000 mg metformin ). this dose is usually taken once a day , usually at the beginning of the day ( 1 to 8 hours apart ). the maximum dose is 4 mg rosciglitrazone ( corresponding to 1000mg metformina ). thisdose is usually given once a morning , usually in the evening , at the end of the 1 to 9 hour period . your doctor may increase
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions to avandamanet may include raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), which may cause difficulty in breathing collapse . if you get any of these symptoms , stop taking avandandamnet and contact your doctor straightaway . lactic acidosis ( build up of lactic acids in the blood ( lacticacidosis ) is a common side effect of metformin in patients with severe kidney disease . symptoms of lact acidosis include rapid breathing ,
keep this medicine out of the sight and reach of children . do not use avandamet after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this if you notice any change in the appearance of the tablets . do away with the blister after first opening . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what avandamet contains the active substances are rosiglitazone and metformin . avandamanet tablets come in different strengths . each tablet contains 1 mg rosigllitazon ( 500 mg metforma ), 2 mg roSiglitasone ( 500mg metforman ), and 2 mg metsimlitazione ( 1000 mg met formin ). each tablet also contains 4 mg ro siglitazaone ( 1000mg met formformin ). the other ingredients are sodium starch glycollate , hypromellose , microcrystalline cellulose , lactose monohydrate ,
clopidogrel mylan contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidiogrelmylan is taken to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombization , which can lead to atherotrombotic events ( such as
do not take clopidogrel mylan 31 if you are allergic to clopidineogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelmylan . warnings and precautions talk to your doctor or pharmacist before taking any of your medicines : if you think any of this applies to you ( or you are not sure ), talk to the doctor or
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl mylan ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel mylan contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 " clopideogrel Mylan contains hydrogenatedcastor oil "), polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc , macrogl 3000
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease with low platelet count ( thrombolocytopenia ). it is used as a medical procedure to reduce the risk of bleeding . it works by reducing the number of platelets . platelets are blood cells that are needed in the blood to clot and prevent bleeding .
do not use doptelet if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using doptelelet if : you have ever had blood clots in the veins or arteries . this is because dopteel may increase the risk of blood cl clots forming in the future . you have cancer . you are taking the contraceptive birth control pill or hormone replacement therapy . you recently had surgery or are seriously injured . you weigh less than 23 kg . you suffer from advanced chronic liver disease . children and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose for your procedure is one 5 mg tablet once a day . your doctor may increase your dose to one 8 mg tablet twice a day depending on your response to doptelet . your dose may be adjusted by your doctor if necessary . the dose of dopteol to be taken orally once a morning is 20 mg , 40 mg or 60 mg once a week . your physician may increase the dose to 5 mg once daily depending on the response to your platelet counts . if you take more dop
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( may effect up to 1 in 100 people ): low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain , swelling bone pain , muscle aches and fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains avatormboprag maleate equivalent to 20 mg avatrambopg . - the other ingredients are lactose monohydrate ( see section 2 ), microcrystalline cellulose , crospovidone type b [ e ], silica , colloidal anhydrous , magnesium stearate . - film - coating : vinyl alcohol , talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what dopteel looks like and contents of
rapiscan belongs to a group of medicines called ' coronary vasodilators '. it works by blocking the flow of blood through the heart arteries , thus increasing heart rate and helping to relax the muscles of the heart . rapiscan is used for a type of heart scan called ' myocardial perfusion imaging '. the scan uses a radioactive substance called a ' radiopharmaceutical '. these images are taken using the muscles in the heart using a readmill . a scan is given to help your doctor decide whether a small amount of radiopharma is being injected into your body ( intravenously ) or into a vein ( hand
do not take rapiscan if you have slow heart rate , high degree heart block , sinus node disease ( when a pacemaker is not working properly ), chest pain ( unstable angina ), or treatment for low blood pressure ( hypotension ) or heart failure if you are allergic to regadenoson or any of the other ingredients of rapiscin ( listed in section 6 ). warnings and precautions talk to your doctor before taking rapiscen if any of these apply to you : if you : have a recent serious heart problem , including a heart attack have abnormal heart rhythms ( a heart rhythm where the heartbeat is very fast or
rapiscan will be given to you by a doctor or nurse who is experienced in the treatment of your heart and blood pressure . it will be injected into a vein ( intravenously ) over a period of approximately 400 minutes . the recommended dose is a 5 ml solution the injection will be administered over a minimum of 5 to 10 minutes depending on your weight . the dose may be given as an injection of sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection ( intravenous ) over approximately 5 minutes . if you are given a radioactive substance ( radiopharmaceutical ), your doctor will decide how much rapiscan
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects are usually mild to moderate and usually disappear after the rapiscin injection has been given at least 30 minutes after any treatment . tell your doctor immediately if you notice any of the following side effects : sudden stopping of the heart , which may be a sign of damage to the heart ( heart block ), a disorder of theheart ' s electrical signal , rapid heart beat low blood pressure , fainting , mini strokes , weakness of the face and inability to speak . rapiscans may cause a stroke ( cerebrovascular accident
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . viag is a treatment for adult men with erectile dysfunction or impotence . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking medicines called nitrates , which could lead to a dangerous fall in your blood pressure . if you have been taking any of these medicines for angina pectoris ( often called " chest pain "), tell your doctor . - if the medicines you are using are nitric oxide donors such as amyl nitrite , which may lead to an increased risk of a dangerous drop in yourblood pressure . - when you are being
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 50 mg . you should take viagra twice a day , once in the morning and once inthe evening . viagra film - coated tablets are also available as viagra orodispersible tablets . you can take viagagra with or without food . swallow the tablet whole with a glass of water . do not crush or chew the tablet . taking viagra with food will help you to get an erection . if you feel sexually stimulated while taking viaga , you should continue to
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with viagra are usually mild to moderate . if you experience any of the following side effects while taking viagra : an allergic reaction ( may affect up to 1 in 100 people ): symptoms include sudden wheeziness , difficulty in breathing , dizziness , swelling of the eyelids , face , lips or throat , chest pains and may lead to a semi - sitting position . you may need to take nitrates to control your chest pain . prolonged and sometimes painful erections ( may occur rarely , may affect upto 1 in 1
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildenedafil ( as the citrate salt ). - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and are engraved with the
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamine receptors in the brain . stimulation of the dopamine receptors triggers nerve impulses in thebrain that help to control body movements . sifrol is used to : treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa . treat parkinson ', s disease is characterised by the symptoms associated with moderate to severe primary restless legs syndrome .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sifol : - if your doctor has told you that you have any medical conditions that could be associated with symptoms of kidney disease . - if any of these apply to you , tell your doctor straight away . - hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are visual . - dyskinesia ( abnormal , uncontrolled movements of the limbs ). in patients with advanced parkinson ' s disease ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for parkinson ' s disease is 3 tablets taken once a day . during the first week , take 1 tablet of sufrol 0 . 088 mg ( equivalent to 0 . 264 mg / m2 ). after 1 week , your doctor may increase your dose of the sifol 0 .088 mg to 0. 264 mg once a daily . this may be until your symptoms improve . your doctor will tell you how many tablets to take . the usual starting dose is
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common ( may affect more than 1 in 10 people ) common ( likely to affect up to 1 in 100 people ) uncommon ( likely 1 in 1 , 000 people ) rare ( likelyto affect up in 1 to 10 , 000 patients ) not known ( frequency cannot be estimated from the available data ) if you have parkinson ' s disease , tell your doctor straight away if you notice any of the following side effects : - dyskinesia ( abnormal , uncontrolled movements of the limbs
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 . 18 mg , or 0 . 35 mg , of which 0 . 7 mg pramipxole is equivalent to 0 . 125 mg , , 0. 25 mg , and 0 . 5 mg of pramidexole dihydrochloride monohydrate . the other ingredients are mannitol , maize starch , anhydrous colloidal silica , povidone k 25 , magnesium stearate . what sifroll looks like and contents of the pack sifol 0 .
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . it is used to prevent allergic conditions from occurring in the eye , and to reduce the allergic reaction . allergic conjjunctivis may occur with some materials ( allergens ) that may be present in the body . allergic reactions may include itching , redness and swelling on the surface of your eye . if you notice any of these , tell your doctor immediately . do not try to cover any areas of the surface with any other medicine . do tell your eye doctor if you feel worse .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is more than 3 years old . warnings and precautions talk to your doctor or pharmacist before using emadadine . children and adolescents do not give this medicine to children under the age of 3 years because benzalkonium chloride has been shown to affect the growth of the baby . emadin should not be used in children under 6 years old , as it has not been studied in clinical trials . other medicines and emadines tell your doctor if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use adults use one drop twice a day ( morning and evening ). use in children and adolescents use in adults and adolescents ( 3 years of age and older ) use in the same eye as adults . use in infants and children ( 12 years of old and older ), use in adolescents ( 12 to 17 years of years ) use the emadine bottle once a day . wash your hands after using it . do not remove the bottle . the cap must not be broken . remove cap and snap collar
like all medicines , this medicine can cause side effects , although not everybody gets them . the effects may be more serious when the drops are used . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye and eye redness . uncommon side effects : ( may effect up to1 in 100 people )effects in the back of the eye ( corneal disorder ): abnormal eye sensation , increased tear production , tired eyes , eye irritation , blurred vision , cornealing staining , dry eye . general side effects including headache , difficulty sleeping , sinus headache , bad taste
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect from infections .
what emadine contains - the active substance is emadastine 0 . 5 mg / ml . - the other ingredients are difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid , sodium hydroxide ( for acidity levels and ph levels ). what emadrine looks like and contents of the pack emadadine is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop -tainer ) bottle with a screw cap . not all pack sizes may be marketed .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetiratam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy , to treat a certain form of epilepsy . epilepsy is a condition where the patients have repeated fits ( seizures ). levevetirateam is used for the epilepsy form in which the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the body ( partial onset seizure with or without secondary generalisation ). leveriracetamm has
do not take levetiracetam actavis - if you are allergic to leveturacetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking levetiraacetamactavis - tell your doctor if you have kidney problems - tell the doctor if any slow down in the growth or puberty has been observed . - if your child is taking anti - epileptics , levetiaracetam actsavis may cause thoughts of harming or killing themselves . tell your physician if your son has any symptoms of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of levetiracetam actavis twice a day , once in the morning and once inthe evening . monotherapy dose in adults and adolescents from 16 years of age and older : one tablet once a day ( 1 , 000 mg ) for 3 weeks . your doctor will tell you the dose of leveriraceta actavis to take . the dose may be increased by 2 mg to 1 ,000 mg before therapy dose in children and adolescents ( 12 to 17 years
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor or the nearest emergency department immediately if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ). flu - like symptoms , with a rash on the face or an extended rash with a high temperature . increased levels of liver enzymes seen in blood tests . decrease in a type of white blood cell 56 ( eosinophilia
what levetiracetam actavis contains the active substance is levetiraacetam . levetaracetamactavis 250 mg : each film - coated tablet contains 250 mg of levetoracetam ( as levetrimacetam ). leveturacetam actingavis 500 mg : one film - coating contains 500 mg of the active ingredient levetiroacetam , as leveriracetamine actavis 750 mg : the active substances are levetieracetam and water for injections . levervetiratam activ 1 , 000 mg : every film - treated tablet contains 1 , 500 mg
celemetha contains the active substance umeclidinium bromide which belongs to a group of medicines called bronchodilators . incruse ellipta is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways in your lungs become damaged and you develop breathing difficulties . this causes difficulties in breathing due to tightening of the muscles around the airway . this medicine prevents tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to control your breathing difficulties and helps to
do not use incruse ellipta 27 if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have asthma . incruruse ellipta should not be used in patients with asthma . if you suffer from heart problems . if your doctor has told you that you have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , a blockage in your bladder ). if you know that you suffer severe liver problems . immediate breathing difficulties
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . use incruse ellipta every day . if you use more incruce ellipta than you should if you have used more inculse elliptas than you have been told to , contact your doctor immediately . symptoms of using too much of this medicine may include a sudden attack of breathlessness and wheezing . if this attack occurs , you may need to use
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta , stop taking this medicine and seek medical help immediately : itching skin rash , hives and redness 29 common side effects ( may effect up to1 in 10 people ): faster heart beat painful and frequent urination these may be signs of a urinary tract infection . common cold infection of nose , throat cough , feeling of pressure , pain in the cheeks and forehead these may indicate inflammation of the sin
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the inhaler after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the inhalcer in the sealed tray in order to protect from light . after first opening of the tray , the inhal should be used within 6 months . once the inhaluer has been opened , use the inhal inhaler within 30 . do away with the inhalER . do this once you have opened the tray
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose of 55 micrograms umecylidiniol ( equivalent to 65 microgram ) umechloridinIUM bromides . - the other ingredients are lactose monohydrate ( see section 2 under ' incrusemipta contains lactose '), magnesium stearate . what incrusey ellipta looks like and contents of the pack incrute ellipta is an inhalation powder . the ellipta inhaler is supplied in a grey plastic body , a
what nucala is nucal contains the active substance mepolizumab , a monoclonal antibody . this is a type of protein that recognises and attaches to specific proteins in the body . what nucalan is used for nucalya is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils ( a type white blood cell that helps the lungs breathe ) in the form of eosinsophilic asthma . in asthma nucalo is used in adults to prevent asthma attacks and to reduce the use of medicines called high
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have worsening asthma 58 if you experience asthma - related side effects , your doctor may decide to stop nucal treatment . if your asthma is not controlled with nucalan , your asthma may get worse . if you think you may be allergic , talk to a doctor or go to a hospital straight away . injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic
nucala is given under the skin ( subcutaneous injection ). adults and adolescents 12 years of age and older : the recommended dose is 100 mg once a week . the recommended starting dose is 1 mg once daily . you may inject nucala with or without food . your doctor will decide how many injections you need . your physician will decide the dose that is right for you . always use the pre - filled pen exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much nucal to use your doctor may decide to increase the dose of nucale or stop
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur ( may affect up to 1 in 10 people ) at the site of the injection . sometimes symptoms can be severe . symptoms can include chest tightness , cough , difficulty breathing fainting dizziness feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you have a reaction or if you experience a similar reaction to nucal . other
keep out of the reach and sight of children . do not use nucala after the expiry date which is stated on the carton and on the pre - filled pen after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre filled pen in the outer carton in order to protect from light . after first opening , use within 7 days . do away with the pre- filled pen once you have removed it from the refrigerator and it must be used within 7 weeks . do throw away any medicines via wastewater or household waste . ask your
what nucala contains the active substance is mepolizumab . each 1 ml ampoule contains 100 mg of mepolzumab ( as besilate ). the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate and water for injections . what nucal looks like and contents of the pack nucale 1 mg is supplied as a pack containing 1 ampoules or a multipack containing 3 ampouls or 1 ampuele . not all pack sizes may be
what ninlaro is ninlar is a cancer medicine that contains the active substance ixazomib , a ' proteasome inhibitor '. what it is used for ninlara is used to treat a cancer of the bone marrow called multiple myeloma . ixezomib is used in cell survival to stop myelomas cells from growing because it affects a lot of proteins called proteasomes . what it does with ninlalo what it can do for people with multiple myelo ? ninlero is used when multiple myelinoma is first diagnosed . it is given in combination with lenalidomide
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ninlar if any of these apply to you . if you have any of those conditions , please tell your doctor . warnings and symptoms talk to the doctor or nurse before taking this medicine . if any are not treated , please contact your doctor , pharmacist or nurse . if the following apply to your child , please inform your doctor before taking the medicine . stop taking ninlonaro and see your doctor immediately if your
instructions for use and use of ninlaro must be given to you by a doctor experienced in the treatment of multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of ninflaro is lenalidomide ( a medicine that dissolves fat ) and dexamethasone ( an anti - inflammatory medicine ). the recommended starting dose of each dose of the combination of ninlio with lenalidomeide and dexmethasONE is 4 - week . you will take one dose of
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ) nose bleeds that can easily bruise nausea , vomiting , diarrhoea numbness , tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet (> peripheral oedema ) skin rash ( itchy , often on the surface of the body ). rare side effects these may affect up to 1 in 1 , 000 people : severe skin rashes , red to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and carton after exp . the exp date refers to the last day of that month . do store above 30 . store in the original package in order to protect from moisture . once the capsule has been opened , use this medicinal product immediately . do this medicine only if you notice any damage or signs of tampering to medicine packaging . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ninlaro contains the active substance of ninlar is ixazomib . each capsule contains 2 . 3 mg ixezomib and 3 . 3mg ixabomib citrate . the other ingredients are microcrystalline cellulose , magnesium stearate , talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ), shellac , propylene glycol , potassium hydroxide , black iron oxide . the printing ink contains : - the capsule content contains : ixar 3 mg / ixzomib ( 4 . 3 mill
do not use palforzia if you are allergic to peanuts or arachis hypogaea . warnings and precautions talk to your doctor or pharmacist before using palfiorzia . children and adolescents from 4 to 17 years of age should not receive treatment for peanut allergy because the medicine contains traces of peanut ( desensitisation ). palforszia is not intended to cause allergic reactions . palfORzia should not be used in children and young people with food allergies . talk to a doctor or nurse before using this medicine if you have any questions about how palforbzia works or why
do not take palforzia if you are allergic to peanut or soya if you have severe asthma if your asthma is getting worse or if you had a problem swallowing it is due to long term problems with your digestive system if you suffer from a severe mast cell disorder if you develop severe or life - threatening anaphylaxis within 60 days of starting treatment with palfiorzia . warnings and precautions talk to your doctor or pharmacist before taking palfurzia : if the symptoms of peanut allergy occur , stop taking pforzias and tell your doctor straight away . an allergic reaction may occur during
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . allergy if allergic reactions ( anaphylaxis ) occur , contact your doctor immediately . the recommended dose is 3 mg once daily . your doctor will decide on the dose you need to take . duration of treatment with palforzia initial doseescalation and up - dosing steps are described below . your physician will determine the dose that is appropriate for you . these treatment steps will be repeated every three weeks . the initial dose escalation and up dosing phases will be overseen by your doctor . how to
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with palforzia : severe allergic reactions if you have any of the following symptoms while taking palforbzia , stop taking the medicine and seek medical help immediately : trouble breathing , throat tightness , feeling offulness , trouble swallowing or speaking - changes in voice , dizziness or fainting severe stomach cramps , pain , vomiting , diarrhoea , severe flushing or itching of the skin palforsia may cause problems with the stomach and digestive system ( eosinophilic
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any hard lumps of powder in the vials . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what palforzia contains the active substance is palforbavir . each 0 . 5 mg / 1 mg / 10 mg / 20 mg oral powder in capsules are made up of microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palfiorzia 100 mg / 2 mg oralpowder in capsules with opening microcrycrystallrine cellulose ( e460 ), colloidal Anhydroussilica and and magnesium strearatepalforza 300 mg / 5 mg oral solution in sachet microcrystine celluloses ( e463 ), colloid anhyd
zerne belongs to a group of substances called benzodiazepine - related medicinal products . it contains hypnotic actions that help to sleep . zerene is used to treat sleeping problems in adults . it is used during treatment . it should be used during the first week after completing treatment . if you have problems sleeping , you should contact your doctor .
you should not be given zerene : hypersensitivity ( an allergy ) to zaleplon ( the active substance in zeren ) zerenea sleep apnoea syndrome ( when you sleep for short periods ) severe kidney or liver problems myasthenia gravis ( when your muscles become very weak , tired muscles , severe breathing or chest problems ) children and adolescents zerenes is not recommended for use in children and teenagers under 18 years of age . therefore , zerete should not ever be used in this age group . undesirable effects are not known . if you are given any medicine , tell your doctor
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day . if you have difficulty falling asleep , take your capsule and continue to take it at regular times . if your doctor tells you to stop taking zeren , you should talk to your doctor . if the dose is too low , you may be told to stop . if there is no response from 65 years of age or older , the dose may be reduced to 5 mg once daily . if mild to moderate liver problems are not well controlled , the recommended starting
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) very rare ( affects less than 1 users in 10 , 000 ). very rare : very rare , affects lessthan 1 user of 10 ,000 . not known ( frequency cannot be estimated from the available data ). very common : may
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are microcrystalline cellulose , pregelatinised starch , silicon dioxide ( e171 ), sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( t171 ). - the ingredients are gelatin , titanium dioxide , red iron oxide ( e172 ), yellow iron oxide , black iron oxide (< e172 ) and sodium laurel sulphacy ( e133 ), silicon dioxide . ( s - 13050 ). - printing ink : shellac ,
